+

WO2007069498A1 - Compound for electroluminescent device and method for producing same - Google Patents

Compound for electroluminescent device and method for producing same Download PDF

Info

Publication number
WO2007069498A1
WO2007069498A1 PCT/JP2006/324243 JP2006324243W WO2007069498A1 WO 2007069498 A1 WO2007069498 A1 WO 2007069498A1 JP 2006324243 W JP2006324243 W JP 2006324243W WO 2007069498 A1 WO2007069498 A1 WO 2007069498A1
Authority
WO
WIPO (PCT)
Prior art keywords
bis
amino
pyridine
group
amine
Prior art date
Application number
PCT/JP2006/324243
Other languages
French (fr)
Japanese (ja)
Inventor
Takaki Kanbara
Takakazu Yamamoto
Yasuhiko Shirota
Nobutaka Fujimoto
Yuichi Onoda
Original Assignee
Sumitomo Seika Chemicals Co., Ltd.
Tokyo Institute Of Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Seika Chemicals Co., Ltd., Tokyo Institute Of Technology filed Critical Sumitomo Seika Chemicals Co., Ltd.
Publication of WO2007069498A1 publication Critical patent/WO2007069498A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/631Amine compounds having at least two aryl rest on at least one amine-nitrogen atom, e.g. triphenylamine
    • H10K85/636Amine compounds having at least two aryl rest on at least one amine-nitrogen atom, e.g. triphenylamine comprising heteroaromatic hydrocarbons as substituents on the nitrogen atom
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/10OLEDs or polymer light-emitting diodes [PLED]
    • H10K50/14Carrier transporting layers

Definitions

  • the present invention relates to a low molecular weight organic compound useful as a charge transport material, a light emitting layer material, and a photosensitive part material such as a photoconductive imaging element in an electroluminescent (electral luminescence: EL) element, and a method for producing the same. .
  • low molecular weight organic compounds having a light-to-electron conversion function, especially amorphous films with high flexibility, have been suitably used.
  • These low molecular weight organic compounds include, for example, N, N, one diphenyl, one N, N, one bis (3-methylphenol), one, one, one biphenyl —4, 4, one diamine.
  • Non-Patent Document 1 As an amorphous film, for those amorphous films that are strong themselves, or those having poor film formability, a Noinder resin such as polycarbonate resin and the low molecular weight organic compound are dissolved in an organic solvent, An amorphous film obtained by coating and drying is used (see Non-Patent Document 2).
  • Non-Patent Document 1 Electronic Materials, December 2001, pp. 18-23 (2001)
  • Non-Patent Document 2 Appl. Phys. Lett., Vol. 61, p. 761 (1992)
  • the present invention aims to provide a low molecular weight organic compound that can form an amorphous film having photoelectron transformation and excellent heat resistance by itself, and a method for producing the same. Target.
  • the present invention relates to a low molecular weight organic compound and a method for producing the same as described below.
  • each of! ⁇ -Is independently a hydrogen atom, a hydroxyl group, a carboxyl group, a cyano group, a strong rubermoyl group, an alkyl group having 1 to 10 carbon atoms, or an alkanoyl having 1 to 10 carbon atoms.
  • V represents a nitrogen atom or carbon atom
  • two Ws simultaneously represent a nitrogen atom or carbon atom
  • V and W may be the same It is different and relates to a compound represented by
  • the compound of the present invention is preferably represented by the general formula (1)! ⁇ ⁇ Are all hydrogen atoms.
  • the present invention also provides a general formula ( ⁇ ):
  • R 1 represents a hydrogen atom, a hydroxyl group, a carboxyl group, a cyano group, a strong rubamoyl group, an alkyl group having 1 to 10 carbon atoms, or an alkanoyl group having 1 to 10 carbon atoms, and V represents nitrogen.
  • R 2 and R 3 are each independently a hydrogen atom, a hydroxyl group, a carboxyl group, a cyano group, a strong rubamoyl group, an alkyl group having 1 to 10 carbon atoms, or an alkyl group having 1 to 10 may be the same or different and W may be the same or different. W represents a nitrogen atom or a carbon atom.
  • General formula (I) characterized by reacting in the presence of a catalyst containing a compound and a base:
  • ⁇ ⁇ are each independently a hydrogen atom, a hydroxyl group, a carboxyl group, a cyano group, a strong rubermoyl group, an alkyl group having 1 to 10 carbon atoms, or an alkanoyl having 1 to 10 carbon atoms
  • V represents a nitrogen atom or carbon atom
  • Ws simultaneously represent a nitrogen atom or carbon atom
  • V and W may be the same It is different and relates to a method for producing a compound represented by
  • the compound of the present invention is a novel substance represented by the following general formula (I).
  • each of the scales 1 to! ⁇ Is independently a hydrogen atom, a hydroxyl group, a carboxy group, a cyan group, a strong rubamoyl group, or an alkyl group having 1 to C carbon atoms: Or an alkanoyl group having 1 to 10 carbon atoms, which may be the same or different!
  • V represents a nitrogen atom or a carbon atom
  • two Ws simultaneously represent a nitrogen atom or a carbon atom
  • V and W may be the same or different.
  • ⁇ ⁇ Are each independently a hydrogen atom, a hydroxyl group, a carboxyl group, a cyano group, a strong rubermoyl group, an alkyl group having 1 to 10 carbon atoms, or an alkanoyl having 1 to 10 carbon atoms) 1, 3-bis [di (pyridin-2-yl) amino] benzene compounds represented by the following formulas, which may be the same or different:
  • V is a nitrogen atom and W is a carbon atom (3):
  • ⁇ -Are each independently a hydrogen atom, a hydroxyl group, a carboxyl group, a cyano group, a strong rubamoyl group, an alkyl group having 1 to 10 carbon atoms, or an alkanoy having 1 to 10 carbon atoms. These groups may be the same or different.
  • 2,6-bis [(phenol) (pyridine-2-yl) amino] pyridine compound and
  • V and W are both carbon atoms.
  • Specific examples of the compound represented by the general formula (I) include, for example, as the general formula (1), 2, 6-bis [di (pyridine-1-yl) amino] pyridine, 2, 6-bis [di (4-methylpyridin-2-yl) amino] pyridine, 2,6-bis [di (5-methylpyridine-2-yl) amino] pyridine, 2,6-bis [di (6-Methylpyridine-1-yl) amino] pyridine, 2,6-bis [di (4-ethylpyridine-2-amino) pyridine], 2,6-bis [di (5-ethylpyridine-2-) Yl) amino] pyridine, 2, 6-bis [di (6-ethylpyridine-2-yl) amino] pyridin, 2,6-bis [di (4-n-propylpyridine-2-yl) amino] Pyridine, 2,6-bis [di (5-n-propylpyridine-2-yl) amino] pyridine, 2,6-bis [
  • 6-Neopentylviridine-2-yl) amino] pyridine 1,3bis [(4-Neopentylphenol) (5-Neopentylviridine-2-yl) amino] pyridine, 1,3bis [( 3—n—Hexylphenol) (4—n—Hexylpyridine—2-yl) amino] pyridine, 1,3bis [(3—n—hexylphenol) (6—n—hexyl) 1-yl) amino] pyridine
  • the compound of the present invention represented by the general formula (I) can be produced, for example, as follows. That is, the general formula ( ⁇ ):
  • R 1 represents a hydrogen atom, a hydroxyl group, a carboxyl group, a cyano group, a strong rubamoyl group, an alkyl group having 1 to 10 carbon atoms, or an alkanoyl group having 1 to 10 carbon atoms, and V represents nitrogen.
  • R 2 and R 3 are each independently a hydrogen atom, a hydroxyl group, a carboxyl group, a cyano group, a strong rubamoyl group, an alkyl group having 1 to 10 carbon atoms, or an alkyl group having 1 to 10 may be the same or different, and W may be the same or different. W represents a nitrogen atom or a carbon atom.
  • the target compound can be obtained by reacting in the presence of a catalyst containing the compound and a base.
  • examples of the halogen atom represented by X include a fluorine atom, a chlorine atom, a bromine atom, and an iodine atom.
  • V is a nitrogen atom.
  • 2, 6 dihalogenopyridine compound and in the case where V is a carbon atom, 1,3-dihalogenobenzene compound can be mentioned.
  • 2,6 dihalogenopyridine compounds include 2,6 difluoropyridin, 2,6 dicyclopyridine, 2,6 dibromopyridine, 2,6 jodopyridine, 2,6-dichloro-3 methylpyridine, 2 , 6 dichloro-4 methylpyridine, 2,6 dichloro-5 methylpyridine, 2,6 dichloro-3 ethylpyridine, 2,6 dichloro-4-ethylpyridine, 2,6 dichloro-5 ethylpyridine, 2,6 dichloro-3 isopropylpyridine, 2,6 dichloro-4 Isopropylpyridine, 2,6 dichloro-5 isopropylpyridine, 2,6 dichloro-1-3-n-propylpyridine, 2,6 dichloro-4-n-propinoleviridine, 2,6 dichloro-5-n-propinoleviridine, 2, 6 Dichloro-3—n-Butylpyridine, 2, 6 Dichloro-4 n-Butylpyridine, 2, 6 Dichloro-5
  • 1,3 dihalogenobenzene compounds include 1,3 difluorobenzene, 1,3 dichlorobenzene, 1,3 dibromobenzene, 1,3 jodobenzene, 1,3—dib-mouthed —Methylolebenzene, 1,3 Jib mouth mode 2 Ethenolebenzene, 1,3 Jib mouth mode 2—n—Hexinolebenzene, 1,3 Jib port mode 2—n—Octinolebenzene, 1, 3 —Jib port Mo 2— n-decylbenzene, 1, 3 dib-mouthed MO 4-methylbenzene, 1, 3 Jib-mouthed Mo 4-ethylenobenzene, 1, 3 Jib-mouthed Mo 4—n—hexynolebenzene, 1, 3 Jib mouth mode 4 n—octylbenzene, 1, 3 Jib port mode 4 n decylbenzene, 1, 3 Jib mode mode 5—Methinor
  • amine compound represented by the general formula (III) when W is a nitrogen atom, bis (pyridine-1-yl) amine, bis (4-methylpyridine 2-yl) amine, bis (5-methylpyrrolidine-2-yl) amine, bis (6-methylpyridine-2-yl) amine, bis (4-ethylpyridine-2-yl) amamine, bis (5- Ethylpyridine 2-yl) amine, bis (6-ethylpyridine-2-yl) amine, bis (4-n-propylpyridine-2-yl) amine, bis (5-n-propylpyridine-2-yl) amine Bis (6-n-propylpyridin-2-yl) amine, bis (4-isopropylpyridine-2-yl) amine, bis (5-isopropylpyridine-2-yl) amine, bis (6 —Isopropylpyridine-2-yl) amine, bis (4-n-butyl) Lysine
  • bis (pyridine-2-yl) amine and bis (5-methylpyridine 2-yl) amine are preferably used from the viewpoint of availability and economy.
  • specific examples of the amine compound represented by the general formula (III) include, when W is a carbon atom, (phenyl) (pyridine 2-yl) amine, (3 methylphenol) (4 Methylpyridine-2-yl) amine, (3-Methylphenol) (6-Methylpyridine-2-yl) amine, (4 Methylphenol) (5 Methylpyridine-2-yl) amine, (3 Ethylphenyl) (4 ethylpyridine 2-yl) amine, (3 ethylphenol) (6 ethylpyridine-2-yl) amine, (4 ethylphenyl) (5 ethylpyridine-2-yl) amamine, (3— n — Propylphenol) (4-n-propylpyridine-2-yl) amine, (3-n-n-prop
  • amine compounds used in the present invention can be obtained from commercially available products or appropriately synthesized. Any of the above may be used. As a method for synthesizing these amine compounds, for example,
  • the amount of the amine compound used is preferably 2.0 to 3.0 moles, more preferably 2.0 to 2.5 moles per mole of the dihalogeno monocyclic compound.
  • the amount of the amine compound used is less than 2.0 mol, the reaction is difficult to proceed and the reaction may be difficult to complete. Also, if the amount of amine compound used exceeds 3.0 moles, there is a risk that the effect will not be commensurate with the amount used and it will not be economical.
  • the palladium compound as a catalyst used in the reaction for obtaining the compound of the present invention is not particularly limited, but, for example, sodium hexalopalladium (IV) acid sodium tetrahydrate.
  • Tetravalent palladium compounds such as potassium hexapalladium (IV); palladium chloride ( ⁇ ), palladium bromide ( ⁇ ), palladium acetate ( ⁇ ), radium acetyl acetylacetonate (II), dichlorobis (benzonitrinore ) Palladium ( ⁇ ), dichlorobis (acetonitryl) palladium ( ⁇ ), dichlorobis (triphenylphosphine) palladium ( ⁇ ), dichlorobis (triolphosphine) palladium ( ⁇ ), dichlorotetraamminepalladium ( ⁇ ), di Divalent, such as black and white (Cycloocta 1, 5 Gen) palladium ( ⁇ ), palladium trifluoroacetate (II) Radium
  • a zero-valent palladium compound is preferable from the viewpoint of high reaction activity.
  • tris (dibenzylideneacetone) dipalladium (0) has the highest reaction activity and is preferably used.
  • These palladium compounds may be used alone or in combination of two or more.
  • the amount of the palladium compound used is preferably 0.0001 to 0.2 monole in terms of palladium conversion per mole of dino or oral genomonocyclic compound S, preferably 0.00002 to 0.05 monole. Something is better than power ⁇ . If the amount of the radium compound used is less than 0.0001 mol, the reaction may proceed. If the amount of noradium compound used exceeds 0.2 mol, There is a risk that it will not be economical because there is no effect corresponding to the amount used.
  • the phosphine compound used as the catalyst for the reaction for obtaining the compound of the present invention is not particularly limited.
  • 2, 2'-bis (diphenylphosphino) 1 1, 1, -binaphthyl, 1,1, -bis (diphenylphosphino) fecene N, N, -dimethyl — 1—
  • 2, 2 bis (diphosphosphino) ferrocer] 9, 9 dimethyl-4,5 —
  • Phosphinic compounds having chelating ability as bidentate ligands such as bis (diphenylphosphino) xanthene.
  • 2,2′-bis (diphenylphosphino) -1,1, -binaphthyl and 9,9 dimethyl-4,5bis (diphenylphosphino) xanthene are preferably used from the viewpoint of high reaction activity.
  • These phosphine compounds can be used alone or in combination of two or more.
  • the amount of the phosphine compound used is preferably 0.1 to 10 moles, more preferably 0.5 to 5 moles per mole of the palladium compound. If the amount of the phosphine compound used is less than 0.1 mol, the reaction may proceed. Also, if the amount of phosphine compound used exceeds 10 moles, there is a risk that the effect will not be commensurate with the amount used and that it will not be economical.
  • the palladium compound and the phosphine compound may be individually added to the reaction system, or those prepared in the form of a complex in advance may be added.
  • the base used in the reaction for obtaining the compound of the present invention is not particularly limited, and examples thereof include sodium methoxide, sodium ethoxide, potassium methoxide, potassium ethoxide, and lithium-tert.
  • examples include alkali metal alkoxides such as —butoxide, sodium-tert butoxide and potassium-tert butoxide.
  • These bases may be used alone or in combination of two or more. Further, each of them may be directly added to the reaction system, or one prepared from an alkali metal, an alkali metal hydride, a hydroxide or an alkali metal, and a corresponding alcohol may be added.
  • the amount of the base used is preferably 2 to 30 mol, more preferably 2 to 10 mol, relative to 1 mol of the dihalogeno monocyclic compound. If the amount of base used is less than 2 moles, the yield may decrease. If the amount of base used exceeds 30 moles, it will be commensurate with the amount used. There is a risk that it will not be effective and economical.
  • the solvent used in the reaction for obtaining the compound of the present invention is not particularly limited as long as it is an inert solvent for the reaction.
  • aromatic hydrocarbons such as benzene, toluene, xylene and the like.
  • Solvents ether solvents such as jetyl ether, tetrahydrofuran, dioxane, etc .; acetonitrile, dimethylformamide, dimethyl sulfoxide, hexamethyl phosphotriamide and the like.
  • aromatic hydrocarbon solvents such as benzene, toluene and xylene are preferably used because the solvent can be easily recycled.
  • the amount of the solvent used is not particularly limited, but from the viewpoint of facilitating the reaction and obtaining an effect sufficient for the amount of use, the dihalogeno monocyclization represented by the general formula ( ⁇ ) It is preferable that it is 500 to 10000 parts by weight per 100 parts by weight of the compound! /.
  • the reaction temperature is not particularly limited, but is preferably 20 to 250 ° C, more preferably 50 to 150 ° C. If the reaction temperature is lower than 20 ° C, the reaction may take a long time. On the other hand, when the reaction temperature is higher than 250 ° C, side reactions may occur and the yield may decrease. Since the reaction time varies depending on the reaction temperature, it cannot be generally stated, but it is usually 1 to 20 hours.
  • the compound of the present invention obtained by force can be isolated by a conventional method, after filtration and washing to remove the catalyst and the like, followed by drying.
  • a catalyst and a base comprising a dihalogeno monocyclic compound represented by the general formula ( ⁇ ) and an amine compound represented by the general formula ( ⁇ ), a noradium compound and a phosphinic compound
  • the production method of the present invention wherein the compound represented by the general formula (I) is obtained by reacting in the presence of the compound, also obtains a compound having a structure similar to that of the compound represented by the general formula (I). It can use suitably also as a manufacturing method.
  • R 4 and R 5 are each independently a hydrogen atom, a hydroxyl group, a carboxyl group, a cyano group, a strong rubamoyl group, an alkyl group having 1 to 10 carbon atoms, or an alkyl group having 1 to In the same manner as in the production method of the present invention except that a diphenylamine compound represented by formula (VI) is used. ):
  • Ar represents a monocyclic 6-membered aromatic ring group which may have a substituent.
  • R 4 and R 5 each independently represents a hydrogen atom, a hydroxyl group, or a carboxyl group.
  • a high yield of about 90% can be obtained with respect to the dihalogeno compound used.
  • the compound strength obtained was confirmed to be 2, 6 bis [di (pyridine-2-yl) amino] pyridine by the following analysis results.
  • Example 1 The 2, 6 bis [di (pyridine-2-yl) amino] pyridine obtained in Example 1 was evaluated for light emission characteristics and thermal stability.
  • the 2,6-bis [di (pyridine-2-yl) amino] pyridine obtained in Example 1 was dissolved in 1-methyl-2-pyrrolidone, and a measurement sample (concentration: 1 X 10 " 3 g / L) was obtained.
  • a measurement sample concentration: 1 X 10 " 3 g / L
  • the emission wavelength was measured using a spectrophotometer (Hitachi Ltd., trade name F-2500). As a result, it was confirmed that 2,6-bis [di (pyridine-2-yl) amino] pyridine obtained in Example 1 had a light emitting function.
  • the fluorescence wavelength was 385 nm.
  • Example 1 2,6-bis [di (pyridine-2-yl) amino] pyridine obtained in Example 1 can be suitably used as a material for a light emitting layer in, for example, an EL device. That's right.
  • the thermal decomposition temperature of 2,6-bis [di (pyridine-1-yl) amino] pyridine obtained in Example 1 was measured by differential thermal analysis, and glass transfer was further performed by differential scanning calorimetry. The temperature was measured.
  • 2,6-bis [di (pyridine-1-yl) amino] pyridine obtained in Example 1 is thermally stable at a thermal decomposition temperature of 255 ° C. Thus, it can be easily formed, and since it does not have a crystallization temperature, it can be seen that the formed amorphous film has excellent heat resistance.
  • Example 1 bis (5-methylpyridine-2-yl) amine 9.55 g (48 mmol) was used instead of bis (pyridine-2-yl) amine 8.22 g (48 mmol).
  • Example 2 bis (5-methylpyridine-2-yl) amine 9.55 g (48 mmol) was used instead of bis (pyridine-2-yl) amine 8.22 g (48 mmol).
  • 6.58 g of 2,6-bis [di (5methylpyridine 2-yl) amino] pyridin of the present invention was obtained.
  • the yield of 2,6bis [di (5-methylpyridine-2-yl) amino] pyridin obtained was 58% based on 2,6 dibromopyridine used.
  • Example 2 The 2,6-bis [di (5methylpyridine 2-yl) amino] pyridine obtained in Example 2 was evaluated for luminescent properties and thermal stability.
  • Example 2 In the same manner as in Example 1, the emission wavelength was measured using a fluorescence spectrophotometer. As a result, it was confirmed that 2,6-bis [di (5-methylpyridine-2-yl) amino] pyridine obtained in Example 2 had a light emitting function. The fluorescence wavelength was 391 nm. Therefore, 2,6 bis [di (5-methylpyridine-2-yl) amino] pyridin obtained in Example 2 can be suitably used as a material for a light emitting layer in, for example, an EL device. It turns out that the possibility is high.
  • Example 3 Differential scanning calorimetry showed that the glass transition temperature was 49 ° C. Further, during this repeated measurement, no exothermic peak due to crystallization from amorphous was observed. Therefore, the 2, 6 bis [di (5 methylpyridine-2-yl) obtained in Example 2 was used. ) Amino] pyridine has a thermal decomposition temperature of 261 ° C and is thermally stable, so it can be easily formed by vapor deposition and the like, and since it does not have a crystallization temperature, It turns out that it has the outstanding heat resistance. [0067] Example 3
  • Example 3 The 1,3-bis [di (pyridine-2-yl) amino] benzene obtained in Example 3 was evaluated for luminescent properties and thermal stability.
  • the thermal decomposition temperature of 1,3 bis [di (pyridine-2-yl) amino] benzene obtained in Example 3 was measured by differential thermal analysis, and the glass transition temperature was determined by differential scanning calorimetry. It was measured.
  • 1,3 bis [di (pyridine-2-yl) amino] benzene obtained in Example 3 is thermally stable at 260 ° C. Since it can be easily formed and does not have a crystallization temperature, it can be seen that the formed amorphous film has excellent heat resistance.
  • Example 3 instead of 8.22 g (48 mmol) of bis (pyridine-2-yl) amine, 9.55 g (48 mmol) of bis (5-methylpyridine-2-yl) amine was used. Except for the above, in the same manner as in Example 3, 5.89 g of 1,3 bis [di (5-methylpyridine 2-yl) amino] benzene of the present invention was obtained. The yield of the obtained 1,3 bis [di (5-methylpyridine-1-yl) amino] benzene was 52% based on 1,3 dibromobenzene used.
  • the compound strength obtained was 1, 3 bis [di (5-methylpyridine-2-yl) amino] ben It was confirmed by the following analysis results that it was Zen.
  • Example 4 The 1,3-bis [di (5-methylpyridin-2-yl) amino] benzene obtained in Example 4 was evaluated for luminescent properties and thermal stability.
  • Example 4 In the same manner as in Example 3, the emission wavelength was measured using a fluorescence spectrophotometer. As a result, it was confirmed that 1,3-bis [di (5-methylpyridine-2-yl) amino] benzene obtained in Example 4 had a light emitting function. The fluorescence wavelength was 404 nm. Therefore, the 1,3-bis [di (5-methylpyridine-2-yl) amino] benzene obtained in Example 4 can be suitably used as a material for a light emitting layer in, for example, an EL device. It turns out that there is a high possibility of being able to do it.
  • the 1,3-bis [di (5-methylpyridine) obtained in Example 4 2-yl) amino] benzene has a thermal decomposition temperature of 262 ° C and is thermally stable, so it can be easily formed by vapor deposition, etc., and it has no crystallization temperature. It can be seen that the amorphous film has excellent heat resistance.
  • Example 5 The 2,6-bis [(phenol) (pyridine-2-yl) amino] pyridine obtained in Example 5 was evaluated for luminescent properties and thermal stability.
  • the 2,6bis [(phenol) (pyridine-2-yl) amino] pyridine obtained in Example 5 has a thermal decomposition temperature of 265 ° C and is thermally stable. It can be seen that the deposited amorphous film has excellent heat resistance because it can be easily formed by vapor deposition and has no crystallization temperature.
  • Example 5 instead of (phenol) (pyridine-2-yl) amine 8.16 g (48 mmol), (4-methylphenol) (5-methylpyridine-2-yl) amine 9 2.90 g of 2,6bis [(4 methylphenol) (5-methylpyridine-2-yl) amino] pyridine of the invention as in Example 5 except that 50 (48 mmol) was used. Got. The yield of 2,6bis [(4-methylphenol) (5-methylpyridine-2-yl) amino] pyridine obtained was 61% based on 2,6 dibromopyridine used.
  • the obtained compound was confirmed to be 2, 6 bis [(4 methylphenol) (5 methylpyridine 2 -yl) amino] pyridine by the following analysis results.
  • Example 6 The 2,6bis [(4-methylphenol) (5-methylpyridine-2-yl) amino] pyridine obtained in Example 6 was evaluated for luminescent properties and thermal stability.
  • Example 6 In the same manner as in Example 5, the emission wavelength was measured using a fluorescence spectrophotometer. As a result, it was confirmed that the 2,6bis [(4 methylphenol) (5 methylpyridine 2yl) amino] pyridine obtained in Example 6 had a light emitting function. The fluorescence wavelength was 430 nm. Accordingly, the 2,6bis [(4 methylphenol) (5-methylpyridine-2-yl) amino] pyridine obtained in Example 6 should be suitably used as a material for the light emitting layer in, for example, an EL device. It is clear that there is a high possibility that
  • the obtained compound strength was confirmed to be 1,3-bis [(phenol) (pyridine-2-yl) amino] benzene by the following analysis results.
  • Example 7 The 1,3-bis [(phenol) (pyridine-2-yl) amino] benzene obtained in Example 7 was evaluated for luminescent properties and thermal stability.
  • the thermal decomposition temperature of 1,3-bis [(phenol) (pyridine-2-yl) amino] benzene obtained in Example 7 was measured by differential thermal analysis, and further analyzed by differential scanning calorimetry. The glass transition temperature was measured.
  • the differential thermal analysis was performed using 1,3-bis [(phenol) (pyridine-2-yl) a obtained in Example 7.
  • Mino] benzene lmg was weighed and heated from room temperature to 500 ° C at a temperature increase rate of 10 ° CZ in a nitrogen atmosphere. As a result, the thermal decomposition temperature was 268 ° C.
  • the 1,3bis [(phenol) (pyridine-2-yl) amino] benzene obtained in Example 7 has a thermal decomposition temperature of 268 ° C and is thermally stable. It can be easily formed by vapor deposition or the like, and since it does not have a crystallization temperature, it can be seen that the formed amorphous film has excellent heat resistance.
  • Example 7 instead of (phenol) (pyridine-2-yl) amine 8.16 g (48 mmol), (4-methylphenol) (5-methylpyridine-2-yl) amine 9 1. 53 bis [(4 methylphenol) (5-methylpyridine-2-yl) amino] benzene of the present invention in the same manner as in Example 7 except that 50 (48 mmol) was used 5.53 g Got. The yield of the obtained 1,3 bis [(4 methylphenol) (5 methylpyridine 2yl) amino] benzene was 49% based on the 1,3 dibromobenzene used.
  • the obtained compound was confirmed to be 1, 3 bis [(4 methylphenol) (5 methylpyridine-2-yl) amino] benzene by the following analysis results.
  • Example 8 In the same manner as in Example 7, the emission wavelength was measured using a fluorescence spectrophotometer. As a result, it was confirmed that the 1,3 bis [(4-methylphenol) (5-methylpyridine-1-yl) amino] benzene obtained in Example 8 had a light emitting function. The fluorescence wavelength was 435 nm. Therefore, 1,3 bis [(4-methylphenol) (5-methylpyridine 2-yl) amino] benzene obtained in Example 8 is suitably used as a material for a light emitting layer in, for example, an EL device. It turns out that there is a high possibility of being able to.
  • the 1,3 bis [(4 methylphenol) (5 Methyl pyridine-2-yl) amino] benzene has a thermal decomposition temperature of 267 ° C and is thermally stable. Therefore, it can be easily formed by vapor deposition and has no crystallization temperature. It can be seen that the amorphous film formed has excellent heat resistance.
  • the compound of the present invention is thermally stable and can form an amorphous film having excellent heat resistance, it is useful as a charge transport material and a light emitting layer material in EL devices and the like.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Pyridine Compounds (AREA)
  • Electroluminescent Light Sources (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Indole Compounds (AREA)

Abstract

Disclosed is a low molecular weight organic compound having photo-electron conversion function and capable of forming an amorphous film having excellent heat resistance by itself. Also disclosed is a method for producing such a low molecular weight organic compound. Specifically disclosed are a compound represented by the general formula (I) below and a method for producing such a compound. (I) (In the formula, R1-R3 independently represent a hydrogen atom, a hydroxyl group, a carboxyl group, a cyano group, a carbamoyl group, an alkyl group having 1-10 carbon atoms or an alkanoyl group having 1-10 carbon atoms, and they may be the same or different from each other; V represents a nitrogen atom or a carbon atom; two W’s both represent nitrogen atoms or carbon atoms at the same time; and V and W’s may be the same as or different from each other.)

Description

明 細 書  Specification
電界発光素子用化合物およびその製造方法  Compound for electroluminescent device and method for producing the same
技術分野  Technical field
[0001] 本発明は、電界発光 (エレクト口ルミネッセンス: EL)素子における電荷輸送材料や 発光層用材料および光導電性撮像素子等の感光部材料等として有用な低分子量 有機化合物およびその製造方法に関する。  TECHNICAL FIELD [0001] The present invention relates to a low molecular weight organic compound useful as a charge transport material, a light emitting layer material, and a photosensitive part material such as a photoconductive imaging element in an electroluminescent (electral luminescence: EL) element, and a method for producing the same. .
背景技術  Background art
[0002] 従来から、電界発光素子や光導電性撮像素子等の電子デバイスにおいて、光 '電 子変換機能を有する低分子量有機化合物の薄膜、中でもフレキシビリティーに富む アモルファス膜が好適に用いられている。これらの低分子量有機化合物としては、例 えば、 N, N,一ジフエ-ル一 N, N,一ビス(3—メチルフエ-ル)一 1, 1,一ビフエ-ル —4, 4,一ジァミン、 N, N,一ジ [ (1 ナフタレ-ル)一 N, N,一ジフエ-ル]— 1, 1 'ービフエ-ルー 4, 4'ージァミン等が知られており(非特許文献 1参照)、ァモルフ ァス膜としては、これら自身力 なるアモルファス膜や、成膜性が悪いものについては 、ポリカーボネート榭脂のようなノインダー榭脂と当該低分子量有機化合物とを有機 溶剤に溶解させ、これを塗布、乾燥して得られたアモルファス膜が用いられている( 非特許文献 2参照)。  [0002] Conventionally, in electronic devices such as electroluminescent elements and photoconductive imaging elements, thin films of low molecular weight organic compounds having a light-to-electron conversion function, especially amorphous films with high flexibility, have been suitably used. Yes. These low molecular weight organic compounds include, for example, N, N, one diphenyl, one N, N, one bis (3-methylphenol), one, one, one biphenyl —4, 4, one diamine. N, N, Iji [(1 Naphthalene) 1 N, N, I Diphenyl] — 1, 1'-biferro-4, 4'-diamin etc. are known (see Non-Patent Document 1) As an amorphous film, for those amorphous films that are strong themselves, or those having poor film formability, a Noinder resin such as polycarbonate resin and the low molecular weight organic compound are dissolved in an organic solvent, An amorphous film obtained by coating and drying is used (see Non-Patent Document 2).
[0003] しカゝしながら、従来、知られて ヽるこれら低分子量有機化合物を用いて形成された アモルファス膜は、時間の経過と共に結晶化する傾向があるため、耐熱性や耐久性 が不十分であるという問題や、バインダー榭脂を用いた場合に、当該低分子量有機 化合物の有する機能がバインダー榭脂に希釈されてしまうという問題がある。  However, since amorphous films formed using these conventionally known low molecular weight organic compounds have a tendency to crystallize over time, they have poor heat resistance and durability. There is a problem that it is sufficient, and there is a problem that when the binder resin is used, the function of the low molecular weight organic compound is diluted in the binder resin.
[0004] 非特許文献 1 :電子材料, 2001年 12月号, pp. 18— 23 (2001)  [0004] Non-Patent Document 1: Electronic Materials, December 2001, pp. 18-23 (2001)
非特許文献 2 :Appl. Phys. Lett., Vol. 61, p. 761 (1992)  Non-Patent Document 2: Appl. Phys. Lett., Vol. 61, p. 761 (1992)
発明の開示  Disclosure of the invention
発明が解決しょうとする課題  Problems to be solved by the invention
[0005] 本発明は、光 ·電子変 能を有し、それ自身で耐熱性に優れたアモルファス膜を 形成することができる低分子量有機化合物およびその製造方法を提供することを目 的とする。 [0005] The present invention aims to provide a low molecular weight organic compound that can form an amorphous film having photoelectron transformation and excellent heat resistance by itself, and a method for producing the same. Target.
課題を解決するための手段  Means for solving the problem
[0006] 本発明は、以下に示すとおりの、低分子量有機化合物、およびその製造方法に関 する。  [0006] The present invention relates to a low molecular weight organic compound and a method for producing the same as described below.
すなわち、本発明は、一般式 (I):  That is, the present invention relates to the general formula (I):
[0007] [化 1]  [0007] [Chemical 1]
Figure imgf000004_0001
Figure imgf000004_0001
[0008] (式中、!^〜 は、それぞれ独立して、水素原子、水酸基、カルボキシル基、シァノ 基、力ルバモイル基、炭素数 1〜10のアルキル基、または炭素数 1〜10のアルカノィ ル基を示し、これらは同一であっても異なっていてもよぐ Vは窒素原子または炭素原 子を示し、 2つの Wは同時に窒素原子または炭素原子を示し、 Vおよび Wは同一で あっても異なって 、てもよ 、。 )で表される化合物に関する。  [0008] (In the formula, each of! ^-Is independently a hydrogen atom, a hydroxyl group, a carboxyl group, a cyano group, a strong rubermoyl group, an alkyl group having 1 to 10 carbon atoms, or an alkanoyl having 1 to 10 carbon atoms. May be the same or different, V represents a nitrogen atom or carbon atom, two Ws simultaneously represent a nitrogen atom or carbon atom, and V and W may be the same It is different and relates to a compound represented by
[0009] 本発明の化合物は、好ましくは、前記一般式(1)における!^〜 が、すべて水素 原子のものである。  [0009] The compound of the present invention is preferably represented by the general formula (1)! ^ ~ Are all hydrogen atoms.
本発明はまた、一般式 (Π) :  The present invention also provides a general formula (Π):
[0010] [化 2]
Figure imgf000004_0002
[0010] [Chemical 2]
Figure imgf000004_0002
[0011] (式中、 R1は、水素原子、水酸基、カルボキシル基、シァノ基、力ルバモイル基、炭素 数 1〜10のアルキル基、または炭素数 1〜10のアルカノィル基を示し、 Vは窒素原子 または炭素原子を示し、 Xはハロゲン原子を示す。)で表されるジハロゲノ単環化合 物と、一般式 (ΠΙ) : [0012] [化 3] (In the formula, R 1 represents a hydrogen atom, a hydroxyl group, a carboxyl group, a cyano group, a strong rubamoyl group, an alkyl group having 1 to 10 carbon atoms, or an alkanoyl group having 1 to 10 carbon atoms, and V represents nitrogen. Dihalogeno monocyclic compounds represented by the general formula (ΠΙ): [0012] [Chemical 3]
Figure imgf000005_0001
Figure imgf000005_0001
[0013] (式中、 R2および R3は、それぞれ独立して、水素原子、水酸基、カルボキシル基、シ ァノ基、力ルバモイル基、炭素数 1〜10のアルキル基、または炭素数 1〜10のアル力 ノィル基を示し、これらは同一であっても異なっていてもよぐ Wは窒素原子または炭 素原子を示す。)で表されるアミンィ匕合物とを、ノ ラジウム化合物およびホスフィンィ匕 合物を含む触媒並びに塩基の存在下、反応させることを特徴とする一般式 (I):(Wherein R 2 and R 3 are each independently a hydrogen atom, a hydroxyl group, a carboxyl group, a cyano group, a strong rubamoyl group, an alkyl group having 1 to 10 carbon atoms, or an alkyl group having 1 to 10 may be the same or different and W may be the same or different. W represents a nitrogen atom or a carbon atom.) General formula (I) characterized by reacting in the presence of a catalyst containing a compound and a base:
[0014] [化 4] [0014] [Chemical 4]
Figure imgf000005_0002
Figure imgf000005_0002
[0015] (式中、!^〜 は、それぞれ独立して、水素原子、水酸基、カルボキシル基、シァノ 基、力ルバモイル基、炭素数 1〜10のアルキル基、または炭素数 1〜10のアルカノィ ル基を示し、これらは同一であっても異なっていてもよぐ Vは窒素原子または炭素原 子を示し、 2つの Wは同時に窒素原子または炭素原子を示し、 Vおよび Wは同一で あっても異なって 、てもよ 、。 )で表される化合物の製造方法に関する。  [0015] (wherein! ^ ~ Are each independently a hydrogen atom, a hydroxyl group, a carboxyl group, a cyano group, a strong rubermoyl group, an alkyl group having 1 to 10 carbon atoms, or an alkanoyl having 1 to 10 carbon atoms) May be the same or different, V represents a nitrogen atom or carbon atom, two Ws simultaneously represent a nitrogen atom or carbon atom, and V and W may be the same It is different and relates to a method for producing a compound represented by
[0016] 以下、本発明を詳細に説明する。  Hereinafter, the present invention will be described in detail.
本発明の化合物は、下記一般式 (I)で表される新規物質である。  The compound of the present invention is a novel substance represented by the following general formula (I).
[0017] [化 5] R1 [0017] [Chemical 5] R 1
Figure imgf000006_0001
Figure imgf000006_0001
[0018] 一般式 (I)にお 、て、尺1〜!^は、それぞれ独立して、水素原子、水酸基、カルボキ シル基、シァノ基、力ルバモイル基、炭素数 1〜: L0のアルキル基、または炭素数 1〜 10のアルカノィル基を示し、これらは同一であっても異なって!/ヽてもよ!/、。 [0018] In the general formula (I), each of the scales 1 to! ^ Is independently a hydrogen atom, a hydroxyl group, a carboxy group, a cyan group, a strong rubamoyl group, or an alkyl group having 1 to C carbon atoms: Or an alkanoyl group having 1 to 10 carbon atoms, which may be the same or different!
!^〜 で示される炭素数 1〜10のアルキル基としては、例えば、メチル基、ェチル 基、 n—プロピル基、イソプロピル基、 n—ブチル基、イソブチル基、 sec—ブチル基、 tert—ブチル基、 n—ペンチル基、イソペンチル基、ネオペンチル基、 n キシル 基、イソへキシル基、 n—ォクチル基および n—デシル基等が挙げられる。  ! Examples of the alkyl group having 1 to 10 carbon atoms represented by ^ to include, for example, methyl group, ethyl group, n-propyl group, isopropyl group, n-butyl group, isobutyl group, sec-butyl group, tert-butyl group, Examples include n-pentyl group, isopentyl group, neopentyl group, n xyl group, isohexyl group, n-octyl group and n-decyl group.
!^〜 で示される炭素数 1〜10のアルカノィル基としては、例えば、メタノィル基、 エタノィル基、ブタノィル基およびデカノィル基等が挙げられる。  ! Examples of the alkanol group having 1 to 10 carbon atoms represented by ^ to include a methanol group, an ethanol group, a butanol group, and a decanol group.
[0019] 一般式 (I)において、 Vは窒素原子または炭素原子を示し、 2つの Wは同時に窒素 原子または炭素原子を示し、 Vおよび Wは同一であっても異なっていてもよい。 In the general formula (I), V represents a nitrogen atom or a carbon atom, two Ws simultaneously represent a nitrogen atom or a carbon atom, and V and W may be the same or different.
[0020] 一般式 (I)で表される化合物の具体例として、 [0020] As specific examples of the compound represented by the general formula (I),
1)前記一般式 (I)において、 Vおよび Wが共に、窒素原子である一般式(1): [0021] [化 6]  1) In the general formula (I), V and W are both nitrogen atoms. General Formula (1): [0021] [Chemical Formula 6]
Figure imgf000006_0002
Figure imgf000006_0002
[0022] (式中、!^〜 は、それぞれ独立して、水素原子、水酸基、カルボキシル基、シァノ 基、力ルバモイル基、炭素数 1〜10のアルキル基、または炭素数 1〜10のアルカノィ ル基を示し、これらは同一であっても異なっていてもよい。)で表される 2, 6—ビス [ジ (ピリジン一 2—ィル)ァミノ]ピリジンィ匕合物、 [0022] (In the formula,! ^-Are each independently a hydrogen atom, a hydroxyl group, a carboxyl group, Group, a strong rubermoyl group, an alkyl group having 1 to 10 carbon atoms, or an alkanol group having 1 to 10 carbon atoms, which may be the same or different. ) 2, 6-bis [di (pyridine-1-yl) amino] pyridine compound,
2)前記一般式 (I)において、 Vが炭素原子であって、 Wが窒素原子である一般式( 2) :  2) In the general formula (I), the general formula (2) in which V is a carbon atom and W is a nitrogen atom:
[0023] [化 7]  [0023] [Chemical 7]
Figure imgf000007_0001
Figure imgf000007_0001
[0024] (式中、!^〜 は、それぞれ独立して、水素原子、水酸基、カルボキシル基、シァノ 基、力ルバモイル基、炭素数 1〜10のアルキル基、または炭素数 1〜10のアルカノィ ル基を示し、これらは同一であっても異なっていてもよい。)で表される 1, 3—ビス [ジ (ピリジンー2—ィル)ァミノ]ベンゼン化合物、  [0024] (wherein! ^ ~ Are each independently a hydrogen atom, a hydroxyl group, a carboxyl group, a cyano group, a strong rubermoyl group, an alkyl group having 1 to 10 carbon atoms, or an alkanoyl having 1 to 10 carbon atoms) 1, 3-bis [di (pyridin-2-yl) amino] benzene compounds represented by the following formulas, which may be the same or different:
3)前記一般式 (I)において、 Vが窒素原子であって、 Wが炭素原子である一般式( 3) :  3) In the general formula (I), V is a nitrogen atom and W is a carbon atom (3):
[0025] [化 8]  [0025] [Chemical 8]
Figure imgf000007_0002
Figure imgf000007_0002
[0026] (式中、!^〜 は、それぞれ独立して、水素原子、水酸基、カルボキシル基、シァノ 基、力ルバモイル基、炭素数 1〜10のアルキル基、または炭素数 1〜10のアルカノィ ル基を示し、これらは同一であっても異なっていてもよい。)で表される 2, 6—ビス [ ( フエ-ル)(ピリジン— 2—ィル)ァミノ]ピリジンィ匕合物、および [0026] (wherein! ^-Are each independently a hydrogen atom, a hydroxyl group, a carboxyl group, a cyano group, a strong rubamoyl group, an alkyl group having 1 to 10 carbon atoms, or an alkanoy having 1 to 10 carbon atoms. These groups may be the same or different. ), 2,6-bis [(phenol) (pyridine-2-yl) amino] pyridine compound, and
4)前記一般式 (I)において、 Vおよび Wが共に、炭素原子である一般式 (4):  4) In the general formula (I), V and W are both carbon atoms.
[化 9]  [Chemical 9]
Figure imgf000008_0001
Figure imgf000008_0001
[0028] (式中、!^〜 は、それぞれ独立して、水素原子、水酸基、カルボキシル基、シァノ 基、力ルバモイル基、炭素数 1〜10のアルキル基、または炭素数 1〜10のアルカノィ ル基を示し、これらは同一であっても異なっていてもよい。)で表される 1, 3—ビス [ ( フエ-ル)(ピリジン— 2—ィル)ァミノ]ベンゼンィ匕合物が挙げられる。  [0028] (wherein! ^ ~ Are each independently a hydrogen atom, a hydroxyl group, a carboxyl group, a cyano group, a strong rubermoyl group, an alkyl group having 1 to 10 carbon atoms, or an alkanoyl having 1 to 10 carbon atoms) A 1,3-bis [(phenol) (pyridine-2-yl) amino] benzene compound represented by the following formula: .
[0029] 前記一般式 (I)で表される化合物の具体例としては、例えば、一般式(1)として、 2, 6—ビス [ジ(ピリジン一 2—ィル)ァミノ]ピリジン、 2, 6—ビス [ジ(4—メチルピリジ ン— 2—ィル)ァミノ]ピリジン、 2, 6—ビス [ジ(5—メチルピリジン— 2—ィル)ァミノ]ピ リジン、 2, 6—ビス [ジ(6—メチルピリジン一 2—ィル)ァミノ]ピリジン、 2, 6—ビス [ジ( 4—ェチルピリジン— 2—ィル)ァミノ]ピリジン、 2, 6—ビス [ジ(5—ェチルピリジン— 2—ィル)ァミノ]ピリジン、 2, 6—ビス [ジ(6—ェチルピリジンー2—ィル)ァミノ]ピリジ ン、 2, 6—ビス [ジ(4— n—プロピルピリジン一 2—ィル)ァミノ]ピリジン、 2, 6—ビス [ ジ(5— n—プロピルピリジン— 2—ィル)ァミノ]ピリジン、 2, 6—ビス [ジ(6— n—プロ ピルピリジン一 2—ィル)ァミノ]ピリジン、 2, 6—ビス [ジ(4—イソプロピルピリジン一 2 —ィル)ァミノ]ピリジン、 2, 6—ビス [ジ(5—イソプロピルピリジン— 2—ィル)ァミノ]ピ リジン、 2, 6—ビス [ジ(6—イソプロピルピリジン一 2—ィル)ァミノ]ピリジン、 2, 6—ビ ス [ジ(4— n—ブチルピリジン— 2—ィル)ァミノ]ピリジン、 2, 6—ビス [ジ(5— n—ブ チルピリジン— 2—ィル)ァミノ]ピリジン、 2, 6—ビス [ジ(6— n—ブチルピリジン— 2 —ィル)ァミノ]ピリジン、 2, 6—ビス [ジ(4—イソブチルピリジン— 2—ィル)ァミノ]ピリ ジン、 2, 6—ビス [ジ(5—イソブチルピリジン一 2—ィル)ァミノ]ピリジン、 2, 6—ビス [ ジ(6—イソブチルピリジン— 2—ィル)ァミノ]ピリジン、 2, 6—ビス [ジ(4— sec—ブチ ルビリジン— 2—ィル)ァミノ]ピリジン、 2, 6—ビス [ジ(5— sec—ブチルピリジン— 2 —ィル)ァミノ]ピリジン、 2, 6—ビス [ジ(6— sec—ブチルピリジン— 2—ィル)ァミノ] ピリジン、 2, 6—ビス [ジ(4— tert—ブチルピリジン— 2—ィル)ァミノ]ピリジン、 2, 6 —ビス [ジ(5— tert—ブチルピリジン— 2—ィル)ァミノ]ピリジン、 2, 6—ビス [ジ(6— tert—ブチルピリジン— 2—ィル)ァミノ]ピリジン、 2, 6—ビス [ジ(4— n—ペンチルビ リジン— 2—ィル)ァミノ]ピリジン、 2, 6—ビス [ジ(5— n—ペンチルビリジン— 2—ィル )ァミノ]ピリジン、 2, 6—ビス [ジ(6— n—ペンチルビリジン— 2—ィル)ァミノ]ピリジン 、 2, 6—ビス [ジ(4—イソペンチルビリジン一 2—ィル)ァミノ]ピリジン、 2, 6—ビス [ジ (5—イソペンチルビリジン一 2—ィル)ァミノ]ピリジン、 2, 6—ビス [ジ(6—イソペンチ ルビリジン一 2—ィル)ァミノ]ピリジン、 2, 6—ビス [ジ(4—ネオペンチルビリジン一 2 —ィル)ァミノ]ピリジン、 2, 6—ビス [ジ(5—ネオペンチルビリジン— 2—ィル)ァミノ] ピリジン、 2, 6—ビス [ジ(6—ネオペンチルビリジン一 2—ィル)ァミノ]ピリジン、 2, 6 —ビス [ジ(4— n—へキシルピリジン一 2—ィル)ァミノ]ピリジン、 2, 6—ビス [ジ(5— n—へキシルピリジン一 2—ィル)ァミノ]ピリジン、 2, 6—ビス [ジ(6— n—へキシルビ リジン一 2—ィル)ァミノ]ピリジン、 2, 6—ビス [ジ(4—イソへキシルピリジン一 2—ィル )ァミノ]ピリジン、 2, 6—ビス [ジ(5—イソへキシルピリジン一 2—ィル)ァミノ]ピリジン 、 2, 6—ビス [ジ(6—イソへキシルピリジン一 2—ィル)ァミノ]ピリジン、 2, 6—ビス [ジ (4— n—ォクチルビリジン一 2—ィル)ァミノ]ピリジン、 2, 6—ビス [ジ(5— n—ォクチ ルビリジン一 2—ィル)ァミノ]ピリジン、 2, 6—ビス [ジ(6— n—ォクチルビリジン一 2— ィル)ァミノ]ピリジン、 2, 6—ビス [ジ(4— n—デシルビリジン— 2—ィル)ァミノ]ピリジ ン、 2, 6—ビス [ジ(5— n—デシルビリジン一 2—ィル)ァミノ]ピリジン、 2, 6—ビス [ジ (6— n—デシルビリジン一 2—ィル)ァミノ]ピリジン、 2, 6—ビス [ジ(4—ヒドロキシル ピリジン一 2—ィル)ァミノ]ピリジン、 2, 6—ビス [ジ(5—ヒドロキシルピリジン一 2—ィ ル)ァミノ]ピリジン、 2, 6—ビス [ジ(6—ヒドロキシルピリジン— 2—ィル)ァミノ]ピリジ ン、 2, 6—ビス [ジ(4—アルカノィルピリジン一 2—ィル)ァミノ]ピリジン、 2, 6—ビス [ ジ(5—アルカノィルピリジン一 2—ィル)ァミノ]ピリジン、 2, 6—ビス [ジ(6—アルカノ ィルピリジン— 2—ィル)ァミノ]ピリジン、 2, 6 ビス [ジ(4—力ルバモイルビリジン— 2 ィル)ァミノ]ピリジン、 2, 6 ビス [ジ(5—力ルバモイルビリジン 2 ィル)ァミノ] ピリジン、 2, 6 ビス [ジ(6—力ルバモイルビリジン一 2—ィル)ァミノ]ピリジン、 2, 6 —ビス [ジ(4—カルボキシルピリジン一 2—ィル)ァミノ]ピリジン、 2, 6 ビス [ジ(5— カルボキシルピリジン— 2—ィル)ァミノ]ピリジン、 2, 6 ビス [ジ(6—カルボキシルビ リジン一 2—ィル)ァミノ]ピリジン、 2, 6 ビス [ジ(4 シァノピリジン一 2—ィル)ァミノ ]ピリジン、 2, 6 ビス [ジ(5 シァノピリジン一 2—ィル)ァミノ]ピリジン、 2, 6 ビス [ ジ(6 シァノピリジン一 2—ィル)ァミノ]ピリジン、 [0029] Specific examples of the compound represented by the general formula (I) include, for example, as the general formula (1), 2, 6-bis [di (pyridine-1-yl) amino] pyridine, 2, 6-bis [di (4-methylpyridin-2-yl) amino] pyridine, 2,6-bis [di (5-methylpyridine-2-yl) amino] pyridine, 2,6-bis [di (6-Methylpyridine-1-yl) amino] pyridine, 2,6-bis [di (4-ethylpyridine-2-amino) pyridine], 2,6-bis [di (5-ethylpyridine-2-) Yl) amino] pyridine, 2, 6-bis [di (6-ethylpyridine-2-yl) amino] pyridin, 2,6-bis [di (4-n-propylpyridine-2-yl) amino] Pyridine, 2,6-bis [di (5-n-propylpyridine-2-yl) amino] pyridine, 2,6-bis [di (6-n-propylpyridine-2-yl) a )] Pyridine, 2,6-bis [di (4-isopropylpyridine-2-yl) amino] pyridine, 2,6-bis [di (5-isopropylpyridine-2-yl) amino] pyridine, 2 , 6-bis [di (6-isopropylpyridine-1-yl) amino] pyridine, 2,6-bis [di (4-n-butylpyridine-2-yl) amino] pyridine, 2, 6- Bis [di (5-n-butylpyridine-2-yl) amino] pyridine, 2,6-bis [di (6-n-butylpyridine-2-yl) amino] pyridine, 2,6-bis [ Di (4-isobutylpyridine-2-yl) amino] pyri Gin, 2, 6-bis [di (5-isobutylpyridine-2-yl) amino] pyridine, 2,6-bis [di (6-isobutylpyridine-2-yl) amino] pyridine, 2, 6- Bis [di (4-sec-butyrubiridin-2-yl) amino] pyridine, 2,6-bis [di (5-sec-butylpyridine-2-yl) amino] pyridine, 2,6-bis [ Di (6-sec-butylpyridine-2-yl) amino] pyridine, 2,6-bis [di (4-tert-butylpyridine-2-yl) amino] pyridine, 2,6-bis [di ( 5-tert-butylpyridine-2-yl) amino] pyridine, 2,6-bis [di (6-tert-butylpyridine-2-yl) amino] pyridine, 2,6-bis [di (4- n-pentylvinylidine-2-yl) amino] pyridine, 2,6-bis [di (5-n-pentylvinylidine-2-yl) amino] pyridine, 2,6-bis [di (6 — N-pentylviridine-2-yl) amino] pyridine, 2,6-bis [di (4-isopentylviridine-2-yl) amino] pyridine, 2,6-bis [di (5-isopentyl) Bilysine-2-yl) amino] pyridine, 2,6-bis [di (6-isopentylviridine-2-yl) amino] pyridine, 2,6-bis [di (4-neopentylviridine-1-2] ) Amino] pyridine, 2,6-bis [di (5-neopentylviridine-2-yl) amino] pyridine, 2,6-bis [di (6-neopentylviridine-2-yl) amino] Pyridine, 2,6-bis [di (4-n-hexylpyridine-1-yl) amino] pyridine, 2,6-bis [di (5-n-hexylpyridine-2-yl) amino] Pyridine, 2,6-bis [di (6-n-hexylvinyl lysine-2-yl) amino] pyridine, 2,6-bis [di (4-isohexyl] Pyridine-2-yl) amino] pyridine, 2,6-bis [di (5-isohexylpyridine-1-2-yl) amino] pyridine, 2,6-bis [di (6-isohexylpyridine) 2-yl) amino] pyridine, 2,6-bis [di (4-n-octylviridine-2-yl) amino] pyridine, 2,6-bis [di (5-n-octylviridine-2- ) Amino] pyridine, 2,6-bis [di (6-n-octylviridine-2-yl) amino] pyridine, 2,6-bis [di (4-n-decylviridine-2-yl) amino] Pyridine, 2,6-bis [di (5-n-decylviridine-2-yl) amino] pyridine, 2,6-bis [di (6-n-decylviridine-1-2-yl) amino] pyridine, 2 , 6-bis [di (4-hydroxylpyridine-2-yl) amino] pyridine, 2,6-bis [di (5-hydroxylpyridine-2-yl) Mino] pyridine, 2,6-bis [di (6-hydroxylpyridine-2-yl) amino] pyridin, 2,6-bis [di (4-alkanoylpyridine-2-yl) amino] pyridine 2, 6-bis [di (5-alkanoylpyridine-2-yl) amino] pyridine, 2,6-bis [di (6-alkano Ylpyridine—2-yl) amino] pyridine, 2, 6 bis [di (4—force rubamoylviridine—2 yl) amino] pyridine, 2,6 bis [di (5—force rubamoylviridine 2 yl) Amino] pyridine, 2, 6 bis [di (6-branyl pyridine] 2-amino) pyridine, 2, 6-bis [di (4-carboxylpyridine-2-yl) amino] pyridine, 2 , 6 bis [di (5-carboxylpyridine-2-yl) amino] pyridine, 2,6 bis [di (6-carboxylpyridine-2-yl) amino] pyridine, 2,6 bis [di (4 Cyanopyridine-2-yl) amino] pyridine, 2,6 bis [di (5 Cyanpyridine-1-2-yl) amino] pyridine, 2,6 bis [di (6 Cyanpyridine1-2-yl) amino] pyridine,
一般式(2)として、 1, 3 ビス [ジ(ピリジン— 2—ィル)ァミノ]ベンゼン、 1, 3 ビス [ジ(4—メチルピリジン— 2—ィル)ァミノ]ベンゼン、 1, 3 ビス [ジ(5—メチルピリジ ン— 2—ィル)ァミノ]ベンゼン、 1, 3 ビス [ジ(6—メチルピリジン— 2—ィル)ァミノ] ベンゼン、 1, 3 ビス [ジ(4 ェチルピリジン— 2—ィル)ァミノ]ベンゼン、 1, 3 ビ ス [ジ(5 ェチルピリジン— 2—ィル)ァミノ]ベンゼン、 1, 3 ビス [ジ(6 ェチルピリ ジン— 2—ィル)ァミノ]ベンゼン、 1, 3 ビス [ジ(4— n—プロピルピリジン— 2—ィル )ァミノ]ベンゼン、 1, 3 ビス [ジ(5— n—プロピルピリジン— 2—ィル)ァミノ]ベンゼ ン、 1, 3 ビス [ジ(6— n—プロピノレピリジン一 2—ィノレ)ァミノ]ベンゼン、 1, 3 ビス [ジ(4—イソプロピルピリジン一 2—ィル)ァミノ]ベンゼン、 1, 3 ビス [ジ(5—イソプ 口ピルピリジン一 2—ィル)ァミノ]ベンゼン、 1, 3 ビス [ジ(6—イソプロピルピリジン —2—ィル)ァミノ]ベンゼン、 1, 3 ビス [ジ(4— n—ブチルピリジン— 2—ィル)ァミノ ]ベンゼン、 1, 3 ビス [ジ(5— n—ブチルピリジン— 2—ィル)ァミノ]ベンゼン、 1, 3 —ビス [ジ(6— n—ブチルピリジン— 2—ィル)ァミノ]ベンゼン、 1, 3 ビス [ジ(4—ィ ソブチルビリジン— 2—ィル)ァミノ]ベンゼン、 1, 3 ビス [ジ(5—イソブチルピリジン —2—ィル)ァミノ]ベンゼン、 1, 3 ビス [ジ(6—イソブチルピリジン— 2—ィル)ァミノ ]ベンゼン、 1, 3 ビス [ジ(4 sec ブチルピリジン— 2—ィル)ァミノ]ベンゼン、 1, 3 ビス [ジ(5— sec ブチルピリジン— 2—ィル)ァミノ]ベンゼン、 1, 3 ビス [ジ(6 sec ブチルピリジン 2 ィル)ァミノ]ベンゼン、 1, 3 ビス [ジ(4 tert—ブチ ルビリジン— 2—ィル)ァミノ]ベンゼン、 1, 3 ビス [ジ(5— tert—ブチルピリジン— 2 —ィル)ァミノ]ベンゼン、 1, 3 ビス [ジ(6— tert—ブチルピリジン— 2—ィル)ァミノ] ベンゼン、 1, 3—ビス [ジ(4— n—ペンチルビリジン— 2—ィル)ァミノ]ベンゼン、 1, 3 —ビス [ジ(5— n—ペンチルビリジン— 2—ィル)ァミノ]ベンゼン、 1, 3—ビス [ジ(6— n—ペンチルビリジン一 2—ィル)ァミノ]ベンゼン、 1, 3—ビス [ジ(4—イソペンチルビ リジン— 2—ィル)ァミノ]ベンゼン、 1, 3—ビス [ジ(5—イソペンチルビリジン— 2—ィ ル)ァミノ]ベンゼン、 1, 3—ビス [ジ(6—イソペンチルビリジン— 2—ィル)ァミノ]ベン ゼン、 1, 3—ビス [ジ(4—ネオペンチルピリジン— 2—ィル)ァミノ]ベンゼン、 1, 3— ビス [ジ(5—ネオペンチルビリジン— 2—ィル)ァミノ]ベンゼン、 1, 3—ビス [ジ(6— ネオペンチルビリジン— 2—ィル)ァミノ]ベンゼン、 1, 3—ビス [ジ(4— n—へキシル ピリジン— 2—ィル)ァミノ]ベンゼン、 1, 3—ビス [ジ(5— n—へキシルピリジン— 2— ィル)ァミノ]ベンゼン、 1, 3—ビス [ジ(6— n—へキシルピリジン— 2—ィル)ァミノ]ベ ンゼン、 1, 3—ビス [ジ(4—イソへキシルピリジン一 2—ィル)ァミノ]ベンゼン、 1, 3— ビス [ジ(5—イソへキシルピリジン一 2—ィル)ァミノ]ベンゼン、 1, 3—ビス [ジ(6—ィ ソへキシルピリジン一 2—ィル)ァミノ]ベンゼン、 1, 3—ビス [ジ(4— n—ォクチルピリ ジン— 2—ィル)ァミノ]ベンゼン、 1, 3—ビス [ジ(5— n—ォクチルビリジン— 2—ィル )ァミノ]ベンゼン、 1, 3—ビス [ジ(6— n—ォクチルビリジン— 2—ィル)ァミノ]ベンゼ ン、 1, 3—ビス [ジ(4— n—デシルビリジン— 2—ィル)ァミノ]ベンゼン、 1, 3—ビス [ ジ(5— n—デシルビリジン— 2—ィル)ァミノ]ベンゼン、 1, 3—ビス [ジ(6— n—デシ ルピリジン— 2—ィル)ァミノ]ベンゼン、 1, 3—ビス [ジ(4—ヒドロキシルピリジン— 2 —ィル)ァミノ]ベンゼン、 1, 3—ビス [ジ(5—ヒドロキシルピリジン一 2—ィル)ァミノ] ベンゼン、 1, 3—ビス [ジ(6—ヒドロキシルピリジン一 2—ィル)ァミノ]ベンゼン、 1, 3 —ビス [ジ(4—アルカノィルピリジン— 2—ィル)ァミノ]ベンゼン、 1, 3—ビス [ジ(5— アルカノィルピリジン— 2—ィル)ァミノ]ベンゼン、 1, 3—ビス [ジ(6—アルカノィルピ リジン— 2—ィル)ァミノ]ベンゼン、 1, 3—ビス [ジ(4—力ルバモイルビリジン— 2—ィ ル)ァミノ]ベンゼン、 1, 3—ビス [ジ(5—力ルバモイルビリジン— 2—ィル)ァミノ]ベン ゼン、 1, 3—ビス [ジ(6—力ルバモイルピリジン— 2—ィル)ァミノ]ベンゼン、 1, 3— ビス [ジ(4—カルボキシルピリジン— 2—ィル)ァミノ]ベンゼン、 1, 3—ビス [ジ(5—力 ルボキシルピリジン— 2—ィル)ァミノ]ベンゼン、 1, 3—ビス [ジ(6—カルボキシルピリ ジン一 2—ィル)ァミノ]ベンゼン、 1, 3—ビス [ジ(4—シァノピリジン一 2—ィル)ァミノ ]ベンゼン、 1, 3 ビス [ジ(5 シァノピリジン一 2—ィル)ァミノ]ベンゼン、 1, 3 ビ ス [ジ(6 シァノピリジン― 2 ィル)ァミノ]ベンゼン、 In general formula (2), 1,3 bis [di (pyridine-2-yl) amino] benzene, 1,3 bis [di (4-methylpyridine-2-yl) amino] benzene, 1,3 bis [Di (5-methylpyridin-2-yl) amino] benzene, 1,3 bis [di (6-methylpyridine-2-yl) amino] benzene, 1,3 bis [di (4-ethylpyridine-2— Yl) amino] benzene, 1,3 bis [di (5-ethylpyridin-2-yl) amino] benzene, 1,3 bis [di (6 ethylpyridine-2-yl) amino] benzene, 1, 3 Bis [di (4-n-propylpyridine-2-yl) amino] benzene, 1,3 bis [di (5-n-propylpyridine-2-yl) amino] benzen, 1,3 bis [di (6-N-propynolepyridine-1-2-inole) amino] benzene, 1,3 bis [di (4-isopropylpyridine-1-2-yl) amino] ben 1,3 bis [di (5-isopropylpyridyl-2-yl) amino] benzene, 1,3 bis [di (6-isopropylpyridine-2-yl) amino] benzene, 1,3 bis [ Di (4-n-butylpyridine-2-yl) amino] benzene, 1,3bis [di (5-n-butylpyridine-2-yl) amino] benzene, 1,3-bis [di (6 — N-Butylpyridine— 2-yl) amino] benzene, 1,3 bis [di (4-isobutylviridine-2-yl) amino] benzene, 1,3 bis [di (5-isobutylpyridine —2— Yl) amino] benzene, 1,3 bis [di (6-isobutylpyridine-2-yl) amino] benzene, 1,3 bis [di (4 sec butylpyridine-2-yl) amino] benzene, 1 , 3 bis [di (5-sec butylpyridine-2-yl) amino] benzene, 1,3 bis [di (6 sec butylpyridine 2 yl Amino] benzene, 1,3 bis [di (4 tert-butyryridine-2-yl) amino] benzene, 1,3 bis [di (5-tert-butylpyridine-2-yl) amino] benzene, 1 , 3 Bis [di (6-tert-butylpyridine-2-yl) amino] Benzene, 1,3-bis [di (4-n-pentylviridine-2-yl) amino] benzene, 1,3-bis [di (5-n-pentylviridine-2-yl) amino] benzene, 1,3-bis [di (6-n-pentylviridine-2-yl) amino] benzene, 1,3-bis [di (4-isopentylviridine-2-yl) amino] benzene, 1, 3— Bis [di (5-isopentylviridine-2-yl) amino] benzene, 1,3-bis [di (6-isopentylviridine-2-yl) amino] benzene, 1,3-bis [di (4-Neopentylpyridine-2-yl) amino] benzene, 1,3-bis [di (5-Neopentylviridine-2-yl) amino] benzene, 1,3-bis [di (6-neo Pentylviridine—2-yl) amino] benzene, 1,3-bis [di (4-n-hexylpyridine-2-yl) amino] benzene, 1 , 3-bis [di (5-n-hexylpyridine-2-yl) amino] benzene, 1,3-bis [di (6-n-hexylpyridine-2-yl) amino] benzene, 1,3-bis [di (4-isohexylpyridine-1-yl) amino] benzene, 1,3-bis [di (5-isohexylpyridine-1-yl) amino] benzene, 1, 3-bis [di (6-isohexylpyridine-2-yl) amino] benzene, 1,3-bis [di (4-n-octylpyridin-2-yl) amino] benzene, 1, 3 —Bis [di (5-n-octylviridine-2-yl) amino] benzene, 1,3-bis [di (6-n-octylviridine-2-yl) amino] benzen, 1,3-bis [ Di (4-n-decylviridine-2-yl) amino] benzene, 1,3-bis [di (5-n-decylviridine-2-yl) amino] benzene, 1,3-bis [di (6- n Decylpyridine—2-yl) amino] benzene, 1,3-bis [di (4-hydroxylpyridine-2-yl) amino] benzene, 1,3-bis [di (5-hydroxylpyridine) Le) amino] benzene, 1,3-bis [di (6-hydroxylpyridine-2-yl) amino] benzene, 1,3-bis [di (4-alkanoylpyridine-2-yl) amino] Benzene, 1,3-bis [di (5-alkanoylpyridine-2-yl) amino] benzene, 1,3-bis [di (6-alkanoylpyridin-2-yl) amino] benzene, 1, 3-bis [di (4-force rubermoylviridine-2-yl) amino] benzene, 1,3-bis [di (5-forcerubamoylviridine-2-yl) amino] benzene, 1, 3 —Bis [di (6—force rubamoylpyridine-2-yl) amino] benzene, 1, 3—bis [di (4-carboxyl Pyridine-2-yl) amino] benzene, 1,3-bis [di (5-force ruboxylpyridine-2-yl) amino] benzene, 1,3-bis [di (6-carboxylpyridine) Yl) amino] benzene, 1,3-bis [di (4-cyanopyridine-2-yl) amino ] Benzene, 1,3 bis [di (5 cyanopyridine-2-yl) amino] benzene, 1,3 bis [di (6 cyanopyridine-2-yl) amino] benzene,
一般式(3)として、 2, 6 ビス [ (フエ-ル)(ピリジン一 2—ィル)ァミノ]ピリジン、 2, 6 ビス [ (3—メチルフエ-ル)(4—メチルピリジン一 2—ィル)ァミノ]ピリジン、 2, 6— ビス [ (3—メチルフエ-ル)(6—メチルピリジン一 2—ィル)ァミノ]ピリジン、 2, 6 ビス [ (4—メチルフエ-ル)(5—メチルピリジン一 2—ィル)ァミノ]ピリジン、 2, 6 ビス [ (3 —ェチルフエ-ル)(4 ェチルピリジン— 2—ィル)ァミノ]ピリジン、 2, 6 ビス [ (3— ェチルフエ-ル)(6 ェチルピリジン— 2—ィル)ァミノ]ピリジン、 2, 6 ビス [ (4—ェ チルフエ-ル)(5 ェチルピリジン— 2—ィル)ァミノ]ピリジン、 2, 6 ビス [ (3— n— プロピルフエ-ル)(4— n—プロピルピリジン— 2—ィル)ァミノ]ピリジン、 2, 6 ビス [ (3— n—プロピルフエ-ル)(6— n—プロピルピリジン— 2—ィル)ァミノ]ピリジン、 2, 6 ビス [ (4— n プロピルフエ-ル)( 5— n プロピルピリジン— 2 ィル)ァミノ]ピリ ジン、 2, 6 ビス [ (3—イソプロピルフエ-ル)(4—イソプロピルピリジン一 2—ィル)ァ ミノ]ピリジン、 2, 6 ビス [ (3—イソプロピルフエ-ル)(6—イソプロピルピリジン一 2 —ィル)ァミノ]ピリジン、 2, 6 ビス [ (4—イソプロピルフエ-ル)(5—イソプロピルピリ ジン— 2—ィル)ァミノ]ピリジン、 2, 6 ビス [ (3— n—ブチルフエ-ル)(4— n—ブチ ルビリジン— 2—ィル)ァミノ]ピリジン、 2, 6 ビス [ (3— n—ブチルフエ-ル)(6— n —ブチルビリジン— 2—ィル)ァミノ]ピリジン、 2, 6 ビス [ (4— n—ブチルフエ-ル)( 5— n—ブチルピリジン— 2—ィル)ァミノ]ピリジン、 2, 6 ビス [ (3—イソブチルフエ -ル)(4—イソブチルピリジン— 2—ィル)ァミノ]ピリジン、 2, 6 ビス [ (3—イソブチ ルフエ-ル)(6—イソブチルピリジン一 2—ィル)ァミノ]ピリジン、 2, 6 ビス [ (4—イソ ブチルフエ-ル)(5—イソブチルピリジン— 2—ィル)ァミノ]ピリジン、 2, 6 ビス [ (3 — sec ブチルフエ-ル)(4 sec ブチルピリジンー2 ィル)ァミノ]ピリジン、 2, 6 ビス [ (3 sec ブチルフエ-ル)(6 sec ブチルピリジン 2 ィル)ァミノ]ピリ ジン、 2, 6 ビス [ (4 sec ブチルフエ-ル)(5 sec ブチルピリジンー2 ィル) ァミノ]ピリジン、 2, 6 ビス [ (3— tert ブチルフエ-ル)(4— tert—ブチルピリジン —2—ィル)ァミノ]ピリジン、 2, 6 ビス [ (3— tert—ブチルフエ-ル)(6— tert—ブ チルピリジン— 2—ィル)ァミノ]ピリジン、 2, 6 ビス [ (4— tert—ブチルフエ-ル)(5 —tert—ブチルピリジン— 2—ィル)ァミノ]ピリジン、 2, 6 ビス [ (3— n—ペンチルフ ェ -ル)(4— n ペンチルビリジン— 2—ィル)ァミノ]ピリジン、 2, 6 ビス [ (3— n— ペンチルフエ-ル)(6— n—ペンチルビリジン— 2—ィル)ァミノ]ピリジン、 2, 6 ビス [ (4— n—ペンチルフエ-ル)(5— n—ペンチルビリジン— 2—ィル)ァミノ]ピリジン、 2 , 6 ビス [ (3 イソペンチルフエ-ル)(4 イソペンチルビリジン 2 ィル)ァミノ] ピリジン、 2, 6 ビス [ (3—イソペンチルフエ-ル)(6—イソペンチルビリジン一 2—ィ ル)ァミノ]ピリジン、 2, 6 ビス [ (4—イソペンチルフエ-ル)(5—イソペンチルピリジ ン一 2—ィル)ァミノ]ピリジン、 2, 6 ビス [ (3—ネオペンチルフエ-ル)(4—ネオペ ンチルピリジン一 2—ィル)ァミノ]ピリジン、 2, 6 ビス [ (3—ネオペンチルフエ-ル) ( 6—ネオペンチルビリジン— 2—ィル)ァミノ]ピリジン、 2, 6 ビス [ (4—ネオペンチル フエ-ル)(5—ネオペンチルビリジン一 2—ィル)ァミノ]ピリジン、 2, 6 ビス [ (3— n —へキシルフエ-ル)(4— n—へキシルピリジン一 2—ィル)ァミノ]ピリジン、 2, 6 ビ ス [ (3— n—へキシルフエ-ル)(6— n—へキシルピリジン一 2—ィル)ァミノ]ピリジン 、 2, 6 ビス [ (4— n—へキシルフエ-ル)(5— n—へキシルピリジン一 2—ィル)アミ ノ]ピリジン、 2, 6 ビス [ (3—イソへキシルフエ-ル)(4—イソへキシルピリジン一 2— ィル)ァミノ]ピリジン、 2, 6 ビス [ (3—イソへキシルフエ-ル)(6—イソへキシルピリ ジン一 2—ィル)ァミノ]ピリジン、 2, 6 ビス [ (4—イソへキシルフエ-ル)(5—イソへ キシルピリジン一 2—ィル)ァミノ]ピリジン、 2, 6 ビス [ (3— n—ォクチルフエ-ル)( 4— n—ォクチルビリジン一 2—ィル)ァミノ]ピリジン、 2, 6 ビス [ (3— n—ォクチルフ ェ -ル)(6— n—ォクチルビリジン一 2—ィル)ァミノ]ピリジン、 2, 6 ビス [ (4— n— ォクチルフエ-ル)(5— n—ォクチルビリジン— 2—ィル)ァミノ]ピリジン、 2, 6 ビス [ (3— n—デシルフエ-ル)(4— n—デシルビリジン— 2—ィル)ァミノ]ピリジン、 2, 6— ビス [ (3— n—デシルフエ-ル)(6— n—デシルビリジン— 2—ィル)ァミノ]ピリジン、 2 , 6 ビス [ (4— n—デシルフエ-ル)(5— n—デシルビリジン— 2—ィル)ァミノ]ピリジ ン、 2, 6 ビス [ (3—ヒドロキシルフエ-ル)(4 ヒドロキシルピリジン一 2—ィル)アミ ノ]ピリジン、 2, 6 ビス [ (3 ヒドロキシルフエ-ル)(6 ヒドロキシルピリジン一 2—ィ ル)ァミノ]ピリジン、 2, 6 ビス [ (4 -ヒドロキシルフエ-ル)(5 ヒドロキシルピリジン —2—ィル)ァミノ]ピリジン、 2, 6—ビス [ (3—アルカノィルフエ-ル)(4—アルカノィ ルビリジン— 2—ィル)ァミノ]ピリジン、 2, 6 ビス [ (3 アルカノィルフエ-ル)(6— アルカノィルピリジン一 2—ィル)ァミノ]ピリジン、 2, 6 ビス [ (4—アルカノィルフエ- ル)(5 アルカノィルピリジン— 2—ィル)ァミノ]ピリジン、 2, 6 ビス [ (3—カルバモ ィルフエ-ル)(4—力ルバモイルビリジン— 2—ィル)ァミノ]ピリジン、 2, 6 ビス [ (3 —力ルバモイルフエ-ル)(6—力ルバモイルビリジン— 2—ィル)ァミノ]ピリジン、 2, 6 -ビス [ (4 -力ルバモイルフエ-ル)(5 力ルバモイルビリジン 2 ィル)ァミノ]ピリ ジン、 2, 6 ビス [ (3—カルボキシルフエ-ル)(4—カルボキシルピリジン一 2—ィル )ァミノ]ピリジン、 2, 6 ビス [ (3—カルボキシルフエ-ル)(6—カルボキシルピリジン —2—ィル)ァミノ]ピリジン、 2, 6 ビス [ (4—カルボキシルフエ-ル)(5—カルボキシ ルビリジン一 2—ィル)ァミノ]ピリジン、 2, 6 ビス [ (3 シァノフエ-ル)(4 シァノビ リジン一 2—ィル)ァミノ]ピリジン、 2, 6 ビス [ (3—シァノフエ-ル)(6 シァノピリジ ン一 2—ィル)ァミノ]ピリジン、 2, 6 ビス [ (4—シァノフエ-ル)(5 シァノピリジン一 2—ィル)ァミノ]ピリジン、 In general formula (3), 2, 6 bis [(phenol) (pyridine-2-yl) amino] pyridine, 2, 6 bis [(3-methylphenol) (4-methylpyridine-2-yl ) Amino] pyridine, 2, 6-bis [(3-methylphenol) (6-methylpyridine-2-yl) amino] pyridine, 2,6bis [(4-methylphenol) (5-methyl) Pyridine 1-yl) amino] pyridine, 2, 6 bis [(3 —ethylphenyl) (4 ethylpyridine-2-yl) amino] pyridine, 2, 6 bis [(3-ethyl) (6 Ethylpyridine—2-yl) amino] pyridine, 2,6bis [(4-ethylpropyl) (5-ethylpyridine-2-yl) amino] pyridine, 2,6bis [(3-n-propylphenol) ) (4-N-propylpyridine-2-yl) amino] pyridine, 2,6bis [(3-n-propylphenol) (6-n-propylpyridine) 2-yl) amino] pyridine, 2,6-bis [(4-n-propylpropyl) (5-n-propylpyridine-2-yl) amino] pyridine, 2,6-bis [(3-isopropylphenol) ) (4-Isopropylpyridine-2-yl) amino] pyridine, 2,6bis [(3-Isopropylphenol) (6-isopropylpyridine-1-yl) amino] pyridine, 2,6bis [ (4-Isopropyl file) (5-Isopropylpyridine-2-yl) amino] pyridine, 2, 6 bis [(3-n-Butylphenol) (4-n-Butyryridine-2-yl) ) Amino] pyridine, 2, 6 bis [(3-n-butylphenol) (6-n-butylviridine-2-yl) amino] pyridine, 2,6 bis [(4-n-butylphenol) (5-n-butylpyridine-2-yl) amino] pyridine, 2,6bis [(3-isobutylphenol) (4-isobutyl Lysine-2-yl) amino] pyridine, 2,6bis [(3-isobutylphenyl) (6-isobutylpyridine-2-yl) amino] pyridine, 2,6bis [(4-isobutylphenol- ) (5-Isobutylpyridine-2-yl) amino] pyridine, 2, 6 bis [(3 — sec butylphenol) (4 sec butylpyridine-2-yl) amino] pyridine, 2, 6 bis [(3 sec Butylphenol) (6 sec butylpyridine 2-yl) amino] pyridine, 2, 6 bis [(4 sec butylphenol) (5 sec butylpyridine-2-yl) amino] pyridine, 2, 6 bis [(3— tert-butylphenyl) (4-tert-butylpyridine-2-yl) amino] pyridine, 2,6bis [(3-tert-butylphenol) (6-tert-butylpyridine-2-yl) amino ] Pyridine, 2, 6 bis [(4-tert-butylphenol) (5 —Tert-Butylpyridine— 2-yl) amino] pyridine, 2, 6 bis [(3-n-pentylphenol) (4- n pentylviridine-2-yl) amino] pyridine, 2, 6 bis [(3— n-pentylphenol) (6— n-pentylviridine-2-yl) amino] pyridine, 2, 6 bis [(4- n-pentylphenol) (5- n-pentylpyridine-2) —Yl) amino] pyridine, 2, 6 bis [(3 isopentylphenol) (4 isopentylpyridine 2 ylamino)] pyridine, 2, 6 bis [(3-isopentylphenol) (6 —Isopentylpyrrolidine-2-yl) amino] pyridine, 2, 6bis [(4-Isopentylphenyl) (5-isopentylpyridin-2-yl) amino] pyridine, 2,6bis [(3-Neopentylphenol) (4-Neopentylpyridine-2-yl) amino] pyridine, 2, 6 Bis [(3-Neo Ntylphenol) (6-Neopentylviridine-2-yl) amino] pyridine, 2,6bis [(4-Neopentylphenol) (5-Neopentylpyridine-2-amino) amino] pyridine, 2 , 6 Bis [(3-n-hexylphenol) (4-n-hexylpyridine 1- 2-yl) amino] pyridine, 2, 6 bis [(3- n-hexylphenol) (6 — N-hexylpyridine 1-yl) amino] pyridine, 2,6bis [(4-n-hexylphenol) (5-n-hexylpyridine-2-yl) amino] pyridine, 2, 6 Bis [(3-Isohexylphenol) (4-Isohexylpyridine-2-yl) amino] pyridine, 2, 6 Bis [(3-Isohexylphenol) (6-Isohexene) Xylpyridin-2-yl) amino] pyridine, 2, 6 bis [(4-isohexylphenol) (5-isohexylpyridine-2-yl) amino] Pyridine, 2, 6bis [(3-n-octylphenol) (4-n-octylviridine-2-yl) amino] pyridine, 2,6bis [(3-n-octylphenol) (6— n-octylviridine-2-yl) amino] pyridine, 2,6bis [(4-n-octylphenyl) (5-n-octylviridine-2-yl) amino] pyridine, 2,6bis [(3 — N-decylphenol) (4— n-decylviridine-2-yl) amino] pyridine, 2, 6-bis [(3- n-decylphenyl) (6- n-decylviridine-2-yl) Amino] pyridine, 2,6bis [(4-n-decylphenyl) (5-n-decylviridine-2-yl) amino] pyridin, 2,6bis [(3-hydroxylphenyl) (4 Hydroxylpyridine 1-yl) amino] pyridine, 2, 6 bis [(3 Hydroxylphenol) (6-hydroxylpyridine 2- 2-y ) Amino] pyridine, 2, 6-bis [(4 - hydroxyl Hue - Le) (5 hydroxyl-2-I le) Amino] pyridine, 2, 6-bis [(3-Arukanoirufue - Le) (4 Arukanoi Rubilidine-2-yl) amino] pyridine, 2,6bis [(3 alkanoylphenol) (6-alkanoylpyridine-2-yl) amino] pyridine, 2,6bis [(4-alkanoylphenol) ) (5 alkanoylpyridine-2-yl) amino] pyridine, 2, 6 bis [(3-carbamoylphenol) (4-force rubamoylpyridine-2-yl) amino] pyridine, 2, 6 Bis [(3 —Strength Lumamoyl File) (6—Strength Lumamoyl Viridine—2-yl) amino] pyridine, 2, 6 -Bis [(4-Strength Lumamoyl File) (5 T ) Amino] pyridine, 2, 6 bis [(3-carboxyl phenol) (4-carboxyl pyridine-2-yl) amino] pyridine, 2, 6 bis [(3-carboxyl phenol) (6— Carboxylpyridine —2-yl) amino] pyridine, 2, 6 bis [(4-carboxyl Ethyl) (5-carboxyrubiridin-2-yl) amino] pyridine, 2,6bis [(3 cyanophyl) (4 cyanobilysine-2-yl) amino] pyridine, 2,6bis [( 3-Cyanophyl) (6 Cyanopyridine-2-yl) amino] pyridine, 2, 6 bis [(4-Cyanofenol) (5-Cyanofyridine-2-yl) amino] pyridine,
一般式(4)として、 1, 3 ビス [ (フエ-ル)(ピリジン一 2—ィル)ァミノ]ベンゼン、 1, 3 ビス [ (3—メチルフエ-ル)(4—メチルピリジン— 2—ィル)ァミノ]ピリジン、 1, 3— ビス [ (3—メチルフエ-ル)(6—メチルピリジン一 2—ィル)ァミノ]ピリジン、 1, 3 ビス [ (4—メチルフエ-ル)(5—メチルピリジン一 2—ィル)ァミノ]ピリジン、 1, 3 ビス [ (3 —ェチルフエ-ル)(4 ェチルピリジン— 2—ィル)ァミノ]ピリジン、 1, 3 ビス [ (3— ェチルフエ-ル)(6 ェチルピリジン— 2—ィル)ァミノ]ピリジン、 1, 3 ビス [ (4—ェ チルフエ-ル)(5 ェチルピリジン— 2—ィル)ァミノ]ピリジン、 1, 3 ビス [ (3— n— プロピルフエ-ル)(4— n—プロピルピリジン— 2—ィル)ァミノ]ピリジン、 1, 3 ビス [ (3— n—プロピルフエ-ル)(6— n—プロピルピリジン— 2—ィル)ァミノ]ピリジン、 1, 3 ビス [ (4— n プロピルフエ-ル)( 5— n プロピルピリジン— 2 ィル)ァミノ]ピリ ジン、 1, 3 ビス [ (3—イソプロピルフエ-ル)(4—イソプロピルピリジン一 2—ィル)ァ ミノ]ピリジン、 1, 3 ビス [ (3—イソプロピルフエ-ル)(6—イソプロピルピリジン一 2 —ィル)ァミノ]ピリジン、 1, 3 ビス [ (4—イソプロピルフエ-ル)(5—イソプロピルピリ ジン— 2—ィル)ァミノ]ピリジン、 1, 3 ビス [ (3— n—ブチルフエ-ル)(4— n—ブチ ルビリジン— 2—ィル)ァミノ]ピリジン、 1, 3 ビス [ (3— n—ブチルフエ-ル)(6— n —ブチルビリジン— 2—ィル)ァミノ]ピリジン、 1, 3 ビス [ (4— n—ブチルフエ-ル)(In general formula (4), 1,3 bis [(phenol) (pyridine-2-yl) amino] benzene, 1,3 bis [(3-methylphenol) (4-methylpyridine-2-y L) amino] pyridine, 1,3-bis [(3-methylphenol) (6-methylpyridine-2-yl) amino] pyridine, 1,3bis [(4-methylphenol) (5-methyl) Pyridine 1-yl) amino] pyridine, 1,3 bis [(3-ethyl) phenyl (4-ethylpyridine-2-yl) amino] pyridine, 1,3 bis [(3-ethyl) (6) Ethylpyridine—2-yl) amino] pyridine, 1,3 bis [(4-ethylpropyl) (5-ethylpyridine-2-yl) amino] pyridine, 1,3 bis [(3-n-propylphenol) ) (4-N-propylpyridine-2-yl) amino] pyridine, 1,3 bis [(3-n-propylphenol) (6-n-propylpyridine) 2-yl) amino] pyridine, 1,3-bis [(4-npropylpropyl) (5-npropylpyridine-2-yl) amino] pyridine, 1,3-bis [(3-isopropylphenol) ) (4-Isopropylpyridine-2-yl) amino] pyridine, 1,3bis [(3-Isopropylphenol) (6-isopropylpyridine-1-yl) amino] pyridine, 1,3bis [ (4-Isopropyl file) (5-Isopropylpyridine-2-yl) amino] pyridine, 1,3 bis [(3-n-Butylphenol) (4-n-Butyryridine-2-yl) ) Amino] pyridine, 1,3 bis [(3— n-butylphenol) (6— n —Butylviridine— 2-yl) amino] pyridine, 1,3 bis [(4— n-butylphenol) (
5— n—ブチルピリジン— 2—ィル)ァミノ]ピリジン、 1, 3 ビス [ (3—イソブチルフエ -ル)(4—イソブチルピリジン— 2—ィル)ァミノ]ピリジン、 1, 3 ビス [ (3—イソブチ ルフエ-ル)(6—イソブチルピリジン一 2—ィル)ァミノ]ピリジン、 1, 3 ビス [ (4—イソ ブチルフエ-ル)(5—イソブチルピリジン— 2—ィル)ァミノ]ピリジン、 1, 3 ビス [ (3 — sec ブチルフエ-ル)(4 sec ブチルピリジンー2 ィル)ァミノ]ピリジン、 1, 3 ビス [ (3 sec ブチルフエ-ル)(6 sec ブチルピリジン 2 ィル)ァミノ]ピリ ジン、 1, 3 ビス [ (4 sec ブチルフエ-ル)(5— sec ブチルピリジン 2 ィル) ァミノ]ピリジン、 1, 3 ビス [ (3— tert ブチルフエ-ル)(4— tert—ブチルピリジン —2—ィル)ァミノ]ピリジン、 1 , 3 ビス [ (3— tert—ブチルフエ-ル)(6— tert—ブ チルピリジン— 2—ィル)ァミノ]ピリジン、 1, 3 ビス [ (4— tert—ブチルフエ-ル)(5 —tert—ブチルピリジン— 2—ィル)ァミノ]ピリジン、 1, 3 ビス [ (3— n—ペンチルフ ェ -ル)(4— n ペンチルビリジン— 2—ィル)ァミノ]ピリジン、 1, 3 ビス [ (3— n— ペンチルフエ-ル)(6— n—ペンチルビリジン— 2—ィル)ァミノ]ピリジン、 1, 3 ビス [ (4— n—ペンチルフエ-ル)(5— n—ペンチルビリジン— 2—ィル)ァミノ]ピリジン、 1 , 3 ビス [ (3 イソペンチルフエ-ル)(4 イソペンチルビリジン 2 ィル)ァミノ] ピリジン、 1, 3 ビス [ (3—イソペンチルフエ-ル)(6—イソペンチルビリジン一 2—ィ ル)ァミノ]ピリジン、 1, 3 ビス [ (4—イソペンチルフエ-ル)(5—イソペンチルピリジ ン一 2—ィル)ァミノ]ピリジン、 1, 3 ビス [ (3—ネオペンチルフエ-ル)(4—ネオペ ンチルピリジン— 2—ィル)ァミノ]ピリジン、 1, 3 ビス [ (3—ネオペンチルフエ-ル) (5— n-butylpyridine— 2-yl) amino] pyridine, 1,3 bis [(3-isobutylphenol) (4-isobutylpyridine-2-yl) amino] pyridine, 1,3 bis [( 3-isobutylphenyl) (6-isobutylpyridine-2-yl) amino] pyridine, 1,3-bis [(4-isobutylphenol) (5-isobutylpyridine-2-yl) amino] pyridine, 1, 3 Bis [(3 — sec Butyl Phenol) (4 sec Butyl Pyridine-2-yl) amino] pyridine, 1, 3 Bis [(3 sec Butyl Phenol) (6 sec Butyl Pyridine 2 Fil) amino] Pyridine , 1,3 bis [(4 sec butylphenol) (5-sec butylpyridine 2-ylamino) pyridine, 1,3 bis [(3-tert butylphenol) (4-tert-butylpyridine —2— Yl) amino] pyridine, 1,3 bis [(3-tert-butylphenol) (6-tert-butylpropyl) N—2-yl) amino] pyridine, 1,3 bis [(4-tert-butylphenol) (5 —tert-butylpyridine-2-yl) amino] pyridine, 1,3 bis [(3— n- Penchirufu E - Le) (4-n-pentylbicyclo lysine - 2-I le) Amino] pyridine, 1, 3-bis [(3- n- Penchirufue - Le) (6- n- pentylbicyclo lysine - 2-I le) Amino] pyridine, 1,3 bis [(4-n-pentylphenol) (5-n-pentylviridine-2-yl) amino] pyridine, 1,3bis [(3 isopentylphenol) (4 Isopentylviridine 2-yl) amino] pyridine, 1,3 bis [(3-isopentylphenyl) (6-isopentylviridine-2-yl) amino] pyridine, 1,3 bis [(4-iso Pentylphenol) (5-isopentylpyridin-2-yl) amino] pyridine, 1,3bis [(3-neopentylphenol) (4 Neopentyl Nchirupirijin - 2-I le) Amino] pyridine, 1, 3-bis [(3-Neopenchirufue - Le) (
6—ネオペンチルビリジン— 2—ィル)ァミノ]ピリジン、 1, 3 ビス [ (4—ネオペンチル フエ-ル)(5—ネオペンチルビリジン一 2—ィル)ァミノ]ピリジン、 1, 3 ビス [ (3— n —へキシルフエ-ル)(4— n—へキシルピリジン— 2—ィル)ァミノ]ピリジン、 1, 3 ビ ス [ (3— n—へキシルフエ-ル)(6— n—へキシルピリジン一 2—ィル)ァミノ]ピリジン6-Neopentylviridine-2-yl) amino] pyridine, 1,3bis [(4-Neopentylphenol) (5-Neopentylviridine-2-yl) amino] pyridine, 1,3bis [( 3—n—Hexylphenol) (4—n—Hexylpyridine—2-yl) amino] pyridine, 1,3bis [(3—n—hexylphenol) (6—n—hexyl) 1-yl) amino] pyridine
、 1, 3 ビス [ (4— n—へキシルフエ-ル)(5— n—へキシルピリジン一 2—ィル)アミ ノ]ピリジン、 1, 3 ビス [ (3—イソへキシルフエ-ル)(4—イソへキシルピリジン一 2— ィル)ァミノ]ピリジン、 1, 3 ビス [ (3—イソへキシルフエ-ル)(6—イソへキシルピリ ジン一 2—ィル)ァミノ]ピリジン、 1, 3 ビス [ (4—イソへキシルフエ-ル)(5—イソへ キシルピリジン一 2—ィル)ァミノ]ピリジン、 1, 3 ビス [ (3— n—ォクチルフエ-ル)( 4— n—ォクチルビリジン一 2—ィル)ァミノ]ピリジン、 1, 3 ビス [ (3— n—ォクチルフ ェ -ル)(6— n—ォクチルビリジン一 2—ィル)ァミノ]ピリジン、 1, 3 ビス [ (4— n— ォクチルフエ-ル)(5— n—ォクチルビリジン— 2—ィル)ァミノ]ピリジン、 1, 3 ビス [ (3— n—デシルフエ-ル)(4— n—デシルビリジン— 2—ィル)ァミノ]ピリジン、 1, 3— ビス [ (3— n—デシルフエ-ル)(6— n—デシルビリジン— 2—ィル)ァミノ]ピリジン、 1 , 3 ビス [ (4— n—デシルフエ-ル)(5— n—デシルビリジン— 2—ィル)ァミノ]ピリジ ン、 1, 3 ビス [ (3 ヒドロキシルフエ-ル)(4 ヒドロキシルピリジン一 2—ィル)アミ ノ]ピリジン、 1, 3 ビス [ (3 ヒドロキシルフエ-ル)(6 ヒドロキシルピリジン一 2—ィ ル)ァミノ]ピリジン、 1, 3 ビス [ (4 ヒドロキシルフエ-ル)(5 ヒドロキシルピリジン —2—ィル)ァミノ]ピリジン、 1, 3 ビス [ (3 アルカノィルフエ-ル)(4 アルカノィ ルビリジン— 2—ィル)ァミノ]ピリジン、 1, 3 ビス [ (3 アルカノィルフエ-ル)(6— アルカノィルピリジン一 2—ィル)ァミノ]ピリジン、 1, 3 ビス [ (4—アルカノィルフエ- ル)(5 アルカノィルピリジン— 2—ィル)ァミノ]ピリジン、 1, 3 ビス [ (3—カルバモ ィルフエ-ル)(4—力ルバモイルビリジン— 2—ィル)ァミノ]ピリジン、 1, 3 ビス [ (3 —力ルバモイルフエ-ル)(6—力ルバモイルビリジン— 2—ィル)ァミノ]ピリジン、 1, 3 -ビス [ (4 -力ルバモイルフエ-ル)(5 力ルバモイルビリジン 2 ィル)ァミノ]ピリ ジン、 1, 3 ビス [ (3—カルボキシルフエ-ル)(4—カルボキシルピリジン一 2—ィル )ァミノ]ピリジン、 1, 3 ビス [ (3—カルボキシルフエ-ル)(6—カルボキシルピリジン —2—ィル)ァミノ]ピリジン、 1, 3 ビス [ (4—カルボキシルフエ-ル)(5—カルボキシ ルビリジン— 2—ィル)ァミノ]ピリジン、 1, 3 ビス [ (3 シァノフエ-ル)(4 シァノビ リジン一 2—ィル)ァミノ]ピリジン、 1, 3 ビス [ (3 シァノフエ-ル)(6 シァノピリジ ン一 2—ィル)ァミノ]ピリジン、 1, 3 ビス [ (4—シァノフエ-ル)(5 シァノピリジン一 2—ィル)ァミノ]ピリジン、等が挙げられる。これらの中で、 2, 6 ビス [ジ(ピリジン— 2—ィル)ァミノ]ピリジン、 2, 6 ビス [ジ(5—メチルピリジン— 2—ィル)ァミノ]ピリジ ン、 1, 3 ビス [ジ(ピリジン一 2—ィル)ァミノ]ベンゼン、 1, 3 ビス [ジ(5—メチルビ リジン一 2—ィル)ァミノ]ベンゼン、 2, 6 ビス [ (フエ-ル)(ピリジン一 2—ィル)ァミノ ]ピリジン、 2, 6 ビス [ (4—メチルフエ-ル)(5—メチルピリジン— 2—ィル)ァミノ]ピ リジン、 1, 3 ビス [ (フエ-ル)(ピリジン— 2—ィル)ァミノ]ベンゼンおよび 1, 3 ビ ス [ (4 メチルフエ-ル)(5 メチルピリジン 2 ィル)ァミノ]ベンゼンが好まし!/、。 , 1,3 bis [(4-n-hexylphenol) (5-n-hexylpyridine-2-yl) amino] pyridine, 1,3 bis [(3-isohexylphenol) ( 4-Isohexylpyridine-2-yl) amino] pyridine, 1,3 bis [(3-Isohexylphenol) (6-isohexylpyridine-2-yl) amino] pyridine, 1, 3 Bis [(4-Isohexylphenol) (5-Isohexyl) Xylpyridine-2-yl) amino] pyridine, 1,3bis [(3-n-octylphenol) (4-n-octylviridine-2-yl) amino] pyridine, 1,3bis [(3— n-octylphenol) (6-n-octylviridine-2-yl) amino] pyridine, 1,3 bis [(4-n-octylphenyl) (5-n-octylviridine-2-yl) amino ] Pyridine, 1,3bis [(3-n-decylphenyl) (4-n-decylviridine-2-yl) amino] pyridine, 1,3-bis [(3-n-decylphenol) (6 — N-decylviridine—2-yl) amino] pyridine, 1,3 bis [(4-n-decylvinyl) (5-n-decylviridine-2-yl) amino] pyridin, 1,3 bis [ (3 hydroxyl file) (4 hydroxyl pyridine 1- 2-yl) amino] pyridine, 1, 3 bis [(3 hydroxyl file) 6 Hydroxylpyridine 1-yl) amino] pyridine, 1,3 bis [(4 hydroxylphenol) (5 Hydroxylpyridine —2-yl) amino] pyridine, 1,3 bis [(3 alkanoylphenol) (4 Alkanorubiridine—2-yl) amino] pyridine, 1,3 bis [(3 Alkanoylphenol) (6-Alkanoylpyridine-1-yl) amino] pyridine, 1,3 bis [(4— Alkanoylphenol) (5 alkanoylpyridine-2-yl) amino] pyridine, 1,3 bis [(3-carbamoylphenol) (4-force rubamoylviridine-2-yl) amino] pyridine, 1, 3 Bis [(3 —Strengthen rubermoyl file) (6—Strength rubermoyl pyridine—2-yl) amino] pyridine, 1, 3-bis [(4 -Strength ruber moyl file) (5-strength ruber moyl ferridine) 2-yl) amino] pyridine, 1, 3 bis [(3-carol Xylphenyl) (4-carboxylpyridine-2-yl) amino] pyridine, 1,3bis [(3-carboxylphenol) (6-carboxylpyridine-2-yl) amino] pyridine, 1, 3 Bis [(4-carboxylphenol) (5-carboxyrubiridin-2-yl) amino] pyridine, 1,3 bis [(3 cyanol) (4 cyanobilysine 2-yl) amino] pyridine, 1,3 bis [(3 cyanophyl) (6-cyanopyridine-2-yl) amino] pyridine, 1,3 bis [(4-cyanophyl) (5-cyanopyridine-2-yl) amino] pyridine, Etc. Among these, 2,6 bis [di (pyridine-2-yl) amino] pyridine, 2,6 bis [di (5-methylpyridine-2-yl) amino] pyridin, 1,3 bis [ Di (pyridine-2-yl) amino] benzene, 1,3 bis [di (5-methylpyridine-1-2-yl) amino] benzene, 2,6 bis [(phenol) (pyridine-2-2 ) Amino] pyridine, 2, 6bis [(4-methylphenol) (5-methylpyridine-2-yl) amino] pi Lysine, 1,3-bis [(phenyl) (pyridine-2-yl) amino] benzene, and 1,3-bis [(4 methylphenol) (5-methylpyridine-2-yl) amino] benzene are preferred. ! /
[0030] 一般式 (I)で表される本発明の化合物は、例えば、以下のようにして製造できる。す なわち、一般式 (Π) :  [0030] The compound of the present invention represented by the general formula (I) can be produced, for example, as follows. That is, the general formula (Π):
[0031] [化 10]
Figure imgf000017_0001
[0031] [Chemical 10]
Figure imgf000017_0001
[0032] (式中、 R1は、水素原子、水酸基、カルボキシル基、シァノ基、力ルバモイル基、炭素 数 1〜10のアルキル基、または炭素数 1〜10のアルカノィル基を示し、 Vは窒素原子 または炭素原子を示し、 Xはハロゲン原子を示す。)で表されるジハロゲノ単環化合 物と、一般式 (ΠΙ) : (In the formula, R 1 represents a hydrogen atom, a hydroxyl group, a carboxyl group, a cyano group, a strong rubamoyl group, an alkyl group having 1 to 10 carbon atoms, or an alkanoyl group having 1 to 10 carbon atoms, and V represents nitrogen. Dihalogeno monocyclic compounds represented by the general formula (ΠΙ):
[0033] [化 11]  [0033] [Chemical 11]
Figure imgf000017_0002
Figure imgf000017_0002
[0034] (式中、 R2および R3は、それぞれ独立して、水素原子、水酸基、カルボキシル基、シ ァノ基、力ルバモイル基、炭素数 1〜10のアルキル基、または炭素数 1〜10のアル力 ノィル基を示し、これらは同一であっても異なっていてもよぐ Wは窒素原子または炭 素原子を示す。)で表されるアミンィ匕合物とを、ノラジウム化合物およびホスフィンィ匕 合物を含む触媒並びに塩基の存在下、反応させることにより、目的とする化合物を得 ることがでさる。 (Wherein R 2 and R 3 are each independently a hydrogen atom, a hydroxyl group, a carboxyl group, a cyano group, a strong rubamoyl group, an alkyl group having 1 to 10 carbon atoms, or an alkyl group having 1 to 10 may be the same or different, and W may be the same or different. W represents a nitrogen atom or a carbon atom.) The target compound can be obtained by reacting in the presence of a catalyst containing the compound and a base.
[0035] 一般式 (Π)で表されるジハロゲノ単環化合物にお 、て、 Xで示されるハロゲン原子 としては、例えば、フッ素原子、塩素原子、臭素原子およびヨウ素原子等が挙げられ る。  In the dihalogeno monocyclic compound represented by the general formula (式), examples of the halogen atom represented by X include a fluorine atom, a chlorine atom, a bromine atom, and an iodine atom.
[0036] 前記一般式 (Π)で表されるジハロゲノ単環化合物の具体例としては、 Vが窒素原子 である場合には、 2, 6 ジハロゲノピリジンィ匕合物、 Vが炭素原子である場合には、 1 , 3—ジハロゲノベンゼン化合物が挙げられる。 [0036] As a specific example of the dihalogeno monocyclic compound represented by the general formula (Π), V is a nitrogen atom. In this case, 2, 6 dihalogenopyridine compound, and in the case where V is a carbon atom, 1,3-dihalogenobenzene compound can be mentioned.
また、 2, 6 ジハロゲノピリジン化合物の具体例としては、 2, 6 ジフルォロピリジ ン、 2, 6 ジクロ口ピリジン、 2, 6 ジブロモピリジン、 2, 6 ジョードピリジン、 2, 6— ジクロロー 3 メチルピリジン、 2, 6 ジクロロー 4 メチルピリジン、 2, 6 ジクロロー 5 メチルピリジン、 2, 6 ジクロロー 3 ェチルピリジン、 2, 6 ジクロロー 4ーェチ ルピリジン、 2, 6 ジクロロー 5 ェチルピリジン、 2, 6 ジクロロー 3 イソプロピル ピリジン、 2, 6 ジクロロー 4 イソプロピルピリジン、 2, 6 ジクロロー 5 イソプロピ ルピリジン、 2, 6 ジクロロ一 3— n—プロピルピリジン、 2, 6 ジクロロ一 4— n—プロ ピノレビリジン、 2, 6 ジクロロー 5—n—プロピノレビリジン、 2, 6 ジクロロー 3—n—ブ チルピリジン、 2, 6 ジクロロー 4 n—ブチルピリジン、 2, 6 ジクロロー 5—n—ブ チルピリジン、 2, 6 ジクロロー 3 sec ブチルピリジン、 2, 6 ジクロロー 4 sec ブチルピリジン、 2, 6 ジクロロー 5 sec ブチルピリジン、 2, 6 ジクロロー 3— tert ブチルピリジン、 2, 6 ジクロロー 4—tert ブチルピリジン、 2, 6 ジクロ口 — 5—tert ブチルピリジン、 2, 6 ジクロロー 3—n—ペンチルビリジン、 2, 6 ジク ロロ一 4— n—ペンチルピリジン、 2, 6 ジクロロ一 5—n—ペンチルピリジン、 2, 6— ジクロロー 3 イソペンチルピリジン、 2, 6 ジクロロー 4 イソペンチルピリジン、 2, 6 ージクロロー 5 イソペンチルピリジン、 2, 6 ジクロロー 3 ネオペンチルピリジン、 2, 6 ジクロロ一 4—ネオペンチルピリジン、 2, 6 ジクロロ一 5—ネオペンチルピリ ジン、 2, 6 ジクロロー 3—n—へキシノレピリジン、 2, 6 ジクロロー 4—n—へキシル ピリジン、 2, 6 ジクロロー 5— n—へキシノレピリジン、 2, 6 ジクロロー 3 イソへキシ ノレピリジン、 2, 6 ジクロロー 4 イソへキシノレピリジン、 2, 6 ジクロロー 5 イソへキ シルピリジン、 2, 6 ジクロロ一 3—n—ォクチルビリジン、 2, 6 ジクロロ一 4—n—ォ クチノレピリジン、 2, 6 ジクロロー 5—n—ォクチノレピリジン、 2, 6 ジクロロー 3—n— デシノレピリジン、 2, 6 ジクロロー 4—n—デシノレピリジン、 2, 6 ジクロロー 5—n— デシノレピリジン、 2, 6 ジクロロー 4 シァノピリジン、 2, 6 ジクロロー 4一力ノレボキ シピリジン、 2, 6 ジクロロ一 4 ヒドロキシピリジン等が挙げられる。中でも、入手しや すく経済的である観点から、 2, 6 ジクロ口ピリジンおよび 2, 6 ジブロモピリジンが 好適に用いられる。 Specific examples of 2,6 dihalogenopyridine compounds include 2,6 difluoropyridin, 2,6 dicyclopyridine, 2,6 dibromopyridine, 2,6 jodopyridine, 2,6-dichloro-3 methylpyridine, 2 , 6 dichloro-4 methylpyridine, 2,6 dichloro-5 methylpyridine, 2,6 dichloro-3 ethylpyridine, 2,6 dichloro-4-ethylpyridine, 2,6 dichloro-5 ethylpyridine, 2,6 dichloro-3 isopropylpyridine, 2,6 dichloro-4 Isopropylpyridine, 2,6 dichloro-5 isopropylpyridine, 2,6 dichloro-1-3-n-propylpyridine, 2,6 dichloro-4-n-propinoleviridine, 2,6 dichloro-5-n-propinoleviridine, 2, 6 Dichloro-3—n-Butylpyridine, 2, 6 Dichloro-4 n-Butylpyridine, 2, 6 Dichloro-5-n— Tylpyridine, 2, 6 dichloro-3 sec butylpyridine, 2, 6 dichloro-4 sec butylpyridine, 2, 6 dichloro-5 sec butylpyridine, 2, 6 dichloro-3-tert-butylpyridine, 2,6-dichloro-4-tert-butylpyridine, 2 , 6 Dichloromethane — 5-tert-butylpyridine, 2,6-dichloro-3-n-pentylpyridine, 2,6-dichloro 4-n-pentylpyridine, 2,6-dichloro-1-5-n-pentylpyridine, 2, 6 — Dichloro-3 isopentylpyridine, 2, 6 dichloro-4 isopentylpyridine, 2, 6-dichloro-5 isopentylpyridine, 2, 6 dichloro-3 neopentylpyridine, 2,6 dichloro 1 4-neopentyl pyridine, 2, 6 dichloro 1 5-Neopentylpyridine, 2,6-dichloro-3-n-hexylolepyridine, 2,6-dichloro-4-n-hexylpyridine, 2,6 di Rollo 5— n-hexenorepyridine, 2, 6 dichloro-3 isohexylene pyridine, 2, 6 dichloro-4 isohexenorepyridine, 2, 6 dichloro-5 isohexyl pyridine, 2, 6 dichloro 1 3-n— Octylviridine, 2,6 dichloro 4-n-octinorepyridine, 2, 6 dichloro-5-n-octinorepyridine, 2, 6 dichloro 3-n-decinorepyridine, 2, 6 dichloro 4-n-decinorepyridine, 2, 6 Examples include dichloro-5-n-decinorepyridine, 2,6 dichloro-4-cyanopyridine, 2,6 dichloro-4 selenium norpyridine pyridine, 2,6 dichloro-4-hydroxypyridine, and the like. Among these, 2,6 diclomental pyridine and 2,6 dibromopyridine are preferred because they are easily available and economical. Preferably used.
[0037] 1, 3 ジハロゲノベンゼン化合物の具体例としては、 1, 3 ジフルォロベンゼン、 1 , 3 ジクロロベンゼン、 1, 3 ジブロモベンゼン、 1, 3 ジョードベンゼン、 1, 3— ジブ口モー 2—メチノレベンゼン、 1, 3 ジブ口モー 2 ェチノレベンゼン、 1, 3 ジブ 口モー 2—n—へキシノレベンゼン、 1, 3 ジブ口モー 2—n—ォクチノレベンゼン、 1, 3 —ジブ口モー 2— n—デシルベンゼン、 1, 3 ジブ口モー 4—メチルベンゼン、 1, 3 ジブ口モー 4ーェチノレベンゼン、 1, 3 ジブ口モー 4—n—へキシノレベンゼン、 1, 3 ジブ口モー 4 n—ォクチルベンゼン、 1, 3 ジブ口モー 4 n デシルベンゼン 、 1, 3 ジブ口モー 5—メチノレベンゼン、 1, 3 ジブ口モー 5 ェチノレベンゼン、 1, 3 ジブ口モー 5—n—へキシノレベンゼン、 1, 3 ジブ口モー 5—n—ォクチノレベンゼン 、 1, 3 ジブ口モー 5— n—デシルベンゼン、 1, 3 ジクロロ 5—メチルベンゼン、 1 , 3 ジクロロ一 5 ェチルベンゼン、 1, 3 ジクロロ一 5— n—へキシノレベンゼン、 1 , 3 ジクロロ一 5— n—ォクチルベンゼン、 1, 3 ジクロロ一 5— n—デシルベンゼン 、 1, 3 ジブ口モー 5 ヒドロキシベンゼン、 1, 3 ジブ口モー 5 アルカノィルベン ゼン、 1, 3 ジブ口モー 5—力ルバモイルベンゼン、 1, 3 ジブ口モー 5 カルボキ シベンゼン、 1, 3 ジブ口モー 5 シァノベンゼン等が挙げられる。中でも、入手しや すく経済的である観点から、 1, 3 ジブロモベンゼンおよび 1, 3 ジクロ口ベンゼン が好適に用いられる。  [0037] Specific examples of 1,3 dihalogenobenzene compounds include 1,3 difluorobenzene, 1,3 dichlorobenzene, 1,3 dibromobenzene, 1,3 jodobenzene, 1,3—dib-mouthed —Methylolebenzene, 1,3 Jib mouth mode 2 Ethenolebenzene, 1,3 Jib mouth mode 2—n—Hexinolebenzene, 1,3 Jib port mode 2—n—Octinolebenzene, 1, 3 —Jib port Mo 2— n-decylbenzene, 1, 3 dib-mouthed MO 4-methylbenzene, 1, 3 Jib-mouthed Mo 4-ethylenobenzene, 1, 3 Jib-mouthed Mo 4—n—hexynolebenzene, 1, 3 Jib mouth mode 4 n—octylbenzene, 1, 3 Jib port mode 4 n decylbenzene, 1, 3 Jib mode mode 5—Methinorebenzene, 1, 3 Jib mode mode 5 Ethinorebenzene, 1, 3 Jib mode mode 5—n— Hexinorebenzene, 1, 3 Jib mouth mor 5-n-octinolebenzene, 1, 3 di 5-n-decylbenzene, 1,3 dichloro 5-methylbenzene, 1,3 dichloro-5-ethylbenzene, 1,3 dichloro 5-5-n-hexenolebenzene, 1,3 dichloro 5-5-n— Octylbenzene, 1,3-dichloro-1,5-n-decylbenzene, 1,3 dib-mouthed mo 5 hydroxybenzene, 1,3 dib-headed mo 5 alkanoylbenzene, 1,3 dib-mouthed mo 5—powered rubermoylbenzene, 1, 3 Examples include jib mouth moe 5 carboxybenzene and 1,3 jib mouth moe 5 cyanobenzene. Of these, 1,3 dibromobenzene and 1,3 dichroic benzene are preferably used from the viewpoint of availability and economy.
[0038] 一般式 (III)で表されるアミンィ匕合物の具体例としては、 Wが窒素原子である場合 には、ビス(ピリジン一 2—ィル)ァミン、ビス(4—メチルピリジン一 2—ィル)ァミン、ビ ス(5—メチルビリジン一 2—ィル)ァミン、ビス(6 メチルピリジン一 2 ィル)ァミン、 ビス(4 -ェチルピリジン一 2 ィル)ァミン、ビス (5-ェチルピリジン 2 ィル)ァミン 、ビス(6 ェチルピリジン— 2—ィル)ァミン、ビス(4—n—プロピルピリジン— 2—ィ ル)ァミン、ビス(5— n—プロピルピリジン— 2—ィル)ァミン、ビス(6— n—プロピルピ リジン一 2—ィル)ァミン、ビス(4—イソプロピルピリジン一 2—ィル)ァミン、ビス(5—ィ ソプロピルピリジン一 2—ィル)ァミン、ビス(6—イソプロピルピリジン一 2—ィル)ァミン 、ビス(4—n—ブチルピリジン— 2—ィル)ァミン、ビス(5— n—ブチルピリジン— 2— ィル)ァミン、ビス(6— n—ブチルピリジン一 2—ィル)ァミン、ビス(4—イソブチルピリ ジン一 2—ィル)ァミン、ビス(5—イソブチルピリジン一 2—ィル)ァミン、ビス(6—イソ ブチノレピリジン一 2 ィノレ)ァミン、ビス(4 - sec -ブチノレピリジン一 2 ィノレ)ァミン、 ビス(5 sec ブチノレピリジン 2 ィル)ァミン、ビス(6 sec ブチノレピリジン 2 —ィル)ァミン、ビス(4— tert—ブチルピリジン— 2—ィル)ァミン、ビス(5— tert—ブ チルピリジン 2 ィル)ァミン、ビス(6— tert ブチルピリジンー2 ィル)ァミン、ビ ス(4—n—ペンチルビリジン 2 ィル)ァミン、ビス(5—n—ペンチルビリジン 2— ィル)ァミン、ビス(6— n—ペンチルビリジン一 2—ィル)ァミン、ビス(4—イソペンチル ピリジン— 2—ィル)ァミン、ビス(5—イソペンチルビリジン— 2—ィル)ァミン、ビス(6 イソペンチルビリジン 2 ィル)ァミン、ビス(4 ネオペンチルビリジン 2—ィル )ァミン、ビス(5 ネオペンチルピリジンー2 ィル)ァミン、ビス(6 ネオペンチルピ リジン— 2—ィル)ァミン、ビス(4— n—へキシルピリジン— 2—ィル)ァミン、ビス(5— n -へキシルピリジン 2 ィル)ァミン、ビス(6— n へキシルピリジン 2 ィル)ァ ミン、ビス(4—イソへキシルピリジン一 2—ィル)ァミン、ビス(5—イソへキシルピリジン —2—ィル)ァミン、ビス(6—イソへキシルピリジン一 2—ィル)ァミン、ビス(4— n—ォ クチルビリジン一 2—ィル)ァミン、ビス(5— n—ォクチルビリジン一 2—ィル)ァミン、ビ ス(6— n—ォクチルビリジン一 2—ィル)ァミン、ビス(4— n—デシルビリジン一 2—ィ ル)ァミン、ビス(5— n—デシルビリジン— 2—ィル)ァミン、ビス(6— n—デシルピリジ ン一 2—ィル)ァミン、ビス(4 ヒドロキシルピリジン一 2—ィル)ァミン、ビス(5 ヒドロ キシルピリジン一 2—ィル)ァミン、ビス(6 ヒドロキシルピリジン一 2—ィル)ァミン、ビ ス(4 アルカノィルピリジン一 2 ィル)ァミン、ビス(5 アルカノィルピリジン一 2 ィ ル)ァミン、ビス(6 アルカノィルピリジン— 2—ィル)ァミン、ビス(4—力ルバモイルビ リジン— 2—ィル)ァミン、ビス(5—力ルバモイルビリジン— 2—ィル)ァミン、ビス(6— 力ルバモイルビリジン— 2—ィル)ァミン、ビス(4—カルボキシルピリジン— 2—ィル) ァミン、ビス(5—カルボキシルピリジン一 2—ィル)ァミン、ビス(6—カルボキシルピリ ジン一 2—ィル)ァミン、ビス(4 シァノピリジン一 2—ィル)ァミン、ビス(5 シァノピリ ジン 2 ィル)ァミンおよびビス(6 シァノピリジン 2 ィル)ァミン等が挙げられ る。中でも、入手しやすく経済的である観点から、ビス (ピリジン— 2—ィル)ァミンおよ びビス(5 メチルピリジン 2 ィル)ァミンが好適に用いられる。 また、一般式 (III)で表されるアミンィ匕合物の具体例としては、 Wが炭素原子である 場合には、 (フエ-ル)(ピリジン 2 ィル)ァミン、 (3 メチルフエ-ル)(4 メチル ピリジン— 2—ィル)ァミン、 (3—メチルフエ-ル)(6—メチルピリジン— 2—ィル)アミ ン、 (4 メチルフエ-ル)(5 メチルピリジンー2 ィル)ァミン、 (3 ェチルフエ-ル ) (4 ェチルピリジン 2 ィル)ァミン、 (3 ェチルフエ-ル)(6 ェチルピリジン 2 ィル)ァミン、 (4 ェチルフエ-ル)(5 ェチルピリジン— 2—ィル)ァミン、 (3— n —プロピルフエ-ル)(4— n—プロピルピリジン— 2—ィル)ァミン、 (3— n—プロピル フエ-ル)(6— n—プロピルピリジン一 2—ィル)ァミン、 (4— n—プロピルフエ-ル) (5 —n—プロピルピリジン一 2—ィル)ァミン、 (3—イソプロピルフエ-ル)(4—イソプロピ ルビリジン一 2—ィル)ァミン、 (3—イソプロピルフエ-ル)(6—イソプロピルピリジン一 2 ィル)ァミン、 (4—イソプロピルフエ-ル)(5—イソプロピルピリジン一 2—ィル)アミ ン、 (3 n—ブチルフエ-ル)(4 n—ブチルピリジンー2 ィル)ァミン、 (3—n—ブ チルフエ-ル)(6 n—ブチルピリジンー2 ィル)ァミン、 (4 n—ブチルフエ-ル)( 5 n—ブチルピリジンー2 ィル)ァミン、 (3 イソブチルフエ-ル)(4 イソブチル ピリジン 2 ィル)ァミン、 (3 イソブチルフエ-ル)(6 イソブチルピリジンー2—ィ ル)ァミン、 (4 イソブチルフエ-ル)(5 イソブチルピリジンー2 ィル)ァミン、 (3— sec ブチルフエ-ル)(4 sec ブチルピリジンー2 ィル)ァミン、 (3 sec ブチ ルフエ-ル)(6 sec ブチルピリジンー2 ィル)ァミン、 (4 sec ブチルフエ-ル ) (5 sec ブチルピリジン 2 ィル)ァミン、 (3—tert ブチルフエ-ル)(4—tert ブチルピリジン 2 ィル)ァミン、 (3—tert ブチルフエ-ル)(6—tert ブチル ピリジン 2 ィル)ァミン、 (4—tert ブチルフエ-ル)(5—tert ブチルピリジン 2 ィル)ァミン、 (3—n—ペンチルフエ-ル)(4— n—ペンチルピリジンー2—ィル )ァミン、 (3—n—ペンチルフエ-ル)(6— n—ペンチルビリジンー2 ィル)ァミン、 (4 —n—ペンチルフエ-ル)(5— n—ペンチルピリジン— 2—ィル)ァミン、 (3—イソペン チルフエ-ル)(4 イソペンチルビリジン 2 ィル)ァミン、 (3 イソペンチルフエ- ル)(6 イソペンチルビリジン 2 ィル)ァミン、 (4 イソペンチルフエ-ル)(5—ィ ソペンチルビリジン 2 ィル)ァミン、 (3 ネオペンチルフエ-ル)(4 ネオペンチ ルビリジン 2 ィル)ァミン、 (3 ネオペンチルフエ-ル)(6 ネオペンチルビリジン —2—ィル)ァミン、 (4—ネオペンチルフエ-ル)(5—ネオペンチルビリジン— 2—ィ ル)ァミン、 (3— n—へキシルフエ-ル)(4— n—へキシルピリジン— 2—ィル)ァミン、 (3— n—へキシルフエ-ル)(6— n—へキシルピリジン— 2—ィル)ァミン、 (4 n キシルフエ-ル)(5— n—へキシルピリジン一 2—ィル)ァミン、 (3—イソへキシルフェ -ル)(4—イソへキシルピリジン一 2—ィル)ァミン、 (3—イソへキシルフエ-ル)(6— イソへキシルピリジン一 2—ィル)ァミン、 (4—イソへキシルフエ-ル)(5—イソへキシ ルビリジン 2 ィル)ァミン、 (3— n—ォクチルフエ-ル)(4— n—ォクチルビリジン 2 ィル)ァミン、 (3— n—ォクチルフエ-ル)(6— n—ォクチルビリジンー2 ィル) ァミン、 (4— n ォクチルフエ-ル)(5— n—ォクチルビリジン一 2—ィル)ァミン、 (3 —n—デシルフヱ-ル)(4— n—デシルビリジン— 2—ィル)ァミン、 (3— n—デシルフ ェ -ル)(6— n—デシルビリジン— 2—ィル)ァミン、 (4— n—デシルフエ-ル)(5— n —デシルビリジン一 2—ィル)ァミン、 (3 ヒドロキシルフエ-ル)(4 ヒドロキシルピリ ジン一 2—ィル)ァミン、 (3 ヒドロキシルフエ-ル)(6 ヒドロキシルピリジン一 2—ィ ル)ァミン、 (4 ヒドロキシルフエ-ル)(5 ヒドロキシルピリジン一 2—ィル)ァミン、 (3 —アルカノィルフエ-ル)(4 アルカノィルピリジン一 2—ィル)ァミン、 (3 アルカノ ィルフエ-ル)(6 アルカノィルピリジン 2 ィル)ァミン、 (4 アルカノィルフエ- ル)(5 アルカノィルピリジン 2 ィル)ァミン、 (3—力ルバモイルフエ-ル)(4一力 ルバモイルピリジン 2 ィル)ァミン、 (3—力ルバモイルフエ-ル)(6—力ルバモイ ルビリジン 2 ィル)ァミン、 (4一力ルバモイルフエ-ル)(5—力ルバモイルビリジン —2—ィル)ァミン、 (3—カルボキシルフエ-ル)(4—カルボキシルピリジン— 2—ィル )ァミン、 (3—カルボキシルフエ-ル)(6—カルボキシルピリジン— 2—ィル)ァミン、 ( 4—カルボキシルフエ-ル)(5—カルボキシルピリジン— 2—ィル)ァミン、 (3 シァノ フエ-ル)(4 シァノピリジン一 2—ィル)ァミン、 (3 シァノフエ-ル)(6 シァノピリ ジンー2 ィル)ァミン、 (4 シァノフエ-ル)(5 シァノピリジンー2 ィル)アミン等 が挙げられる。中でも入手しやすく経済的である観点から、(フ ニル)(ピリジン— 2 ィル)ァミンおよび (4 メチルフエ-ル)(5 メチルピリジン 2 ィル)ァミンが好 適に用いられる。 [0038] As specific examples of the amine compound represented by the general formula (III), when W is a nitrogen atom, bis (pyridine-1-yl) amine, bis (4-methylpyridine 2-yl) amine, bis (5-methylpyrrolidine-2-yl) amine, bis (6-methylpyridine-2-yl) amine, bis (4-ethylpyridine-2-yl) amamine, bis (5- Ethylpyridine 2-yl) amine, bis (6-ethylpyridine-2-yl) amine, bis (4-n-propylpyridine-2-yl) amine, bis (5-n-propylpyridine-2-yl) amine Bis (6-n-propylpyridin-2-yl) amine, bis (4-isopropylpyridine-2-yl) amine, bis (5-isopropylpyridine-2-yl) amine, bis (6 —Isopropylpyridine-2-yl) amine, bis (4-n-butyl) Lysine - 2-I le) Amin, bis (5-n-butylpyridine - 2 I le) Amin, bis (6- n-butylpyridine one 2-I le) Amin, bis (4-Isobuchirupiri Gin-2-yl) amine, bis (5-isobutylpyridine-2-yl) amine, bis (6-isobutynolepyridine-2-inole) amine, bis (4-sec-butynolepyridine-2-inole) Amines, bis (5 sec butynolepyridine 2-yl) amines, bis (6 sec butynolepyridine 2-yl) amines, bis (4-tert-butylpyridine-2-yl) amines, bis (5-tert) —Butylpyridine 2-yl) amine, bis (6-tert-butylpyridine-2-yl) amine, bis (4-n-pentylviridine-2-yl) amine, bis (5-n-pentylviridine-2-yl) amine Bis (6-n-pentylviridine-2-yl) amine, bis (4-isopentylpyridine-2-yl) amine, bis (5-isopentylviridine-2-yl) amine, bis (6-iso) Pentylviridine 2 yl) amine, Sus (4 neopentylpyridine 2-yl) amine, bis (5 neopentylpyridine-2-yl) amine, bis (6 neopentylpyridin-2-yl) amamine, bis (4-n-hexylpyridine-2) —Yl) amine, bis (5-n-hexylpyridine 2-yl) amine, bis (6-n-hexylpyridine 2-yl) amine, bis (4-isohexylpyridine-2-yl) Amines, bis (5-isohexylpyridine-2-yl) amines, bis (6-isohexylpyridine-2-yl) amines, bis (4-n-octylviridine-2-yl) amines, Bis (5-n-octylviridine-2-yl) amine, bis (6-n-octylviridine-2-yl) amine, bis (4-n-decylviridine-2-yl) amine, bis (5- n-decylviridine-2-yl) amine, bis (6-n-decyl) Lysine-2-yl) amine, bis (4-hydroxylpyridine-2-yl) amine, bis (5-hydroxypyridine-2-yl) amine, bis (6-hydroxylpyridine-2-yl) amine, Bis (4 alkanoylpyridine 1-2 yl) amine, bis (5 alkanoyl pyridine 1-2 yl) amine, bis (6 alkanol pyridine-2-yl) amamine, bis (4-strength rubamoylbi) Lysine—2-yl) amine, bis (5-force rubermoyl bilysine—2-yl) amine, bis (6-force rubermoyl bilysin—2-yl) amine, bis (4-carboxylpyridine—— Yl) amine, bis (5-carboxylpyridine-2-yl) amine, bis (6-carboxylpyridine-2-yl) amine, bis (4-cyanopyridine-2-yl) amamine, bis (5-cyanopyridine) Gin 2 Amin and bis (6 Shianopirijin 2 I le) Ru Amin, and the like. Of these, bis (pyridine-2-yl) amine and bis (5-methylpyridine 2-yl) amine are preferably used from the viewpoint of availability and economy. In addition, specific examples of the amine compound represented by the general formula (III) include, when W is a carbon atom, (phenyl) (pyridine 2-yl) amine, (3 methylphenol) (4 Methylpyridine-2-yl) amine, (3-Methylphenol) (6-Methylpyridine-2-yl) amine, (4 Methylphenol) (5 Methylpyridine-2-yl) amine, (3 Ethylphenyl) (4 ethylpyridine 2-yl) amine, (3 ethylphenol) (6 ethylpyridine-2-yl) amine, (4 ethylphenyl) (5 ethylpyridine-2-yl) amamine, (3— n — Propylphenol) (4-n-propylpyridine-2-yl) amine, (3-n-propylphenol) (6-n-propylpyridine-2-yl) amine, (4-n-propylphenol) -Le) (5-n-propylpyridine 1-yl) amine, (3-iso) (Ro-propyl) (4-isopropylpropylidine-2-yl) amine, (3-isopropylphenyl) (6-isopropylpyridine-2-yl) amine, (4-isopropylphenyl) (5-isopropylpyridine) 1-yl) amine, (3 n-butylphenol) (4 n-butylpyridine-2-yl) amine, (3-n-butylpyridine) (6 n-butylpyridine-2-yl) amine, ( 4 n-Butylphenol) (5 n-Butylpyridine-2-yl) amine, (3 Isobutylphenol) (4 Isobutylpyridine-2-ylamine), (3 Isobutylphenol) (6 Isobutylpyridine-2-yl) ) Amine, (4 isobutylphenol) (5 isobutylpyridine-2-ylamine), (3-sec butylphenol) (4 sec butylpyridine-2-yl) amine, (3 sec butylphenol) (6 sec Butylpyridine 2-yl) amine, (4 sec butylphenol) (5 sec butylpyridine 2-ylamine), (3-tert-butylphenol) (4-tert-butylpyridine-2-ylamine), (3-tert-butylphenol) (6-tert-butylpyridine 2-yl) amine, (4-tert-butylphenol) (5-tert-butylpyridine 2-amine), (3-n-pentylphenol) (4-n-pentylpyridine) -2-yl) amine, (3-n-pentylphenol) (6-n-pentylpyridine-2-yl) ammine, (4-n-pentylphenol) (5-n-pentylpyridine-2- Yl) amine, (3-isopentylphenyl) (4 isopentylpyridine 2 yl) amine, (3 isopentyl phthalate) (6 isopentyl pyridine 2 yl) amine, (4 isopentyl phthalate) ) (5--sopentyl pyridine 2 yl) amine, (3 neope Chirufue - Le) (4 neopentyl Rubirijin 2 I le) Amin, (3 Neopenchirufue - Le) (6 neopentyl ruby lysine —2—yl) amine, (4-neopentylphenol) (5-neopentylpyridine-2—yl) amine, (3-n-hexylphenol) (4-n-hexylpyridine— 2-yl) amine, (3-n-hexylphenol) (6-n-hexylpyridine-2-yl) amine, (4 n xylphenyl) (5-n-hexylpyridine) —Yl) amine, (3-isohexylphenol) (4-isohexylpyridine-2-yl) amine, (3-isohexylphenol) (6-isohexylpyridine-2-yl) ) Amine, (4-Isohexylphenol) (5-Isohexylpyridine 2-yl) amine, (3-n-octylphenol) (4-n-octylpyridine 2-yl) amine, (3- n- Okuchirufue - Le) (6- n- O lipped ruby lysine-2 I-le) Amin, (4-n Okuchirufue - Le) (5-n- O click 1-yl) amine, (3-n-decylphenyl) (4-n-decylviridine-2-yl) amine, (3-n-decylphenyl) (6-n-decylviridine-2) —Yl) amine, (4-n-decylphenyl) (5-n—decylviridine-2-yl) amine, (3-hydroxylphenol) (4-hydroxylpyridine-2-yl) amine, ( 3 Hydroxylphenol) (6 Hydroxylpyridine 2-yl) amine, (4 Hydroxylphenol) (5-hydroxylpyridine 2-yl) amine, (3-Alkanophenyl) (4 Alkanoylpyridine) 1 2-yl) amine, (3 alkanoyl pyridine) (6 alkanoyl pyridine 2 yl) amine, (4 alkanoyl pyridine) (5 alkanoyl pyridine 2 yl) amamine, (3—strength rubamoyl phe -Le) (4 power Luba (Ilpyridine 2 yl) amine, (3—Strengthened ruber moyl file) (6—Strengthened ruber molybidine 2 mil), (4—Strength ruber moyl ferrule) (5—Strength rubamoyl ferridine —2—yl) ammine, (3-carboxyl file) (4-carboxylpyridine-2-yl) amine, (3-carboxyl file) (6-carboxylpyridine-2-yl) amine, (4-carboxyl file) (5-carboxylpyridine-2-yl) amin, (3-cyanol) (4-cyanopyridine-2-yl) amin, (3-cyanophyl) (6cyanopyridine-2-yl) amamine, (4cyanophyl) -L) (5-cyanopyrido-2-yl) amine and the like. Of these, (phenyl) (pyridine-2-yl) amine and (4 methylphenol) (5-methylpyridine-2-yl) amine are preferably used from the viewpoint of availability and economy.
本発明に用いられるこれらアミンィ匕合物には、市販品あるいは適宜合成して得られ たもののいずれを用いてもよい。これらアミンィ匕合物を合成する方法としては、例えばThese amine compounds used in the present invention can be obtained from commercially available products or appropriately synthesized. Any of the above may be used. As a method for synthesizing these amine compounds, for example,
、相当する置換基を有する 2 アミノビリジンと相当する置換基を有する 2 プロモピ リジンまたは相当する置換基を有するブロモベンゼンとを窒素気流中、銅化合物の 存在下、加熱還流して反応させる方法を挙げることができる(Chem. Lett. , 1311 ( 1990)参照)。 And a method of reacting 2-aminoviridine having a corresponding substituent with 2-promopyridine having a corresponding substituent or bromobenzene having a corresponding substituent by heating and refluxing in a nitrogen stream in the presence of a copper compound. (See Chem. Lett., 1311 (1990)).
[0041] ァミン化合物の使用量は、ジハロゲノ単環化合物 1モルに対して 2. 0〜3. 0モルで あることが好ましぐ 2. 0〜2. 5モルであることがさらに好ましい。ァミン化合物の使用 量が 2. 0モル未満の場合、反応が進行しにくぐ反応が完結しにくくなるおそれがあ る。また、アミンィ匕合物の使用量が 3. 0モルを超える場合、使用量に見合う効果がな く経済的でなくなるおそれがある。  [0041] The amount of the amine compound used is preferably 2.0 to 3.0 moles, more preferably 2.0 to 2.5 moles per mole of the dihalogeno monocyclic compound. When the amount of the amine compound used is less than 2.0 mol, the reaction is difficult to proceed and the reaction may be difficult to complete. Also, if the amount of amine compound used exceeds 3.0 moles, there is a risk that the effect will not be commensurate with the amount used and it will not be economical.
[0042] 本発明の化合物を得るための前記反応に用いられる触媒としてのパラジウム化合 物は、特に限定されるものではないが、例えば、へキサクロ口パラジウム (IV)酸ナトリ ゥム四水和物、へキサクロ口パラジウム(IV)酸カリウム等の 4価のパラジウム化合物; 塩化パラジウム (Π)、臭化パラジウム (Π)、酢酸パラジウム (Π)、ノ《ラジウムァセチル ァセトナート (II)、ジクロロビス(ベンゾニトリノレ)パラジウム(Π)、ジクロロビス(ァセトニ トリル)パラジウム(Π)、ジクロロビス(トリフエ-ルホスフィン)パラジウム(Π)、ジクロロビ ス(トリ一 ο トリルホスフィン)パラジウム(Π)、ジクロロテトラアンミンパラジウム(Π)、ジ クロ口(シクロォクタ一 1, 5 ジェン)パラジウム(Π)、パラジウムトリフルォロアセテート (II)等の 2価パラジウム化合物;トリス(ジベンジリデンアセトン)二パラジウム(0)、トリ ス(ジベンジリデンアセトン)二パラジウムクロ口ホルム錯体(0)、テトラキス(トリフエ- ルホスフィン)パラジウム(0)等の 0価パラジウム化合物等が挙げられる。中でも、高い 反応活性を有する観点から、 0価パラジウム化合物が好ましい。中でも、トリス (ジベン ジリデンアセトン)二パラジウム (0)が最も反応活性が高く好適に用いられる。これらパ ラジウム化合物は、それぞれ単独で、あるいは 2種以上を併用して用いてもよい。  [0042] The palladium compound as a catalyst used in the reaction for obtaining the compound of the present invention is not particularly limited, but, for example, sodium hexalopalladium (IV) acid sodium tetrahydrate. , Tetravalent palladium compounds such as potassium hexapalladium (IV); palladium chloride (Π), palladium bromide (Π), palladium acetate (Π), radium acetyl acetylacetonate (II), dichlorobis (benzonitrinore ) Palladium (Π), dichlorobis (acetonitryl) palladium (Π), dichlorobis (triphenylphosphine) palladium (Π), dichlorobis (triolphosphine) palladium (Π), dichlorotetraamminepalladium (Π), di Divalent, such as black and white (Cycloocta 1, 5 Gen) palladium (Π), palladium trifluoroacetate (II) Radium compounds: Tris (dibenzylideneacetone) dipalladium (0), tris (dibenzylideneacetone) dipalladium chromatoform complex (0), tetravalent (triphenylphosphine) palladium (0), etc. Is mentioned. Of these, a zero-valent palladium compound is preferable from the viewpoint of high reaction activity. Among these, tris (dibenzylideneacetone) dipalladium (0) has the highest reaction activity and is preferably used. These palladium compounds may be used alone or in combination of two or more.
[0043] パラジウム化合物の使用量は、ジノ、口ゲノ単環化合物 1モルに対してパラジウム換 算で 0. 0001〜0. 2モノレであること力 S好ましく、 0. 0002〜0. 05モノレであること力 ^よ り好ましい。ノ ラジウム化合物の使用量が 0. 0001モル未満の場合、反応が進行し に《なるおそれがある。また、ノラジウム化合物の使用量が 0. 2モルを超える場合、 使用量に見合う効果がなく経済的でなくなるおそれがある。 [0043] The amount of the palladium compound used is preferably 0.0001 to 0.2 monole in terms of palladium conversion per mole of dino or oral genomonocyclic compound S, preferably 0.00002 to 0.05 monole. Something is better than power ^. If the amount of the radium compound used is less than 0.0001 mol, the reaction may proceed. If the amount of noradium compound used exceeds 0.2 mol, There is a risk that it will not be economical because there is no effect corresponding to the amount used.
[0044] 本発明の化合物を得るための前記反応に用いられる触媒としてのホスフィンィ匕合物 は、特に限定されるものではないが、例えば、 2, 2'—ビス(ジフエ-ルホスフイノ)一 1 , 1,—ビナフチル、 1, 1,—ビス(ジフエ-ルホスフイノ)フエ口セン、 N, N,—ジメチル — 1— [ , 2 ビス(ジフエ-ルホスフイノ)フエロセ-ル]、 9, 9 ジメチルー 4, 5— ビス(ジフエ-ルホスフイノ)キサンテン等の 2座配位子としてのキレート能を有するホ スフインィ匕合物が挙げられる。中でも、高い反応活性を有する観点から、 2, 2'—ビス (ジフエ-ルホスフイノ)— 1, 1,—ビナフチルおよび 9, 9 ジメチルー 4, 5 ビス(ジ フエ-ルホスフイノ)キサンテンが好適に用いられる。これらホスフィン化合物は、それ ぞれ単独で、ある!/、は 2種以上を併用して用いてもょ 、。  [0044] The phosphine compound used as the catalyst for the reaction for obtaining the compound of the present invention is not particularly limited. For example, 2, 2'-bis (diphenylphosphino) 1 1, 1, -binaphthyl, 1,1, -bis (diphenylphosphino) fecene, N, N, -dimethyl — 1— [, 2 bis (diphosphosphino) ferrocer], 9, 9 dimethyl-4,5 — Phosphinic compounds having chelating ability as bidentate ligands such as bis (diphenylphosphino) xanthene. Of these, 2,2′-bis (diphenylphosphino) -1,1, -binaphthyl and 9,9 dimethyl-4,5bis (diphenylphosphino) xanthene are preferably used from the viewpoint of high reaction activity. These phosphine compounds can be used alone or in combination of two or more.
[0045] ホスフィン化合物の使用量は、パラジウム化合物 1モルに対して 0. 1〜10モルであ ることが好ましぐ 0. 5〜5モルであることがさらに好ましい。ホスフィン化合物の使用 量が 0. 1モル未満の場合、反応が進行しに《なるおそれがある。また、ホスフィンィ匕 合物の使用量が 10モルを超える場合、使用量に見合う効果がなく経済的でなくなる おそれがある。  [0045] The amount of the phosphine compound used is preferably 0.1 to 10 moles, more preferably 0.5 to 5 moles per mole of the palladium compound. If the amount of the phosphine compound used is less than 0.1 mol, the reaction may proceed. Also, if the amount of phosphine compound used exceeds 10 moles, there is a risk that the effect will not be commensurate with the amount used and that it will not be economical.
[0046] 本発明にお 、て、前記パラジウム化合物およびホスフィンィ匕合物は、反応系にそれ ぞれ単独にカ卩えても、あるいは、予め錯体の形に調製したものを添加してもよい。  [0046] In the present invention, the palladium compound and the phosphine compound may be individually added to the reaction system, or those prepared in the form of a complex in advance may be added.
[0047] 本発明の化合物を得るための前記反応に用いられる塩基としては、特に限定され るものではないが、例えば、ナトリウムメトキシド、ナトリウムエトキシド、カリウムメトキシ ド、カリウムエトキシド、リチウム—tert—ブトキシド、ナトリウム—tert ブトキシドおよ びカリウム—tert ブトキシド等のアルカリ金属アルコキシド等が挙げられる。なお、こ れら塩基は、それぞれ単独で、あるいは 2種以上を併用して用いてもよい。また、反 応系にそれぞれをそのままカ卩えても、あるいは、アルカリ金属、水素化アルカリ金属 および水酸ィ匕アルカリ金属と、相当するアルコールとから調製したものを添加してもよ い。  [0047] The base used in the reaction for obtaining the compound of the present invention is not particularly limited, and examples thereof include sodium methoxide, sodium ethoxide, potassium methoxide, potassium ethoxide, and lithium-tert. Examples include alkali metal alkoxides such as —butoxide, sodium-tert butoxide and potassium-tert butoxide. These bases may be used alone or in combination of two or more. Further, each of them may be directly added to the reaction system, or one prepared from an alkali metal, an alkali metal hydride, a hydroxide or an alkali metal, and a corresponding alcohol may be added.
[0048] 塩基の使用量は、ジハロゲノ単環化合物 1モルに対して 2〜30モルであることが好 ましぐ 2〜10モルであることがより好ましい。塩基の使用量が 2モル未満の場合、収 率が低下するおそれがあり、塩基の使用量が 30モルを超える場合、使用量に見合う 効果がなく経済的でなくなるおそれがある。 [0048] The amount of the base used is preferably 2 to 30 mol, more preferably 2 to 10 mol, relative to 1 mol of the dihalogeno monocyclic compound. If the amount of base used is less than 2 moles, the yield may decrease. If the amount of base used exceeds 30 moles, it will be commensurate with the amount used. There is a risk that it will not be effective and economical.
[0049] 本発明の化合物を得るための前記反応に用いられる溶媒は、当該反応に対して不 活性な溶媒であれば特に限定されず、例えば、ベンゼン、トルエン、キシレン等の芳 香族炭化水素系溶媒;ジェチルエーテル、テトラヒドロフラン、ジォキサン等のエーテ ル系溶媒;ァセトニトリル、ジメチルホルムアミド、ジメチルスルホキシド、へキサメチル ホスホトリアミド等が挙げられる。中でも、溶媒のリサイクルが容易であることから、ベン ゼン、トルエン、キシレン等の芳香族炭化水素系溶媒が好適に用いられる。  [0049] The solvent used in the reaction for obtaining the compound of the present invention is not particularly limited as long as it is an inert solvent for the reaction. For example, aromatic hydrocarbons such as benzene, toluene, xylene and the like. Solvents: ether solvents such as jetyl ether, tetrahydrofuran, dioxane, etc .; acetonitrile, dimethylformamide, dimethyl sulfoxide, hexamethyl phosphotriamide and the like. Of these, aromatic hydrocarbon solvents such as benzene, toluene and xylene are preferably used because the solvent can be easily recycled.
[0050] 溶媒の使用量は、特に制限されるものではないが、反応を円滑にさせる観点および 使用量に見合うだけの効果を得る観点から、一般式 (Π)で表されるジハロゲノ単環化 合物 100重量部に対して、 500〜 10000重量部であることが好まし!/、。 [0050] The amount of the solvent used is not particularly limited, but from the viewpoint of facilitating the reaction and obtaining an effect sufficient for the amount of use, the dihalogeno monocyclization represented by the general formula (Π) It is preferable that it is 500 to 10000 parts by weight per 100 parts by weight of the compound! /.
反応温度は、特に限定されないが、 20〜250°Cであるのが好ましぐ 50〜150°C であることがより好ましい。反応温度が 20°Cより低い場合、反応に長時間を要するお それがある。また、反応温度が 250°Cより高い場合、副反応が起こり、収率が低下す るおそれがある。反応時間は、反応温度により異なるために一概には言えないが、通 常 1〜20時間である。  The reaction temperature is not particularly limited, but is preferably 20 to 250 ° C, more preferably 50 to 150 ° C. If the reaction temperature is lower than 20 ° C, the reaction may take a long time. On the other hand, when the reaction temperature is higher than 250 ° C, side reactions may occur and the yield may decrease. Since the reaction time varies depending on the reaction temperature, it cannot be generally stated, but it is usually 1 to 20 hours.
[0051] 力べして得られた本発明の化合物は、常法により、ろ過、洗浄して触媒等を除去した 後、乾燥すること〖こより単離することができる。  [0051] The compound of the present invention obtained by force can be isolated by a conventional method, after filtration and washing to remove the catalyst and the like, followed by drying.
[0052] なお、前記一般式 (Π)で表されるジハロゲノ単環化合物と、前記一般式 (ΠΙ)で表さ れるァミンィ匕合物とを、ノラジウム化合物およびホスフィンィ匕合物を含む触媒並びに 塩基の存在下、反応させて前記一般式 (I)で表される化合物を得る、本発明の製造 方法は、また、前記一般式 (I)で表される化合物と類似の構造を有する化合物を得る 製造方法としても好適に用いることができる。  [0052] In addition, a catalyst and a base comprising a dihalogeno monocyclic compound represented by the general formula (ァ) and an amine compound represented by the general formula (ΠΙ), a noradium compound and a phosphinic compound The production method of the present invention, wherein the compound represented by the general formula (I) is obtained by reacting in the presence of the compound, also obtains a compound having a structure similar to that of the compound represented by the general formula (I). It can use suitably also as a manufacturing method.
[0053] 具体的には、前記一般式 (Π)で表されるジハロゲノ単環化合物に代えて、一般式( Specifically, instead of the dihalogeno monocyclic compound represented by the general formula (Π), the general formula (
IV) : IV):
[0054] [化 12] zzAr\z (IV) [0055] (式中、 Arは置換基を有してもよい単環式 6員芳香環基を示し、 Zはハロゲン原子を 示す。)で表されるジハロゲノ化合物を用い、さらに前記一般式 (ΠΙ)で表されるァミン 化合物に代えて、一般式 (V) : [0054] [Chemical Formula 12] zz Ar \ z (IV) [0055] (wherein Ar represents a monocyclic 6-membered aromatic ring group which may have a substituent, and Z represents a halogen atom) Show. And a dihalogeno compound represented by the general formula (V):
[0056] [化 13]  [0056] [Chemical 13]
Figure imgf000026_0001
Figure imgf000026_0001
[0057] (式中、 R4および R5は、それぞれ独立して、水素原子、水酸基、カルボキシル基、シ ァノ基、力ルバモイル基、炭素数 1〜10のアルキル基、または炭素数 1〜10のアル力 ノィル基を示し、これらは同一であっても異なっていてもよい。)で表されるジフエ-ル ァミン化合物を用いる以外は本発明の製造方法と同様にして、一般式 (VI): (In the formula, R 4 and R 5 are each independently a hydrogen atom, a hydroxyl group, a carboxyl group, a cyano group, a strong rubamoyl group, an alkyl group having 1 to 10 carbon atoms, or an alkyl group having 1 to In the same manner as in the production method of the present invention except that a diphenylamine compound represented by formula (VI) is used. ):
[0058] [化 14]  [0058] [Chemical 14]
R4 4 R 4 4
Figure imgf000026_0002
Figure imgf000026_0002
[0059] (式中、 Arは置換基を有してもよい単環式 6員芳香環基を示す。 R4および R5は、そ れぞれ独立して、水素原子、水酸基、カルボキシル基、シァノ基、力ルバモイル基、 炭素数 1〜10のアルキル基、または炭素数 1〜10のアルカノィル基を示し、これらは 同一であっても異なっていてもよい。)で表される化合物を、使用したジハロゲノ化合 物に対して約 90%という高収率で得ることができる。 (In the formula, Ar represents a monocyclic 6-membered aromatic ring group which may have a substituent. R 4 and R 5 each independently represents a hydrogen atom, a hydroxyl group, or a carboxyl group. , A cyano group, a strong rubermoyl group, an alkyl group having 1 to 10 carbon atoms, or an alkanoyl group having 1 to 10 carbon atoms, which may be the same or different.) A high yield of about 90% can be obtained with respect to the dihalogeno compound used.
発明の効果  The invention's effect
[0060] 本発明によると、光 ·電子変換機能を有し、それ自身で熱的に安定なアモルファス 膜を形成することができる低分子量有機化合物およびその製造方法を提供すること ができる。 [0060] According to the present invention, there is provided a low molecular weight organic compound having a light-electron conversion function and capable of forming a thermally stable amorphous film by itself, and a method for producing the same. Can do.
発明を実施するための最良の形態  BEST MODE FOR CARRYING OUT THE INVENTION
[0061] 以下に、実施例により本発明を具体的に説明するが、本発明は、これら実施例によ つてなんら限定されるものではな!/、。  [0061] Hereinafter, the present invention will be specifically described by way of examples. However, the present invention is not limited to these examples!
[0062] 実施例 1 [0062] Example 1
2, 6 ビス [ジ(ピリジン— 2—ィル)ァミノ]ピリジン [一般式(1)、 Ι^〜Κ3=Η]の調 製 2, 6 Bis [di (pyridine-2-yl) amino] pyridine [Formula (1), Ι ^ 〜Κ 3 = Η]
冷却管、温度計および攪拌機を備え付けた 300mL容の四つ口フラスコに、 2, 6- ジブロモピリジン 5. 69g (24ミリモル)、ビス(ピリジン— 2—ィル)ァミン 8. 22g (48ミリ モル)、トリス(ジベンジリデンアセトン)二パラジウム(0) 1. 10g (l. 2ミリモル)、 2, 2, —ビス(ジフエ-ルホスフイノ)— 1, 1,—ビナフチル 2. 24g (3. 6ミリモル)、ナトリウム — tert—ブトキシド 6. 92g (72ミリモノレ)およびトノレェン 240mLを仕込んだ。次いで、 窒素雰囲気下で 100°Cまで昇温し、さらに同温度で 8時間攪拌して反応させた。その 後、反応液を室温まで冷却し、析出物をろ別、乾燥して本発明の 2, 6 ビス [ジ (ピリ ジン— 2—ィル)ァミノ]ピリジン 6. 20gを得た。得られた 2, 6 ビス [ジ(ピリジン— 2 —ィル)ァミノ]ピリジンの収率は、使用した 2, 6 ジブロモピリジンに対して 62%であ つた o  A 300 mL four-necked flask equipped with a condenser, thermometer and stirrer was charged with 5.69 g (24 mmol) of 2, 6-dibromopyridine and 8.22 g (48 mmol) of bis (pyridine-2-yl) amine. ), Tris (dibenzylideneacetone) dipalladium (0) 1.10 g (l. 2 mmol), 2, 2, —bis (diphenylphosphino) — 1, 1, -binaphthyl 2.24 g (3.6 mmol) Sodium-tert-butoxide 6.92 g (72 millimonoles) and tonorene 240 mL were charged. Next, the temperature was raised to 100 ° C. under a nitrogen atmosphere, and the reaction was further stirred for 8 hours at the same temperature. Thereafter, the reaction solution was cooled to room temperature, and the precipitate was collected by filtration and dried to obtain 6.20 g of 2,6bis [di (pyridin-2-yl) amino] pyridine of the present invention. The yield of 2,6bis [di (pyridine-2-yl) amino] pyridine obtained was 62% based on the 2,6 dibromopyridine used.
なお、得られた化合物力 2, 6 ビス [ジ (ピリジン— 2—ィル)ァミノ]ピリジンである ことを下記の分析結果により確認した。  The compound strength obtained was confirmed to be 2, 6 bis [di (pyridine-2-yl) amino] pyridine by the following analysis results.
分子量 (大気圧イオン化法による質量分析) :417  Molecular weight (mass spectrometry by atmospheric pressure ionization method): 417
IR(KBr) : 1583, 1566, 1466, 1447, 1426, 1348, 1320, 1304, 1274, 12 62, 776cm"1 IR (KBr): 1583, 1566, 1466, 1447, 1426, 1348, 1320, 1304, 1274, 12 62, 776cm " 1
[0063] 評価 [0063] Evaluation
実施例 1で得られた 2, 6 ビス [ジ(ピリジン— 2—ィル)ァミノ]ピリジンについて、発 光特性および熱安定性を評価した。  The 2, 6 bis [di (pyridine-2-yl) amino] pyridine obtained in Example 1 was evaluated for light emission characteristics and thermal stability.
(発光特性)  (Luminescent characteristics)
実施例 1で得られた 2, 6 -ビス [ジ(ピリジン 2 ィル)ァミノ]ピリジンを 1—メチル —2—ピロリドンに溶解させて測定試料 (濃度: 1 X 10"3g/L)を調製し、蛍光分光光 度計 (株式会社日立製作所、商品名 F— 2500)を用いて発光波長を測定した。そ の結果、実施例 1で得られた 2, 6—ビス [ジ (ピリジン— 2—ィル)ァミノ]ピリジンは、発 光機能を有することが確認できた。また、その蛍光の波長は 385nmであった。従って 、実施例 1で得られた 2, 6—ビス [ジ (ピリジン— 2—ィル)ァミノ]ピリジンは、例えば、 EL素子等における発光層用材料として好適に用いることができる可能性が高いこと がわカゝる。 The 2,6-bis [di (pyridine-2-yl) amino] pyridine obtained in Example 1 was dissolved in 1-methyl-2-pyrrolidone, and a measurement sample (concentration: 1 X 10 " 3 g / L) was obtained. Prepare and fluorescence spectroscopic light The emission wavelength was measured using a spectrophotometer (Hitachi Ltd., trade name F-2500). As a result, it was confirmed that 2,6-bis [di (pyridine-2-yl) amino] pyridine obtained in Example 1 had a light emitting function. The fluorescence wavelength was 385 nm. Therefore, there is a high possibility that 2,6-bis [di (pyridine-2-yl) amino] pyridine obtained in Example 1 can be suitably used as a material for a light emitting layer in, for example, an EL device. That's right.
[0064] (熱安定性) [0064] (Thermal stability)
示差熱分析法により、実施例 1で得られた 2, 6—ビス [ジ (ピリジン一 2—ィル)ァミノ ]ピリジンについて熱分解温度を測定し、さらに示差走査熱量分析法により、ガラス転 移温度を測定した。  The thermal decomposition temperature of 2,6-bis [di (pyridine-1-yl) amino] pyridine obtained in Example 1 was measured by differential thermal analysis, and glass transfer was further performed by differential scanning calorimetry. The temperature was measured.
示差熱分析は、実施例 1で得られた 2, 6—ビス [ジ (ピリジン— 2—ィル)ァミノ]ピリ ジン lmgを秤量し、窒素雰囲気下、 10°CZ分の昇温速度で室温から 500°Cまで昇 温した。その結果、熱分解温度は 255°Cであることがわ力つた。  Differential thermal analysis was performed by weighing 2,6-bis [di (pyridine-2-yl) amino] pyridine lmg obtained in Example 1 at room temperature at a temperature increase rate of 10 ° CZ in a nitrogen atmosphere. The temperature was raised to 500 ° C. As a result, the thermal decomposition temperature was found to be 255 ° C.
示差走査熱量分析は、実施例 1で得られた 2, 6—ビス [ジ (ピリジンー2—ィル)アミ ノ]ピリジン lOmgを秤量し、窒素雰囲気下、 10°CZ分の昇温速度で室温から 200°C まで昇温した。次に、 10°CZ分の降温速度で 200°Cから室温まで冷却した後、再び 、 10°CZ分の昇温速度で室温から 200°Cまで昇温した。その結果、ガラス転移温度 は 53°Cであることがわ力つた。また、この繰り返し測定の際、アモルファスからの結晶 化に基づく発熱ピークは認められなかった。  Differential scanning calorimetry was performed by weighing 2,6-bis [di (pyridin-2-yl) amino] pyridine lOmg obtained in Example 1 at room temperature at a heating rate of 10 ° CZ in a nitrogen atmosphere. To 200 ° C. Next, after cooling from 200 ° C to room temperature at a temperature decrease rate of 10 ° CZ, the temperature was increased from room temperature to 200 ° C at a temperature increase rate of 10 ° CZ again. As a result, the glass transition temperature was found to be 53 ° C. In addition, during this repeated measurement, no exothermic peak due to crystallization from amorphous was observed.
これらのことから、実施例 1で得られた 2, 6—ビス [ジ (ピリジン一 2—ィル)ァミノ]ピリ ジンは、熱分解温度が 255°Cと熱的に安定であるため蒸着等により容易に成膜が可 能であり、また結晶化温度を有さないため、成膜したアモルファス膜は、優れた耐熱 性を有することがわかる。  From these facts, 2,6-bis [di (pyridine-1-yl) amino] pyridine obtained in Example 1 is thermally stable at a thermal decomposition temperature of 255 ° C. Thus, it can be easily formed, and since it does not have a crystallization temperature, it can be seen that the formed amorphous film has excellent heat resistance.
[0065] 実施例 2 [0065] Example 2
2, 6—ビス [ジ(5—メチルピリジン— 2—ィル)ァミノ]ピリジン [一般式(1)、 Ι^=Η、 R2〜R3 = 5—メチル]の調製 Preparation of 2, 6-bis [di (5-methylpyridine-2-yl) amino] pyridine [general formula (1), Ι ^ = Η, R 2 to R 3 = 5-methyl]
実施例 1において、ビス(ピリジン一 2—ィル)ァミン 8. 22g (48ミリモル)に代えて、 ビス(5—メチルピリジン一 2—ィル)ァミン 9. 55g (48ミリモル)を用いた以外は、実施 例 1と同様にして本発明の 2, 6 -ビス [ジ(5 メチルピリジン 2 ィル)ァミノ]ピリジ ン 6. 58gを得た。得られた 2, 6 ビス [ジ(5—メチルピリジン— 2—ィル)ァミノ]ピリジ ンの収率は、使用した 2, 6 ジブロモピリジンに対して 58%であった。 In Example 1, bis (5-methylpyridine-2-yl) amine 9.55 g (48 mmol) was used instead of bis (pyridine-2-yl) amine 8.22 g (48 mmol). Implemented In the same manner as in Example 1, 6.58 g of 2,6-bis [di (5methylpyridine 2-yl) amino] pyridin of the present invention was obtained. The yield of 2,6bis [di (5-methylpyridine-2-yl) amino] pyridin obtained was 58% based on 2,6 dibromopyridine used.
なお、得られた化合物力 2, 6 ビス [ジ(5—メチルピリジン— 2—ィル)ァミノ]ピリ ジンであることを下記の分析結果により確認した。  It was confirmed by the following analytical results that the obtained compound strength was 2,6 bis [di (5-methylpyridine-2-yl) amino] pyridine.
分子量 (大気圧イオン化法による質量分析) :473  Molecular weight (mass spectrometry by atmospheric pressure ionization method): 473
IR(KBr) : 3029, 2996, 1596, 1579, 1479, 1454, 1413, 1384, 1191, 10 30, 788, 712cm"1 IR (KBr): 3029, 2996, 1596, 1579, 1479, 1454, 1413, 1384, 1191, 10 30, 788, 712cm " 1
評価 Evaluation
実施例 2で得られた 2, 6 -ビス [ジ(5 メチルピリジン 2 ィル)ァミノ]ピリジンに ついて、発光特性および熱安定性を評価した。  The 2,6-bis [di (5methylpyridine 2-yl) amino] pyridine obtained in Example 2 was evaluated for luminescent properties and thermal stability.
(発光特性) (Luminescent characteristics)
実施例 1と同様にして蛍光分光光度計を用いて発光波長を測定した。その結果、 実施例 2で得られた 2, 6 -ビス [ジ(5 メチルピリジン一 2 ィル)ァミノ]ピリジンは、 発光機能を有することが確認できた。また、その蛍光の波長は 391nmであった。従 つて、実施例 2で得られた 2, 6 ビス [ジ(5—メチルピリジン一 2—ィル)ァミノ]ピリジ ンは、例えば、 EL素子等における発光層用材料として好適に用いることができる可 能性が高いことがわかる。  In the same manner as in Example 1, the emission wavelength was measured using a fluorescence spectrophotometer. As a result, it was confirmed that 2,6-bis [di (5-methylpyridine-2-yl) amino] pyridine obtained in Example 2 had a light emitting function. The fluorescence wavelength was 391 nm. Therefore, 2,6 bis [di (5-methylpyridine-2-yl) amino] pyridin obtained in Example 2 can be suitably used as a material for a light emitting layer in, for example, an EL device. It turns out that the possibility is high.
(熱安定性) (Thermal stability)
実施例 1と同様にして測定した。  The measurement was performed in the same manner as in Example 1.
示差熱分析より、熱分解温度は 261°Cであることがわ力つた。  Differential thermal analysis showed that the thermal decomposition temperature was 261 ° C.
示差走査熱量分析より、ガラス転移温度は 49°Cであることがわ力つた。また、この繰 り返し測定の際、アモルファスからの結晶化に基づく発熱ピークは認められな力つた これらのことから、実施例 2で得られた 2, 6 ビス [ジ(5 メチルピリジンー2—ィル )ァミノ]ピリジンは、熱分解温度が 261°Cと熱的に安定であるため蒸着等により容易 に成膜が可能であり、また結晶化温度を有さないため、成膜したアモルファス膜は、 優れた耐熱性を有することがわかる。 [0067] 実施例 3 Differential scanning calorimetry showed that the glass transition temperature was 49 ° C. Further, during this repeated measurement, no exothermic peak due to crystallization from amorphous was observed. Therefore, the 2, 6 bis [di (5 methylpyridine-2-yl) obtained in Example 2 was used. ) Amino] pyridine has a thermal decomposition temperature of 261 ° C and is thermally stable, so it can be easily formed by vapor deposition and the like, and since it does not have a crystallization temperature, It turns out that it has the outstanding heat resistance. [0067] Example 3
1, 3 ビス [ジ(ピリジン— 2—ィル)ァミノ]ベンゼン [一般式(2)、 Ι^〜Κ3=Η]の調 製 1, 3 Bis [di (pyridine-2-yl) amino] benzene [Formula (2), Ι ^ 〜Κ 3 = Η]
冷却管、温度計および攪拌機を備え付けた 300mL容の四つ口フラスコに、 1, 3- ジブロモベンゼン 5. 66g (24ミリモル)、ビス(ピリジン— 2—ィル)ァミン 8. 22g (48ミ リモル)、トリス(ジベンジリデンアセトン)ニノ ラジウム(0) 1. 10g (l. 2ミリモル)、 2, 2 ,—ビス(ジフエ-ルホスフイノ)— 1, 1,—ビナフチル 2. 24g (3. 6ミリモル)、ナトリウ ム—tert ブトキシド 6. 92g (72ミリモル)およびトルエン 240mLを仕込んだ。次い で、窒素雰囲気下で 100°Cまで昇温し、さらに同温度で 8時間攪拌して反応させた。 その後、反応液を室温まで冷却し、析出物をろ別、乾燥して本発明の 1, 3 ビス [ジ (ピリジン一 2—ィル)ァミノ]ベンゼン 5. 55gを得た。得られた 1, 3 ビス [ジ(ピリジン —2—ィル)ァミノ]ベンゼンの収率は、使用した 1, 3—ジブロモベンゼンに対して 56 %であった。  To a 300 mL four-necked flask equipped with a condenser, thermometer, and stirrer, was added 1.66 g (24 mmol) of 1,3-dibromobenzene, 8.22 g (48 mmol) of bis (pyridine-2-yl) amine. ), Tris (dibenzylideneacetone) ninoradium (0) 1.10 g (l. 2 mmol), 2,2, -bis (diphenylphosphino) — 1, 1, -binaphthyl 2.24 g (3.6 mmol) Sodium-tert butoxide 6.92 g (72 mmol) and 240 mL toluene were charged. Next, the temperature was raised to 100 ° C under a nitrogen atmosphere, and the reaction was further stirred for 8 hours at the same temperature. Thereafter, the reaction solution was cooled to room temperature, and the precipitate was filtered and dried to obtain 5.55 g of 1,3 bis [di (pyridine-2-yl) amino] benzene of the present invention. The yield of the obtained 1,3 bis [di (pyridine-2-yl) amino] benzene was 56% based on 1,3-dibromobenzene used.
なお、得られた化合物力 1, 3 ビス [ジ (ピリジン— 2—ィル)ァミノ]ベンゼンであ ることを下記の分析結果により確認した。  It was confirmed by the following analytical results that the obtained compound strength was 1,3 bis [di (pyridine-2-yl) amino] benzene.
分子量 (大気圧イオン化法による質量分析) :416  Molecular weight (mass spectrometry by atmospheric pressure ionization method): 416
IR(KBr) : 1583, 1566, 1494, 1466, 1447, 1426, 1350, 1320, 1304, 12 61, 1157, 778cm"1 IR (KBr): 1583, 1566, 1494, 1466, 1447, 1426, 1350, 1320, 1304, 12 61, 1157, 778cm " 1
[0068] 評価 [0068] Evaluation
実施例 3で得られた 1 , 3 -ビス [ジ(ピリジン― 2 ィル)ァミノ]ベンゼンにつ 、て、 発光特性および熱安定性を評価した。  The 1,3-bis [di (pyridine-2-yl) amino] benzene obtained in Example 3 was evaluated for luminescent properties and thermal stability.
(発光特性)  (Luminescent characteristics)
実施例 3で得られた 1 , 3 -ビス [ジ(ピリジン 2 ィル)ァミノ]ベンゼンを 1 メチル —2—ピロリドンに溶解させて測定試料 (濃度: 1 X 10"3g/L)を調製し、蛍光分光光 度計 (株式会社日立製作所、商品名 F 2500)を用いて発光波長を測定した。そ の結果、実施例 3で得られた 1, 3 ビス [ジ (ピリジン— 2—ィル)ァミノ]ベンゼンは、 発光機能を有することが確認できた。また、その蛍光の波長は 397nmであった。従 つて、実施例 3で得られた 1, 3 ビス [ジ (ピリジン— 2—ィル)ァミノ]ベンゼンは、例 えば、 EL素子等における発光層用材料として好適に用いることができる可能性が高 いことがわ力る。 Prepare a measurement sample (concentration: 1 X 10 " 3 g / L) by dissolving the 1,3-bis [di (pyridine-2-ylamino)] benzene obtained in Example 3 in 1 methyl-2-pyrrolidone. The emission wavelength was then measured using a fluorescence spectrophotometer (Hitachi, Ltd., trade name: F 2500), and as a result, the 1,3 bis [di (pyridine-2-y) obtained in Example 3 was measured. It was confirmed that (l) amino] benzene had a light-emitting function, and the fluorescence wavelength was 397 nm, so that the 1,3 bis [di (pyridine-2—) obtained in Example 3 was used. Il) amino] benzene is an example For example, there is a high possibility that it can be suitably used as a material for a light emitting layer in an EL element or the like.
(熱安定性) (Thermal stability)
示差熱分析法により、実施例 3で得られた 1, 3 ビス [ジ (ピリジン— 2—ィル)ァミノ ]ベンゼンについて熱分解温度を測定し、さらに示差走査熱量分析法により、ガラス 転移温度を測定した。  The thermal decomposition temperature of 1,3 bis [di (pyridine-2-yl) amino] benzene obtained in Example 3 was measured by differential thermal analysis, and the glass transition temperature was determined by differential scanning calorimetry. It was measured.
示差熱分析は、実施例 3で得られた 1, 3 ビス [ジ (ピリジン— 2—ィル)ァミノ]ベン ゼン lmgを秤量し、窒素雰囲気下、 10°CZ分の昇温速度で室温から 500°Cまで昇 温した。その結果、熱分解温度は 260°Cであることがわ力つた。  Differential thermal analysis was performed by weighing 1,3 bis [di (pyridin-2-yl) amino] benzene lmg obtained in Example 3 from room temperature at a temperature increase rate of 10 ° CZ in a nitrogen atmosphere. The temperature was raised to 500 ° C. As a result, the thermal decomposition temperature was 260 ° C.
示差走査熱量分析は、実施例 3で得られた 1, 3 ビス [ジ (ピリジンー2 ィル)アミ ノ]ベンゼン lOmgを秤量し、窒素雰囲気下、 10°CZ分の昇温速度で室温から 200 °Cまで昇温した。次に、 10°CZ分の降温速度で 200°Cから室温まで冷却した後、再 び、 10°CZ分の昇温速度で室温から 200°Cまで昇温した。その結果、ガラス転移温 度は 52°Cであることがわ力つた。また、この繰り返し測定の際、アモルファスからの結 晶化に基づく発熱ピークは認められな力つた。  In differential scanning calorimetry, 1,3 bis [di (pyridine-2-yl) amino] benzene lOmg obtained in Example 3 was weighed and measured from room temperature at a temperature increase rate of 10 ° CZ in a nitrogen atmosphere. The temperature was raised to ° C. Next, after cooling from 200 ° C to room temperature at a temperature drop rate of 10 ° CZ, the temperature was raised again from room temperature to 200 ° C at a temperature increase rate of 10 ° CZ. As a result, the glass transition temperature was found to be 52 ° C. During this repeated measurement, no exothermic peak due to crystallization from amorphous was observed.
これらのことから、実施例 3で得られた 1, 3 ビス [ジ (ピリジン一 2—ィル)ァミノ]ベ ンゼンは、熱分解温度が 260°Cと熱的に安定であるため蒸着等により容易に成膜が 可能であり、また結晶化温度を有さないため、成膜したアモルファス膜は、優れた耐 熱性を有することがわかる。  From these facts, 1,3 bis [di (pyridine-2-yl) amino] benzene obtained in Example 3 is thermally stable at 260 ° C. Since it can be easily formed and does not have a crystallization temperature, it can be seen that the formed amorphous film has excellent heat resistance.
実施例 4  Example 4
1, 3 ビス [ジ(5—メチルピリジン— 2—ィル)ァミノ]ベンゼン [一般式(2)、 Ι^=Η 、 R2〜R3=5—メチル]の調製 Preparation of 1,3bis [di (5-methylpyridine-2-yl) amino] benzene [general formula (2), Ι ^ = Η, R 2 ~ R 3 = 5-methyl]
実施例 3において、ビス(ピリジン一 2—ィル)ァミン 8. 22g (48ミリモル)に代えて、 ビス(5—メチルピリジン一 2—ィル)一ァミン 9. 55g (48ミリモル)を用いた以外は、実 施例 3と同様にして本発明の 1 , 3 ビス [ジ( 5 メチルピリジン 2 ィル)ァミノ]ベ ンゼン 5. 89gを得た。得られた 1, 3 ビス [ジ(5—メチルピリジン一 2—ィル)ァミノ] ベンゼンの収率は、使用した 1, 3 ジブロモベンゼンに対して 52%であった。  In Example 3, instead of 8.22 g (48 mmol) of bis (pyridine-2-yl) amine, 9.55 g (48 mmol) of bis (5-methylpyridine-2-yl) amine was used. Except for the above, in the same manner as in Example 3, 5.89 g of 1,3 bis [di (5-methylpyridine 2-yl) amino] benzene of the present invention was obtained. The yield of the obtained 1,3 bis [di (5-methylpyridine-1-yl) amino] benzene was 52% based on 1,3 dibromobenzene used.
なお、得られた化合物力 1, 3 ビス [ジ(5—メチルピリジン— 2—ィル)ァミノ]ベン ゼンであることを下記の分析結果により確認した。 The compound strength obtained was 1, 3 bis [di (5-methylpyridine-2-yl) amino] ben It was confirmed by the following analysis results that it was Zen.
分子量 (大気圧イオン化法による質量分析) :472  Molecular weight (mass spectrometry by atmospheric pressure ionization method): 472
IR(KBr) : 3030, 2991, 1590, 1566, 1484, 1466, 1447, 1350, 1320, 12 61, 1035, 778, 710cm"1 IR (KBr): 3030, 2991, 1590, 1566, 1484, 1466, 1447, 1350, 1320, 12 61, 1035, 778, 710cm " 1
[0070] 評価 [0070] Evaluation
実施例 4で得られた 1 , 3 -ビス [ジ(5—メチルピリジン― 2—ィル)ァミノ]ベンゼン について、発光特性および熱安定性を評価した。  The 1,3-bis [di (5-methylpyridin-2-yl) amino] benzene obtained in Example 4 was evaluated for luminescent properties and thermal stability.
(発光特性)  (Luminescent characteristics)
実施例 3と同様にして蛍光分光光度計を用いて発光波長を測定した。その結果、 実施例 4で得られた 1 , 3 -ビス [ジ(5—メチルピリジン一 2—ィル)ァミノ]ベンゼンは 、発光機能を有することが確認できた。また、その蛍光の波長は 404nmであった。従 つて、実施例 4で得られた 1, 3—ビス [ジ(5—メチルピリジン— 2—ィル)ァミノ]ベン ゼンは、例えば、 EL素子等における発光層用材料として好適に用いることができる 可能性が高いことがわかる。  In the same manner as in Example 3, the emission wavelength was measured using a fluorescence spectrophotometer. As a result, it was confirmed that 1,3-bis [di (5-methylpyridine-2-yl) amino] benzene obtained in Example 4 had a light emitting function. The fluorescence wavelength was 404 nm. Therefore, the 1,3-bis [di (5-methylpyridine-2-yl) amino] benzene obtained in Example 4 can be suitably used as a material for a light emitting layer in, for example, an EL device. It turns out that there is a high possibility of being able to do it.
(熱安定性)  (Thermal stability)
実施例 3と同様にして測定した。  Measurement was performed in the same manner as in Example 3.
示差熱分析により、熱分解温度は 262°Cであることがわ力つた。  Differential thermal analysis showed that the thermal decomposition temperature was 262 ° C.
示差走査熱量分析より、ガラス転移温度は 48°Cであることがわ力つた。また、この繰 り返し測定の際、アモルファスからの結晶化に基づく発熱ピークは認められな力つた これらのことから、実施例 4で得られた 1, 3—ビス [ジ(5—メチルピリジン一 2—ィル )ァミノ]ベンゼンは、熱分解温度が 262°Cと熱的に安定であるため蒸着等により容易 に成膜が可能であり、また結晶化温度を有さないため、成膜したアモルファス膜は、 優れた耐熱性を有することがわかる。  Differential scanning calorimetry showed that the glass transition temperature was 48 ° C. In addition, during this repeated measurement, no exothermic peak due to crystallization from amorphous was observed. Therefore, the 1,3-bis [di (5-methylpyridine) obtained in Example 4 2-yl) amino] benzene has a thermal decomposition temperature of 262 ° C and is thermally stable, so it can be easily formed by vapor deposition, etc., and it has no crystallization temperature. It can be seen that the amorphous film has excellent heat resistance.
[0071] 実施例 5 [0071] Example 5
2, 6—ビス [ (フエ-ル)(ピリジン— 2—ィル)ァミノ]ピリジン [一般式(3)、 1^〜 = H]の調製  Preparation of 2, 6-bis [(phenol) (pyridine-2-yl) amino] pyridine [general formula (3), 1 ^ ~ = H]
冷却管、温度計および攪拌機を備え付けた 300mL容の四つ口フラスコに、 2, 6- ジブロモピリジン 5. 69g (24ミリモル)、 (フエ-ル)(ピリジン— 2—ィル)ァミン 8. 16g (48ミリモル)、トリス(ジベンジリデンアセトン)ニノ ラジウム(0) 1. 10g (l. 2ミリモル) 、 2, 2,—ビス(ジフエ-ルホスフイノ)— 1, 1,—ビナフチル 2. 24g (3. 6ミリモル)、ナ トリウム—tert—ブトキシド 6. 92g (72ミリモル)およびトルエン 240mLを仕込んだ。 次いで、窒素雰囲気下で 100°Cまで昇温し、さらに同温度で 8時間攪拌して反応さ せた。その後、反応液を室温まで冷却し、析出物をろ別、乾燥して本発明の 2, 6—ビ ス [ (フエ-ル)(ピリジン一 2—ィル)ァミノ]ピリジン 6. 75gを得た。得られた 2, 6—ビ ス [ (フエ-ル)(ピリジン— 2—ィル)ァミノ]ピリジンの収率は、使用した 2, 6—ジブ口 モピリジンに対して 68%であった。 To a 300 mL four-necked flask equipped with a condenser, thermometer and stirrer, add 2, 6- Dibromopyridine 5.69 g (24 mmol), (Phenol) (pyridine-2-yl) amamine 8. 16 g (48 mmol), Tris (dibenzylideneacetone) Ninoradium (0) 1.10 g (l. 2 Mmol), 2,2, -bis (diphenylphosphino) -1,1, -binaphthyl 2.24 g (3.6 mmol), sodium-tert-butoxide 6.92 g (72 mmol) and toluene 240 mL. . Next, the temperature was raised to 100 ° C. under a nitrogen atmosphere, and the reaction was further stirred at the same temperature for 8 hours. Thereafter, the reaction solution is cooled to room temperature, and the precipitate is filtered and dried to obtain 6.75 g of 2,6-bis [(phenol) (pyridine-2-yl) amino] pyridine of the present invention. It was. The yield of the resulting 2,6-bis [(phenol) (pyridine-2-yl) amino] pyridine was 68% based on the 2,6-dibu-momopyridine used.
なお、得られた化合物が、 2, 6—ビス [ (フエ-ル)(ピリジン— 2—ィル)ァミノ]ピリジ ンであることを下記の分析結果により確認した。  It was confirmed by the following analysis results that the obtained compound was 2,6-bis [(phenol) (pyridine-2-yl) amino] pyridin.
分子量 (大気圧イオン化法による質量分析) :415  Molecular weight (mass analysis by atmospheric pressure ionization method): 415
IR(KBr) : 1583, 1568, 1494, 1466, 1447, 1415, 1349, 1320, 1304, 12 74, 1261, 1072, 778cm"1 IR (KBr): 1583, 1568, 1494, 1466, 1447, 1415, 1349, 1320, 1304, 12 74, 1261, 1072, 778cm " 1
評価 Evaluation
実施例 5で得られた 2, 6—ビス [ (フエ-ル)(ピリジン— 2—ィル)ァミノ]ピリジンにつ いて、発光特性および熱安定性を評価した。  The 2,6-bis [(phenol) (pyridine-2-yl) amino] pyridine obtained in Example 5 was evaluated for luminescent properties and thermal stability.
(発光特性) (Luminescent characteristics)
実施例 5で得られた 2, 6—ビス [ (フエ-ル)(ピリジン— 2—ィル)ァミノ]ピリジンを 1 —メチル— 2—ピロリドンに溶解させて測定試料 (濃度: 1 X 10"3g/L)を調製し、蛍 光分光光度計 (株式会社日立製作所、商品名 F— 2500)を用いて発光波長を測 定した。その結果、実施例 5で得られた 2, 6—ビス [ (フエ-ル)(ピリジン— 2—ィル) ァミノ]ピリジンは、発光機能を有することが確認できた。また、その蛍光の波長は 423 nmであった。従って、実施例 5で得られた 2, 6—ビス [ (フエニル)(ピリジンー2—ィ ル)ァミノ]ピリジンは、例えば、 EL素子等における発光層用材料として好適に用いる ことができる可能性が高 、ことがわかる。 Sample obtained by dissolving 2,6-bis [(phenol) (pyridine-2-yl) amino] pyridine obtained in Example 5 in 1-methyl-2-pyrrolidone (concentration: 1 X 10 " 3 g / L) was prepared, and the emission wavelength was measured using a fluorescence spectrophotometer (trade name F-2500, Hitachi, Ltd.) As a result, 2, 6— Bis [(phenol) (pyridine-2-yl) amino] pyridine was confirmed to have a light-emitting function, and the fluorescence wavelength was 423 nm. It can be seen that the obtained 2,6-bis [(phenyl) (pyridine-2-yl) amino] pyridine is likely to be suitably used as a light emitting layer material in, for example, EL devices.
(熱安定性) (Thermal stability)
示差熱分析法により、実施例 5で得られた 2, 6—ビス [ (フエ-ル)(ピリジン一 2—ィ ル)ァミノ]ピリジンについて熱分解温度を測定し、さらに示差走査熱量分析法により 、ガラス転移温度を測定した。 By differential thermal analysis, 2, 6-bis [(phenol) The thermal decomposition temperature of [r) amino] pyridine was measured, and the glass transition temperature was further measured by differential scanning calorimetry.
示差熱分析は、実施例 5で得られた 2, 6 ビス [ (フエ-ル)(ピリジン— 2—ィル)ァ ミノ]ピリジン lmgを秤量し、窒素雰囲気下、 10°CZ分の昇温速度で室温から 500°C まで昇温した。その結果、熱分解温度は 265°Cであることがわ力つた。  Differential thermal analysis was performed by weighing 1 mg of 2,6bis [(phenol) (pyridine-2-yl) amino] pyridine obtained in Example 5 and raising the temperature by 10 ° CZ in a nitrogen atmosphere. The temperature was raised from room temperature to 500 ° C. As a result, the thermal decomposition temperature was 265 ° C.
示差走査熱量分析は、実施例 5で得られた 2, 6 ビス [ (フエニル)(ピリジンー2— ィル)ァミノ]ピリジン lOmgを秤量し、窒素雰囲気下、 10°CZ分の昇温速度で室温か ら 200°Cまで昇温した。次に、 10°CZ分の降温速度で 200°Cから室温まで冷却した 後、再び、 10°CZ分の昇温速度で室温から 200°Cまで昇温した。その結果、ガラス 転移温度は 52°Cであることがわ力つた。また、この繰り返し測定の際、アモルファスか らの結晶化に基づく発熱ピークは認められな力つた。  Differential scanning calorimetry was performed by weighing 2,6 bis [(phenyl) (pyridine-2-yl) amino] pyridine lOmg obtained in Example 5 at room temperature at a temperature increase rate of 10 ° CZ in a nitrogen atmosphere. The temperature was raised to 200 ° C. Next, after cooling from 200 ° C to room temperature at a temperature drop rate of 10 ° CZ, the temperature was raised again from room temperature to 200 ° C at a temperature increase rate of 10 ° CZ. As a result, the glass transition temperature was 52 ° C. In addition, during this repeated measurement, no exothermic peak due to crystallization from amorphous was observed.
これらのことから、実施例 5で得られた 2, 6 ビス [ (フエ-ル)(ピリジン一 2—ィル) ァミノ]ピリジンは、熱分解温度が 265°Cと熱的に安定であるため蒸着等により容易に 成膜が可能であり、また結晶化温度を有さないため、成膜したアモルファス膜は、優 れた耐熱性を有することがわかる。  From these results, the 2,6bis [(phenol) (pyridine-2-yl) amino] pyridine obtained in Example 5 has a thermal decomposition temperature of 265 ° C and is thermally stable. It can be seen that the deposited amorphous film has excellent heat resistance because it can be easily formed by vapor deposition and has no crystallization temperature.
実施例 6  Example 6
2, 6 ビス [ (4—メチルフエ-ル)(5—メチルピリジン一 2—ィル)ァミノ]ピリジン [一 般式(3)、 Ι^=Η、 R2=5—メチル、 R3=4—メチル]の調製 2, 6 Bis [(4-methylphenol) (5-methylpyridine-1-yl) amino] pyridine [General formula (3), Ι ^ = Η, R 2 = 5-methyl, R 3 = 4 —Methyl] Preparation
実施例 5において、(フエ-ル)(ピリジン— 2—ィル)ァミン 8. 16g (48ミリモル)に代 えて、 (4—メチルフエ-ル)(5—メチルピリジン— 2—ィル)ァミン 9. 50 (48ミリモル) を用いた以外は、実施例 5と同様にして本発明の 2, 6 ビス [ (4 メチルフエ-ル)( 5—メチルピリジン一 2—ィル)ァミノ]ピリジン 6. 90gを得た。得られた 2, 6 ビス [ (4 —メチルフエ-ル)(5—メチルピリジン— 2—ィル)ァミノ]ピリジンの収率は、使用した 2, 6 ジブロモピリジンに対して 61 %であった。  In Example 5, instead of (phenol) (pyridine-2-yl) amine 8.16 g (48 mmol), (4-methylphenol) (5-methylpyridine-2-yl) amine 9 2.90 g of 2,6bis [(4 methylphenol) (5-methylpyridine-2-yl) amino] pyridine of the invention as in Example 5 except that 50 (48 mmol) was used. Got. The yield of 2,6bis [(4-methylphenol) (5-methylpyridine-2-yl) amino] pyridine obtained was 61% based on 2,6 dibromopyridine used.
なお、得られた化合物が、 2, 6 ビス [ (4 メチルフエ-ル)(5 メチルピリジン 2 —ィル)ァミノ]ピリジンであることを下記の分析結果により確認した。  The obtained compound was confirmed to be 2, 6 bis [(4 methylphenol) (5 methylpyridine 2 -yl) amino] pyridine by the following analysis results.
分子量 (大気圧イオン化法による質量分析) :471  Molecular weight (mass spectrometry by atmospheric pressure ionization method): 471
IR(KBr) : 3030, 2984, 1587, 1562, 1490, 1456, 1435, 1342, 1310, 12 69, 1065, 778, 710cm" IR (KBr): 3030, 2984, 1587, 1562, 1490, 1456, 1435, 1342, 1310, 12 69, 1065, 778, 710cm "
[0074] 評価 [0074] Evaluation
実施例 6で得られた 2, 6 ビス [ (4—メチルフエ-ル)(5—メチルピリジン一 2—ィ ル)ァミノ]ピリジンにつ ヽて、発光特性および熱安定性を評価した。  The 2,6bis [(4-methylphenol) (5-methylpyridine-2-yl) amino] pyridine obtained in Example 6 was evaluated for luminescent properties and thermal stability.
(発光特性)  (Luminescent characteristics)
実施例 5と同様にして蛍光分光光度計を用いて発光波長を測定した。その結果、 実施例 6で得られた 2, 6 ビス [ (4 メチルフエ-ル)(5 メチルピリジン 2 ィル) ァミノ]ピリジンは、発光機能を有することが確認できた。また、その蛍光の波長は 430 nmであった。従って、実施例 6で得られた 2, 6 ビス [ (4 メチルフエ-ル)(5—メ チルピリジンー2—ィル)ァミノ]ピリジンは、例えば、 EL素子等における発光層用材 料として好適に用いることができる可能性が高 、ことがわかる。  In the same manner as in Example 5, the emission wavelength was measured using a fluorescence spectrophotometer. As a result, it was confirmed that the 2,6bis [(4 methylphenol) (5 methylpyridine 2yl) amino] pyridine obtained in Example 6 had a light emitting function. The fluorescence wavelength was 430 nm. Accordingly, the 2,6bis [(4 methylphenol) (5-methylpyridine-2-yl) amino] pyridine obtained in Example 6 should be suitably used as a material for the light emitting layer in, for example, an EL device. It is clear that there is a high possibility that
(熱安定性)  (Thermal stability)
実施例 5と同様にして測定した。  Measurement was performed in the same manner as in Example 5.
示差熱分析により、熱分解温度は 268°Cであることがわ力つた。  Differential thermal analysis showed that the thermal decomposition temperature was 268 ° C.
示差走査熱量分析より、ガラス転移温度は 49°Cであることがわ力つた。また、この繰 り返し測定の際、アモルファスからの結晶化に基づく発熱ピークは認められな力つた これらのことから、実施例 6で得られた 2, 6 ビス [ (4 メチルフエ-ル)(5 メチル ピリジン— 2—ィル)ァミノ]ピリジンは、熱分解温度が 268°Cと熱的に安定であるため 蒸着等により容易に成膜が可能であり、また結晶化温度を有さないため、成膜したァ モルファス膜は、優れた耐熱性を有することがわかる。  Differential scanning calorimetry showed that the glass transition temperature was 49 ° C. In addition, during this repeated measurement, no exothermic peak due to crystallization from amorphous was observed. From these results, it was confirmed that 2, 6 bis [(4 methylphenol) (5 Methyl pyridine-2-yl) amino] pyridine has a thermal decomposition temperature of 268 ° C and is thermally stable, so it can be easily formed by vapor deposition, and it does not have a crystallization temperature. It can be seen that the amorphous film formed has excellent heat resistance.
[0075] 実施例 7 [0075] Example 7
1, 3 ビス [ (フエ-ル)(ピリジン— 2—ィル)ァミノ]ベンゼン [一般式(4)、!^〜R3 =H]の調製 1, 3 Bis [(Phenol) (pyridine-2-yl) amino] benzene [General formula (4)! ^ Preparation of ~R 3 = H]
冷却管、温度計および攪拌機を備え付けた 300mL容の四つ口フラスコに、 1, 3— ジブロモベンゼン 5. 66g (24ミリモル)、 (フエ-ル)(ピリジン— 2—ィル)ァミン 8. 16g (48ミリモル)、トリス(ジベンジリデンアセトン)ニノ ラジウム(0) 1. 10g (l. 2ミリモル) 、 2, 2,一ビス(ジフエ-ルホスフイノ)一 1, 1,一ビナフチル 2. 24g (3. 6ミリモル)、ナ トリウム—tert—ブトキシド 6. 92g (72ミリモル)およびトルエン 240mLを仕込んだ。 次いで、窒素雰囲気下で 100°Cまで昇温し、さらに同温度で 8時間攪拌して反応さ せた。その後、反応液を室温まで冷却し、析出物をろ別、乾燥して本発明の 1, 3—ビ ス [ (フエ-ル)(ピリジン一 2—ィル)ァミノ]ベンゼン 5. 75gを得た。得られた 1, 3—ビ ス [ (フエ-ル)(ピリジン— 2—ィル)ァミノ]ベンゼンの収率は、使用した 1, 3—ジブ口 モベンゼンに対して 58%であった。 In a 300 mL four-necked flask equipped with a condenser, a thermometer and a stirrer, 1, 3-dibromobenzene 5.66 g (24 mmol), (phenol) (pyridine-2-yl) amamine 8. 16 g (48 mmol), tris (dibenzylideneacetone) ninoradium (0) 1.10 g (l. 2 mmol), 2,2,1 bis (diphenylphosphino) 1,1,1, binaphthyl 2.24 g (3. 6 mmol), Na Thorium-tert-butoxide 6.92 g (72 mmol) and toluene 240 mL were charged. Next, the temperature was raised to 100 ° C. under a nitrogen atmosphere, and the reaction was further stirred at the same temperature for 8 hours. Thereafter, the reaction solution is cooled to room temperature, and the precipitate is filtered and dried to obtain 5.75 g of 1,3-bis [(phenyl) (pyridine-2-yl) amino] benzene of the present invention. It was. The yield of the obtained 1,3-bis [(phenol) (pyridine-2-yl) amino] benzene was 58% with respect to the 1,3-dib-mouthed mobenzene used.
なお、得られた化合物力 1, 3—ビス [ (フエ-ル)(ピリジン— 2—ィル)ァミノ]ベン ゼンであることを下記の分析結果により確認した。  The obtained compound strength was confirmed to be 1,3-bis [(phenol) (pyridine-2-yl) amino] benzene by the following analysis results.
分子量 (大気圧イオン化法による質量分析):414  Molecular weight (mass spectrometry by atmospheric pressure ionization method): 414
IR(KBr) : 1583, 1568, 1494, 1466, 1447, 1415, 1351, 1320, 1304, 12 74, 1261, 1157, 1072, 778cm"1 IR (KBr): 1583, 1568, 1494, 1466, 1447, 1415, 1351, 1320, 1304, 12 74, 1261, 1157, 1072, 778cm " 1
評価 Evaluation
実施例 7で得られた 1, 3—ビス [ (フエ-ル)(ピリジン— 2—ィル)ァミノ]ベンゼンに ついて、発光特性および熱安定性を評価した。  The 1,3-bis [(phenol) (pyridine-2-yl) amino] benzene obtained in Example 7 was evaluated for luminescent properties and thermal stability.
(発光特性) (Luminescent characteristics)
実施例 7で得られた 1, 3—ビス [ (フエ-ル)(ピリジン— 2—ィル)ァミノ]ベンゼンを 1 —メチル— 2—ピロリドンに溶解させて測定試料 (濃度: 1 X 10"3g/L)を調製し、蛍 光分光光度計 (株式会社日立製作所、商品名 F— 2500)を用いて発光波長を測 定した。その結果、実施例 7で得られた 1, 3—ビス [ (フエ-ル)(ピリジン— 2—ィル) ァミノ]ベンゼンは、発光機能を有することが確認できた。また、その蛍光の波長は 43 2nmであった。従って、実施例 7で得られた 1, 3—ビス [ (フエ-ノレ)(ピリジン一 2—ィ ル)ァミノ]ベンゼンは、例えば、 EL素子等における発光層用材料として好適に用い ることができる可能性が高 、ことがわかる。 Sample obtained by dissolving 1,3-bis [(phenol) (pyridine-2-yl) amino] benzene obtained in Example 7 in 1-methyl-2-pyrrolidone (concentration: 1 X 10 ") 3 g / L) was prepared, and the emission wavelength was measured using a fluorescence spectrophotometer (trade name F-2500, Hitachi, Ltd.) As a result, 1, 3— Bis [(phenol) (pyridine-2-yl) amino] benzene was confirmed to have a light-emitting function, and the fluorescence wavelength was 43 2 nm. The obtained 1,3-bis [(phenol) (pyridine-2-yl) amino] benzene is likely to be suitably used as a material for a light emitting layer in, for example, an EL device. I understand.
(熱安定性) (Thermal stability)
示差熱分析法により、実施例 7で得られた 1, 3—ビス [ (フエ-ル)(ピリジン— 2—ィ ル)ァミノ]ベンゼンについて熱分解温度を測定し、さらに示差走査熱量分析法により 、ガラス転移温度を測定した。  The thermal decomposition temperature of 1,3-bis [(phenol) (pyridine-2-yl) amino] benzene obtained in Example 7 was measured by differential thermal analysis, and further analyzed by differential scanning calorimetry. The glass transition temperature was measured.
示差熱分析は、実施例 7で得られた 1, 3—ビス [ (フエ-ル)(ピリジン— 2—ィル)ァ ミノ]ベンゼン lmgを秤量し、窒素雰囲気下、 10°CZ分の昇温速度で室温から 500 °Cまで昇温した。その結果、熱分解温度は 268°Cであることがわ力つた。 The differential thermal analysis was performed using 1,3-bis [(phenol) (pyridine-2-yl) a obtained in Example 7. Mino] benzene lmg was weighed and heated from room temperature to 500 ° C at a temperature increase rate of 10 ° CZ in a nitrogen atmosphere. As a result, the thermal decomposition temperature was 268 ° C.
示差走査熱量分析は、実施例 7で得られた 1, 3 ビス [ (フエニル)(ピリジンー2— ィル)ァミノ]ベンゼン lOmgを秤量し、窒素雰囲気下、 10°CZ分の昇温速度で室温 から 200°Cまで昇温した。次に、 10°CZ分の降温速度で 200°Cから室温まで冷却し た後、再び、 10°CZ分の昇温速度で室温から 200°Cまで昇温した。その結果、ガラ ス転移温度は 51°Cであることがわ力つた。また、この繰り返し測定の際、アモルファス 力もの結晶化に基づく発熱ピークは認められな力つた。  Differential scanning calorimetry was performed by weighing 1,3 bis [(phenyl) (pyridine-2-yl) amino] benzene lOmg obtained in Example 7 at room temperature at a rate of 10 ° CZ in a nitrogen atmosphere. The temperature was raised to 200 ° C. Next, after cooling from 200 ° C to room temperature at a temperature drop rate of 10 ° CZ, the temperature was raised again from room temperature to 200 ° C at a temperature increase rate of 10 ° CZ. As a result, the glass transition temperature was found to be 51 ° C. Also, during this repeated measurement, no exothermic peak due to crystallization of amorphous force was observed.
これらのことから、実施例 7で得られた 1, 3 ビス [ (フエ-ル)(ピリジン一 2—ィル) ァミノ]ベンゼンは、熱分解温度が 268°Cと熱的に安定であるため蒸着等により容易 に成膜が可能であり、また結晶化温度を有さないため、成膜したアモルファス膜は、 優れた耐熱性を有することがわかる。  From these facts, the 1,3bis [(phenol) (pyridine-2-yl) amino] benzene obtained in Example 7 has a thermal decomposition temperature of 268 ° C and is thermally stable. It can be easily formed by vapor deposition or the like, and since it does not have a crystallization temperature, it can be seen that the formed amorphous film has excellent heat resistance.
[0077] 実施例 8 [0077] Example 8
1, 3 ビス [ (4—メチルフエ-ル)(5—メチルピリジン— 2—ィル)ァミノ]ベンゼン [ 一般式 (4)、 Ι^=Η、 R2=5—メチル、 R3=4—メチル]の調製 1, 3 Bis [(4-Methylphenol) (5-Methylpyridine-2-yl) amino] benzene [General formula (4), Ι ^ = Η, R 2 = 5—Methyl, R 3 = 4— Of Methyl]
実施例 7において、(フエ-ル)(ピリジン— 2—ィル)ァミン 8. 16g (48ミリモル)に代 えて、 (4—メチルフエ-ル)(5—メチルピリジン— 2—ィル)ァミン 9. 50 (48ミリモル) を用いた以外は、実施例 7と同様にして本発明の 1, 3 ビス [ (4 メチルフエ-ル)( 5—メチルピリジン一 2—ィル)ァミノ]ベンゼン 5. 53gを得た。得られた 1, 3 ビス [ ( 4 メチルフエ-ル)(5 メチルピリジン 2 ィル)ァミノ]ベンゼンの収率は、使用し た 1, 3 ジブロモベンゼンに対して 49%であった。  In Example 7, instead of (phenol) (pyridine-2-yl) amine 8.16 g (48 mmol), (4-methylphenol) (5-methylpyridine-2-yl) amine 9 1. 53 bis [(4 methylphenol) (5-methylpyridine-2-yl) amino] benzene of the present invention in the same manner as in Example 7 except that 50 (48 mmol) was used 5.53 g Got. The yield of the obtained 1,3 bis [(4 methylphenol) (5 methylpyridine 2yl) amino] benzene was 49% based on the 1,3 dibromobenzene used.
なお、得られた化合物が、 1, 3 ビス [ (4 メチルフエ-ル)(5 メチルピリジンー2 —ィル)ァミノ]ベンゼンであることを下記の分析結果により確認した。  The obtained compound was confirmed to be 1, 3 bis [(4 methylphenol) (5 methylpyridine-2-yl) amino] benzene by the following analysis results.
分子量 (大気圧イオン化法による質量分析) :470  Molecular weight (mass spectrometry by atmospheric pressure ionization method): 470
IR(KBr) : 3032, 2985, 1583, 1565, 1489, 1466, 1445, 1349, 1320, 12 69, 1055, 778, 710cm"1 IR (KBr): 3032, 2985, 1583, 1565, 1489, 1466, 1445, 1349, 1320, 12 69, 1055, 778, 710cm " 1
[0078] 評価 [0078] Evaluation
実施例 8で得られた 1, 3 ビス [ (4—メチルフエ-ル)(5—メチルピリジン— 2—ィ ル)ァミノ]ベンゼンにつ ヽて、発光特性および熱安定性を評価した。 1,3 bis [(4-methylphenol) (5-methylpyridine-2-y) obtained in Example 8 Lumino) benzene was evaluated for its luminescent properties and thermal stability.
(発光特性) (Luminescent characteristics)
実施例 7と同様にして蛍光分光光度計を用いて発光波長を測定した。その結果、 実施例 8で得られた 1, 3 ビス [ (4—メチルフエ-ル)(5—メチルピリジン一 2—ィル) ァミノ]ベンゼンは、発光機能を有することが確認できた。また、その蛍光の波長は 43 5nmであった。従って、実施例 8で得られた 1, 3 ビス [ (4—メチルフエ-ル)(5—メ チルピリジン 2—ィル)ァミノ]ベンゼンは、例えば、 EL素子等における発光層用材 料として好適に用いることができる可能性が高 、ことがわかる。  In the same manner as in Example 7, the emission wavelength was measured using a fluorescence spectrophotometer. As a result, it was confirmed that the 1,3 bis [(4-methylphenol) (5-methylpyridine-1-yl) amino] benzene obtained in Example 8 had a light emitting function. The fluorescence wavelength was 435 nm. Therefore, 1,3 bis [(4-methylphenol) (5-methylpyridine 2-yl) amino] benzene obtained in Example 8 is suitably used as a material for a light emitting layer in, for example, an EL device. It turns out that there is a high possibility of being able to.
(熱安定性) (Thermal stability)
実施例 7と同様にして測定した。  Measurement was carried out in the same manner as in Example 7.
示差熱分析により、熱分解温度は 267°Cであることがわ力つた。  Differential thermal analysis showed that the thermal decomposition temperature was 267 ° C.
示差走査熱量分析より、ガラス転移温度は 49°Cであることがわ力つた。また、この繰 り返し測定の際、アモルファスからの結晶化に基づく発熱ピークは認められな力つた これらのことから、実施例 8で得られた 1, 3 ビス [ (4 メチルフエ-ル)(5 メチル ピリジン— 2—ィル)ァミノ]ベンゼンは、熱分解温度が 267°Cと熱的に安定であるた め蒸着等により容易に成膜が可能であり、また結晶化温度を有さないため、成膜した アモルファス膜は、優れた耐熱性を有することがわかる。  Differential scanning calorimetry showed that the glass transition temperature was 49 ° C. In addition, during this repeated measurement, no exothermic peak due to crystallization from amorphous was observed. Therefore, the 1,3 bis [(4 methylphenol) (5 Methyl pyridine-2-yl) amino] benzene has a thermal decomposition temperature of 267 ° C and is thermally stable. Therefore, it can be easily formed by vapor deposition and has no crystallization temperature. It can be seen that the amorphous film formed has excellent heat resistance.
産業上の利用可能性 Industrial applicability
本発明の化合物は、熱的に安定であり、また耐熱性に優れたアモルファス膜を形 成できるため、 EL素子等における電荷輸送材料や発光層用材料として有用である。  Since the compound of the present invention is thermally stable and can form an amorphous film having excellent heat resistance, it is useful as a charge transport material and a light emitting layer material in EL devices and the like.

Claims

請求の範囲 [1] 一般式 (I) Claim [1] General formula (I)
[化 1]  [Chemical 1]
Figure imgf000039_0001
Figure imgf000039_0001
(式中、!^〜 は、それぞれ独立して、水素原子、水酸基、カルボキシル基、シァノ 基、力ルバモイル基、炭素数 1〜10のアルキル基、または炭素数 1〜10のアルカノィ ル基を示し、これらは同一であっても異なっていてもよぐ Vは窒素原子または炭素原 子を示し、 2つの Wは同時に窒素原子または炭素原子を示し、 Vおよび Wは同一で あっても異なっていてもよい。)で表される化合物。  (In the formula, each of! ^ To independently represents a hydrogen atom, a hydroxyl group, a carboxyl group, a cyano group, a strong rubermoyl group, an alkyl group having 1 to 10 carbon atoms, or an alkanoyl group having 1 to 10 carbon atoms. These may be the same or different. V represents a nitrogen atom or carbon atom, two Ws simultaneously represent a nitrogen atom or carbon atom, and V and W may be the same or different. A compound represented by:
[2] 前記一般式 (I)において、 Vおよび Wが共に、窒素原子である請求項 1に記載の化 合物。  [2] The compound according to claim 1, wherein in the general formula (I), V and W are both nitrogen atoms.
[3] 前記一般式 (I)において、 Vが炭素原子であって、 Wが窒素原子である請求項 1に 記載の化合物。  [3] The compound according to claim 1, wherein, in the general formula (I), V is a carbon atom and W is a nitrogen atom.
[4] 前記一般式 (I)において、 Vが窒素原子であって、 Wが炭素原子である請求項 1に 記載の化合物。  [4] The compound according to claim 1, wherein, in the general formula (I), V is a nitrogen atom and W is a carbon atom.
[5] 前記一般式 (I)において、 Vおよび Wが共に、炭素原子である請求項 1に記載の化 合物。  5. The compound according to claim 1, wherein in the general formula (I), V and W are both carbon atoms.
[6] 前記一般式 (I)において、!^1〜!^3が、すべて水素原子である請求項 1〜5いずれか 1記載の化合物。 [6] In the general formula (I),! The compound according to any one of claims 1 to 5, wherein ^ 1 to! ^ 3 are all hydrogen atoms.
[7] 一般式 (Π) :  [7] General formula (Π):
[化 2]
Figure imgf000040_0001
[Chemical 2]
Figure imgf000040_0001
(式中、 R1は、水素原子、水酸基、カルボキシル基、シァノ基、力ルバモイル基、炭素 数 1〜10のアルキル基、または炭素数 1〜10のアルカノィル基を示し、 Vは窒素原子 または炭素原子を示し、 Xはハロゲン原子を示す。)で表されるジハロゲノ単環化合 物と、一般式 (III) : (In the formula, R 1 represents a hydrogen atom, a hydroxyl group, a carboxyl group, a cyano group, a strong rubamoyl group, an alkyl group having 1 to 10 carbon atoms, or an alkanoyl group having 1 to 10 carbon atoms, and V represents a nitrogen atom or a carbon atom. Dihalogeno monocyclic compounds represented by the general formula (III):
[化 3] [Chemical 3]
Figure imgf000040_0002
Figure imgf000040_0002
(式中、 R2および R3は、それぞれ独立して、水素原子、水酸基、カルボキシル基、シ ァノ基、力ルバモイル基、炭素数 1〜10のアルキル基、または炭素数 1〜10のアル力 ノィル基を示し、これらは同一であっても異なっていてもよぐ Wは窒素原子または炭 素原子を示す。)で表されるアミンィ匕合物とを、ノ ラジウム化合物およびホスフィンィ匕 合物を含む触媒並びに塩基の存在下、反応させることを特徴とする一般式 (I): [化 4] (In the formula, R 2 and R 3 are each independently a hydrogen atom, a hydroxyl group, a carboxyl group, a cyano group, a strong rubamoyl group, an alkyl group having 1 to 10 carbon atoms, or an alkyl group having 1 to 10 carbon atoms. And N may be the same or different. W represents a nitrogen atom or a carbon atom.) And an amine compound represented by a noradium compound and a phosphine compound. General formula (I) characterized by reacting in the presence of a catalyst and a base containing:
Figure imgf000040_0003
Figure imgf000040_0003
(式中、!^〜 は、それぞれ独立して、水素原子、水酸基、カルボキシル基、シァノ 基、力ルバモイル基、炭素数 1〜10のアルキル基、または炭素数 1〜10のアルカノィ ル基を示し、これらは同一であっても異なっていてもよぐ Vは窒素原子または炭素原 子を示し、 2つの Wは同時に窒素原子または炭素原子を示し、 Vおよび Wは同一で あっても異なって 、てもよ 、。 )で表される化合物の製造方法。 (In the formula, each of! ^ ~ Is independently a hydrogen atom, a hydroxyl group, a carboxyl group, a cyano group, a strong rubermoyl group, an alkyl group having 1 to 10 carbon atoms, or an alkanoy having 1 to 10 carbon atoms May be the same or different, V represents a nitrogen atom or carbon atom, two Ws simultaneously represent a nitrogen atom or carbon atom, and V and W are the same. Also different. The manufacturing method of the compound represented by this.
[8] 前記一般式 (I)において、 Vおよび Wが共に、窒素原子である請求項 7に記載の化 合物の製造方法。 8. The method for producing a compound according to claim 7, wherein in the general formula (I), V and W are both nitrogen atoms.
[9] 前記一般式 (I)にお 、て、 Vが炭素原子であって、 Wが窒素原子である請求項 7に 記載の化合物の製造方法。  [9] The process for producing a compound according to [7], wherein in the general formula (I), V is a carbon atom and W is a nitrogen atom.
[10] 前記一般式 (I)にお 、て、 Vが窒素原子であって、 Wが炭素原子である請求項 7に 記載の化合物の製造方法。 [10] The method for producing a compound according to [7], wherein in the general formula (I), V is a nitrogen atom and W is a carbon atom.
[11] 前記一般式 (I)において、 Vおよび Wが共に、炭素原子である請求項 7に記載の化 合物の製造方法。 11. The method for producing a compound according to claim 7, wherein in the general formula (I), V and W are both carbon atoms.
PCT/JP2006/324243 2005-12-14 2006-12-05 Compound for electroluminescent device and method for producing same WO2007069498A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2005-360449 2005-12-14
JP2005360449 2005-12-14
JP2006198274A JP2007186490A (en) 2005-12-14 2006-07-20 Compound for electroluminescent device and method for producing the same
JP2006-198274 2006-07-20

Publications (1)

Publication Number Publication Date
WO2007069498A1 true WO2007069498A1 (en) 2007-06-21

Family

ID=38162808

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2006/324243 WO2007069498A1 (en) 2005-12-14 2006-12-05 Compound for electroluminescent device and method for producing same

Country Status (3)

Country Link
JP (1) JP2007186490A (en)
TW (1) TW200736222A (en)
WO (1) WO2007069498A1 (en)

Cited By (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9224963B2 (en) 2013-12-09 2015-12-29 Arizona Board Of Regents On Behalf Of Arizona State University Stable emitters
US9238668B2 (en) 2011-05-26 2016-01-19 Arizona Board Of Regents, Acting For And On Behalf Of Arizona State University Synthesis of platinum and palladium complexes as narrow-band phosphorescent emitters for full color displays
US9324957B2 (en) 2010-04-30 2016-04-26 Arizona Board Of Regents On Behalf Of Arizona State University Synthesis of four coordinated gold complexes and their applications in light emitting devices thereof
US9385329B2 (en) 2013-10-14 2016-07-05 Arizona Board of Regents on behalf of Arizona State University and Universal Display Corporation Platinum complexes and devices
US9382273B2 (en) 2010-04-30 2016-07-05 Arizona Board Of Regents Acting For And On Behalf Of Arizona State University Synthesis of four coordinated palladium complexes and their applications in light emitting devices thereof
US9425415B2 (en) 2011-02-18 2016-08-23 Arizona Board Of Regents Acting For And On Behalf Of Arizona State University Four coordinated platinum and palladium complexes with geometrically distorted charge transfer state and their applications in light emitting devices
US9550801B2 (en) 2009-04-06 2017-01-24 Arizona Board Of Regents Acting For And On Behalf Of Arizona State University Synthesis of four coordinated platinum complexes and their applications in light emitting devices thereof
US9617291B2 (en) 2015-06-03 2017-04-11 Arizona Board Of Regents On Behalf Of Arizona State University Tetradentate and octahedral metal complexes containing naphthyridinocarbazole and its analogues
US9673409B2 (en) 2013-06-10 2017-06-06 Arizona Board Of Regents On Behalf Of Arizona State University Phosphorescent tetradentate metal complexes having modified emission spectra
US9711739B2 (en) 2015-06-02 2017-07-18 Arizona Board Of Regents On Behalf Of Arizona State University Tetradentate metal complexes containing indoloacridine and its analogues
US9711741B2 (en) 2012-08-24 2017-07-18 Arizona Board Of Regents On Behalf Of Arizona State University Metal compounds and methods and uses thereof
US9818959B2 (en) 2014-07-29 2017-11-14 Arizona Board of Regents on behlaf of Arizona State University Metal-assisted delayed fluorescent emitters containing tridentate ligands
US9882150B2 (en) 2012-09-24 2018-01-30 Arizona Board Of Regents For And On Behalf Of Arizona State University Metal compounds, methods, and uses thereof
US9923155B2 (en) 2014-07-24 2018-03-20 Arizona Board Of Regents On Behalf Of Arizona State University Tetradentate platinum (II) complexes cyclometalated with functionalized phenyl carbene ligands and their analogues
US9920242B2 (en) 2014-08-22 2018-03-20 Arizona Board Of Regents On Behalf Of Arizona State University Metal-assisted delayed fluorescent materials as co-host materials for fluorescent OLEDs
US9941479B2 (en) 2014-06-02 2018-04-10 Arizona Board Of Regents On Behalf Of Arizona State University Tetradentate cyclometalated platinum complexes containing 9,10-dihydroacridine and its analogues
US10020455B2 (en) 2014-01-07 2018-07-10 Arizona Board Of Regents On Behalf Of Arizona State University Tetradentate platinum and palladium complex emitters containing phenyl-pyrazole and its analogues
US10033003B2 (en) 2014-11-10 2018-07-24 Arizona Board Of Regents On Behalf Of Arizona State University Tetradentate metal complexes with carbon group bridging ligands
US10056567B2 (en) 2014-02-28 2018-08-21 Arizona Board Of Regents On Behalf Of Arizona State University Chiral metal complexes as emitters for organic polarized electroluminescent devices
US10158091B2 (en) 2015-08-04 2018-12-18 Arizona Board Of Regents On Behalf Of Arizona State University Tetradentate platinum (II) and palladium (II) complexes, devices, and uses thereof
US10177323B2 (en) 2016-08-22 2019-01-08 Arizona Board Of Regents On Behalf Of Arizona State University Tetradentate platinum (II) and palladium (II) complexes and octahedral iridium complexes employing azepine functional groups and their analogues
US10793546B2 (en) 2014-08-15 2020-10-06 Arizona Board Of Regents On Behalf Of Arizona State University Non-platinum metal complexes for excimer based single dopant white organic light emitting diodes
US10822363B2 (en) 2016-10-12 2020-11-03 Arizona Board Of Regents On Behalf Of Arizona State University Narrow band red phosphorescent tetradentate platinum (II) complexes
US10964897B2 (en) 2014-07-28 2021-03-30 Arizona Board Of Regents On Behalf Of Arizona State University Tridentate cyclometalated metal complexes with six-membered coordination rings
US10991897B2 (en) 2014-11-10 2021-04-27 Arizona Board Of Regents On Behalf Of Arizona State University Emitters based on octahedral metal complexes
US10995108B2 (en) 2012-10-26 2021-05-04 Arizona Board Of Regents On Behalf Of Arizona State University Metal complexes, methods, and uses thereof
US11063228B2 (en) 2017-05-19 2021-07-13 Arizona Board Of Regents On Behalf Of Arizona State University Metal-assisted delayed fluorescent emitters employing benzo-imidazo-phenanthridine and analogues
US11101435B2 (en) 2017-05-19 2021-08-24 Arizona Board Of Regents On Behalf Of Arizona State University Tetradentate platinum and palladium complexes based on biscarbazole and analogues
US11183670B2 (en) 2016-12-16 2021-11-23 Arizona Board Of Regents On Behalf Of Arizona State University Organic light emitting diode with split emissive layer
US11329244B2 (en) 2014-08-22 2022-05-10 Arizona Board Of Regents On Behalf Of Arizona State University Organic light-emitting diodes with fluorescent and phosphorescent emitters
US11335865B2 (en) 2016-04-15 2022-05-17 Arizona Board Of Regents On Behalf Of Arizona State University OLED with multi-emissive material layer
US11594688B2 (en) 2017-10-17 2023-02-28 Arizona Board Of Regents On Behalf Of Arizona State University Display and lighting devices comprising phosphorescent excimers with preferred molecular orientation as monochromatic emitters
US11594691B2 (en) 2019-01-25 2023-02-28 Arizona Board Of Regents On Behalf Of Arizona State University Light outcoupling efficiency of phosphorescent OLEDs by mixing horizontally aligned fluorescent emitters
US11647643B2 (en) 2017-10-17 2023-05-09 Arizona Board Of Regents On Behalf Of Arizona State University Hole-blocking materials for organic light emitting diodes
US11708385B2 (en) 2017-01-27 2023-07-25 Arizona Board Of Regents On Behalf Of Arizona State University Metal-assisted delayed fluorescent emitters employing pyrido-pyrrolo-acridine and analogues
US11785838B2 (en) 2019-10-02 2023-10-10 Arizona Board Of Regents On Behalf Of Arizona State University Green and red organic light-emitting diodes employing excimer emitters
US11878988B2 (en) 2019-01-24 2024-01-23 Arizona Board Of Regents On Behalf Of Arizona State University Blue phosphorescent emitters employing functionalized imidazophenthridine and analogues
US11945985B2 (en) 2020-05-19 2024-04-02 Arizona Board Of Regents On Behalf Of Arizona State University Metal assisted delayed fluorescent emitters for organic light-emitting diodes
US12037348B2 (en) 2018-03-09 2024-07-16 Arizona Board Of Regents On Behalf Of Arizona State University Blue and narrow band green and red emitting metal complexes
US12091429B2 (en) 2018-07-16 2024-09-17 Arizona Board Of Regents On Behalf Of Arizona State University Fluorinated porphyrin derivatives for optoelectronic applications

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008024634A (en) * 2006-07-20 2008-02-07 Sumitomo Seika Chem Co Ltd Compound for electroluminescent device and method for producing the same
US8653230B2 (en) * 2011-02-18 2014-02-18 East China University Of Science And Technology Monomers, oligomeric complexes, coordination polymers, and methods for their preparation and use
KR101554680B1 (en) * 2012-03-16 2015-09-21 단국대학교 산학협력단 Aromatic amine compound and organic electroluminescent device including the same

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04182655A (en) * 1990-11-19 1992-06-30 Canon Inc Electrophotographic sensitive body, electrophotographic device fitted with same sensitive body and facsimile
JPH07118234A (en) * 1993-10-25 1995-05-09 Takasago Internatl Corp Tetraaryl-2,6-diaminopyridine derivative and electrophotographic photoreceptor using the same
JP2003335809A (en) * 2002-05-21 2003-11-28 Sumitomo Chem Co Ltd Olefin polymerization catalyst and method for producing olefin polymer

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04182655A (en) * 1990-11-19 1992-06-30 Canon Inc Electrophotographic sensitive body, electrophotographic device fitted with same sensitive body and facsimile
JPH07118234A (en) * 1993-10-25 1995-05-09 Takasago Internatl Corp Tetraaryl-2,6-diaminopyridine derivative and electrophotographic photoreceptor using the same
JP2003335809A (en) * 2002-05-21 2003-11-28 Sumitomo Chem Co Ltd Olefin polymerization catalyst and method for producing olefin polymer

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ICHIKAWA Y. ET AL.: "Yuki EL Display no Kozo to Zairyo", ELECTRONIC MATERIALS AND PARTS, 2001, pages 18 - 23, XP003014466 *
KIDO J. ET AL.: "Organic electroluminescent devices based on molecularly doped polymers", APPL. PHYS. LETT., vol. 61, no. 7, 1992, pages 761 - 763, XP003014467 *
WEI K.-J. ET AL.: "Syntheses, Crystal Structures, and Photoluminescent Properties of a Series of M(II) Coordination Polymers Containing M-X2-M Bridges: From 1-D Chains to 2-D Networks", CRYSTAL GROWTH & DESIGN, vol. 6, no. 6, 2006, pages 1341 - 1350, XP003014465 *

Cited By (82)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9550801B2 (en) 2009-04-06 2017-01-24 Arizona Board Of Regents Acting For And On Behalf Of Arizona State University Synthesis of four coordinated platinum complexes and their applications in light emitting devices thereof
US10263197B2 (en) 2010-04-30 2019-04-16 Arizona Board Of Regents Acting For And On Behalf Of Arizona State University Synthesis of four coordinated palladium complexes and their applications in light emitting devices thereof
US9324957B2 (en) 2010-04-30 2016-04-26 Arizona Board Of Regents On Behalf Of Arizona State University Synthesis of four coordinated gold complexes and their applications in light emitting devices thereof
US9755163B2 (en) 2010-04-30 2017-09-05 Arizona Board Of Regents Acting For Or On Behalf Of Arizona State University Synthesis of four coordinated palladium complexes and their applications in light emitting devices thereof
US9382273B2 (en) 2010-04-30 2016-07-05 Arizona Board Of Regents Acting For And On Behalf Of Arizona State University Synthesis of four coordinated palladium complexes and their applications in light emitting devices thereof
US10727422B2 (en) 2010-04-30 2020-07-28 Arizona Board Of Regents On Behalf Of Arizona State University Synthesis of four coordinated palladium complexes and their applications in light emitting devices thereof
US9711742B2 (en) 2011-02-18 2017-07-18 Arizona Board Of Regents Acting For And On Behalf Of Arizona State University Four coordinated platinum and palladium complexes with geometrically distorted charge transfer state and their applications in light emitting devices
US9425415B2 (en) 2011-02-18 2016-08-23 Arizona Board Of Regents Acting For And On Behalf Of Arizona State University Four coordinated platinum and palladium complexes with geometrically distorted charge transfer state and their applications in light emitting devices
US10804476B2 (en) 2011-05-26 2020-10-13 Arizona Board Of Regents, Acting For And On Behalf Of Arizona State University Synthesis of platinum and palladium complexes as narrow-band phosphorescent emitters for full color displays
US9698359B2 (en) 2011-05-26 2017-07-04 Arizona Board Of Regents, Acting For And On Behalf Of Arizona State University Synthesis of platinum and palladium complexes as narrow-band phosphorescent emitters for full color displays
US11121328B2 (en) 2011-05-26 2021-09-14 Arizona Board Of Regents On Behalf Of Arizona State University Synthesis of platinum and palladium complexes as narrow-band phosphorescent emitters for full color displays
US9238668B2 (en) 2011-05-26 2016-01-19 Arizona Board Of Regents, Acting For And On Behalf Of Arizona State University Synthesis of platinum and palladium complexes as narrow-band phosphorescent emitters for full color displays
US9711741B2 (en) 2012-08-24 2017-07-18 Arizona Board Of Regents On Behalf Of Arizona State University Metal compounds and methods and uses thereof
US11114626B2 (en) 2012-09-24 2021-09-07 Arizona Board Of Regents On Behalf Of Arizona State University Metal compounds, methods, and uses thereof
US9882150B2 (en) 2012-09-24 2018-01-30 Arizona Board Of Regents For And On Behalf Of Arizona State University Metal compounds, methods, and uses thereof
US12232411B2 (en) 2012-09-24 2025-02-18 Arizona Board Of Regents On Behalf Of Arizona State University Metal compounds, methods, and uses thereof
US12043633B2 (en) 2012-10-26 2024-07-23 Arizona Board Of Regents On Behalf Of Arizona State University Metal complexes, methods, and uses thereof
US10995108B2 (en) 2012-10-26 2021-05-04 Arizona Board Of Regents On Behalf Of Arizona State University Metal complexes, methods, and uses thereof
US9899614B2 (en) 2013-06-10 2018-02-20 Arizona Board Of Regents On Behalf Of Arizona State University Phosphorescent tetradentate metal complexes having modified emission spectra
US9673409B2 (en) 2013-06-10 2017-06-06 Arizona Board Of Regents On Behalf Of Arizona State University Phosphorescent tetradentate metal complexes having modified emission spectra
US10211414B2 (en) 2013-06-10 2019-02-19 Arizona Board Of Regents On Behalf Of Arizona State University Phosphorescent tetradentate metal complexes having modified emission spectra
US12167676B2 (en) 2013-10-14 2024-12-10 Arizona Board Of Regents On Behalf Of Arizona State University Platinum complexes and devices
US9385329B2 (en) 2013-10-14 2016-07-05 Arizona Board of Regents on behalf of Arizona State University and Universal Display Corporation Platinum complexes and devices
US9947881B2 (en) 2013-10-14 2018-04-17 Arizona Board Of Regents On Behalf Of Arizona State University Platinum complexes and devices
US11189808B2 (en) 2013-10-14 2021-11-30 Arizona Board Of Regents On Behalf Of Arizona State University Platinum complexes and devices
US9224963B2 (en) 2013-12-09 2015-12-29 Arizona Board Of Regents On Behalf Of Arizona State University Stable emitters
US11930698B2 (en) 2014-01-07 2024-03-12 Arizona Board Of Regents On Behalf Of Arizona State University Tetradentate platinum and palladium complex emitters containing phenyl-pyrazole and its analogues
US10020455B2 (en) 2014-01-07 2018-07-10 Arizona Board Of Regents On Behalf Of Arizona State University Tetradentate platinum and palladium complex emitters containing phenyl-pyrazole and its analogues
US10937976B2 (en) 2014-01-07 2021-03-02 Arizona Board Of Regents On Behalf Of Arizona State University Tetradentate platinum and palladium complex emitters containing phenyl-pyrazole and its analogues
US10056567B2 (en) 2014-02-28 2018-08-21 Arizona Board Of Regents On Behalf Of Arizona State University Chiral metal complexes as emitters for organic polarized electroluminescent devices
US11839144B2 (en) 2014-06-02 2023-12-05 Arizona Board Of Regents On Behalf Of Arizona State University Tetradentate cyclometalated platinum complexes containing 9,10-dihydroacridine and its analogues
US11011712B2 (en) 2014-06-02 2021-05-18 Arizona Board Of Regents On Behalf Of Arizona State University Tetradentate cyclometalated platinum complexes containing 9,10-dihydroacridine and its analogues
US9941479B2 (en) 2014-06-02 2018-04-10 Arizona Board Of Regents On Behalf Of Arizona State University Tetradentate cyclometalated platinum complexes containing 9,10-dihydroacridine and its analogues
US10886478B2 (en) 2014-07-24 2021-01-05 Arizona Board Of Regents On Behalf Of Arizona State University Tetradentate platinum (II) complexes cyclometalated with functionalized phenyl carbene ligands and their analogues
US12082486B2 (en) 2014-07-24 2024-09-03 Arizona Board Of Regents On Behalf Of Arizona State University Tetradentate platinum (II) complexes cyclometalated with functionalized phenyl carbene ligands and their analogues
US9923155B2 (en) 2014-07-24 2018-03-20 Arizona Board Of Regents On Behalf Of Arizona State University Tetradentate platinum (II) complexes cyclometalated with functionalized phenyl carbene ligands and their analogues
US10964897B2 (en) 2014-07-28 2021-03-30 Arizona Board Of Regents On Behalf Of Arizona State University Tridentate cyclometalated metal complexes with six-membered coordination rings
US10790457B2 (en) 2014-07-29 2020-09-29 Arizona Board Of Regents On Behalf Of Arizona State University Metal-assisted delayed fluorescent emitters containing tridentate ligands
US11145830B2 (en) 2014-07-29 2021-10-12 Arizona Board Of Regents On Behalf Of Arizona State University Metal-assisted delayed fluorescent emitters containing tridentate ligands
US12082488B2 (en) 2014-07-29 2024-09-03 Arizona Board Of Regents On Behalf Of Arizona State University Metal-assisted delayed fluorescent emitters containing tridentate ligands
US9818959B2 (en) 2014-07-29 2017-11-14 Arizona Board of Regents on behlaf of Arizona State University Metal-assisted delayed fluorescent emitters containing tridentate ligands
US12043611B2 (en) 2014-08-15 2024-07-23 Arizona Board Of Regents On Behalf Of Arizona State University Non-platinum metal complexes for excimer based single dopant white organic light emitting diodes
US10793546B2 (en) 2014-08-15 2020-10-06 Arizona Board Of Regents On Behalf Of Arizona State University Non-platinum metal complexes for excimer based single dopant white organic light emitting diodes
US11329244B2 (en) 2014-08-22 2022-05-10 Arizona Board Of Regents On Behalf Of Arizona State University Organic light-emitting diodes with fluorescent and phosphorescent emitters
US9920242B2 (en) 2014-08-22 2018-03-20 Arizona Board Of Regents On Behalf Of Arizona State University Metal-assisted delayed fluorescent materials as co-host materials for fluorescent OLEDs
US10745615B2 (en) 2014-08-22 2020-08-18 Arizona Board Of Regents On Behalf Of Arizona State University Metal-assisted delayed fluorescent materials as co-host materials for fluorescent OLEDs
US11339324B2 (en) 2014-08-22 2022-05-24 Arizona Board Of Regents On Behalf Of Arizona State University Metal-assisted delayed fluorescent materials as co-host materials for fluorescent OLEDs
US11795387B2 (en) 2014-08-22 2023-10-24 Arizona Board Of Regents On Behalf Of Arizona State University Metal-assisted delayed fluorescent materials as co-host materials for fluorescent OLEDs
US12221573B2 (en) 2014-08-22 2025-02-11 Arizona Board Of Regents On Behalf Of Arizona State University Metal-assisted delayed fluorescent materials as co-host materials for fluorescent OLEDs
US10944064B2 (en) 2014-11-10 2021-03-09 Arizona Board Of Regents On Behalf Of Arizona State University Tetradentate metal complexes with carbon group bridging ligands
US10991897B2 (en) 2014-11-10 2021-04-27 Arizona Board Of Regents On Behalf Of Arizona State University Emitters based on octahedral metal complexes
US11856840B2 (en) 2014-11-10 2023-12-26 Arizona Board Of Regents On Behalf Of Arizona State University Emitters based on octahedral metal complexes
US10033003B2 (en) 2014-11-10 2018-07-24 Arizona Board Of Regents On Behalf Of Arizona State University Tetradentate metal complexes with carbon group bridging ligands
US11653560B2 (en) 2014-11-10 2023-05-16 Arizona Board Of Regents On Behalf Of Arizona State University Tetradentate metal complexes with carbon group bridging ligands
US10056564B2 (en) 2015-06-02 2018-08-21 Arizona Board Of Regents On Behalf Of Arizona State University Tetradentate metal complexes containing indoloacridine and its analogues
US9711739B2 (en) 2015-06-02 2017-07-18 Arizona Board Of Regents On Behalf Of Arizona State University Tetradentate metal complexes containing indoloacridine and its analogues
US10836785B2 (en) 2015-06-03 2020-11-17 Arizona Board Of Regents On Behalf Of Arizona State University Tetradentate and octahedral metal complexes containing naphthyridinocarbazole and its analogues
US9879039B2 (en) 2015-06-03 2018-01-30 Arizona Board Of Regents On Behalf Of Arizona State University Tetradentate and octahedral metal complexes containing naphthyridinocarbazole and its analogues
US9617291B2 (en) 2015-06-03 2017-04-11 Arizona Board Of Regents On Behalf Of Arizona State University Tetradentate and octahedral metal complexes containing naphthyridinocarbazole and its analogues
US11472827B2 (en) 2015-06-03 2022-10-18 Arizona Board Of Regents On Behalf Of Arizona State University Tetradentate and octahedral metal complexes containing naphthyridinocarbazole and its analogues
US10158091B2 (en) 2015-08-04 2018-12-18 Arizona Board Of Regents On Behalf Of Arizona State University Tetradentate platinum (II) and palladium (II) complexes, devices, and uses thereof
US10930865B2 (en) 2015-08-04 2021-02-23 Arizona Board Of Regents On Behalf Of Arizona State University Tetradentate platinum (II) and palladium (II) complexes, devices, and uses thereof
US11335865B2 (en) 2016-04-15 2022-05-17 Arizona Board Of Regents On Behalf Of Arizona State University OLED with multi-emissive material layer
US10177323B2 (en) 2016-08-22 2019-01-08 Arizona Board Of Regents On Behalf Of Arizona State University Tetradentate platinum (II) and palladium (II) complexes and octahedral iridium complexes employing azepine functional groups and their analogues
US10822363B2 (en) 2016-10-12 2020-11-03 Arizona Board Of Regents On Behalf Of Arizona State University Narrow band red phosphorescent tetradentate platinum (II) complexes
US11183670B2 (en) 2016-12-16 2021-11-23 Arizona Board Of Regents On Behalf Of Arizona State University Organic light emitting diode with split emissive layer
US11708385B2 (en) 2017-01-27 2023-07-25 Arizona Board Of Regents On Behalf Of Arizona State University Metal-assisted delayed fluorescent emitters employing pyrido-pyrrolo-acridine and analogues
US11063228B2 (en) 2017-05-19 2021-07-13 Arizona Board Of Regents On Behalf Of Arizona State University Metal-assisted delayed fluorescent emitters employing benzo-imidazo-phenanthridine and analogues
US11101435B2 (en) 2017-05-19 2021-08-24 Arizona Board Of Regents On Behalf Of Arizona State University Tetradentate platinum and palladium complexes based on biscarbazole and analogues
US11974495B2 (en) 2017-05-19 2024-04-30 Arizona Board Of Regents On Behalf Of Arizona State University Tetradentate platinum and palladium complexes based on biscarbazole and analogues
US12010908B2 (en) 2017-05-19 2024-06-11 Arizona Board Of Regents On Behalf Of Arizona State University Metal-assisted delayed fluorescent emitters employing benzo-imidazo-phenanthridine and analogues
US11594688B2 (en) 2017-10-17 2023-02-28 Arizona Board Of Regents On Behalf Of Arizona State University Display and lighting devices comprising phosphorescent excimers with preferred molecular orientation as monochromatic emitters
US12120945B2 (en) 2017-10-17 2024-10-15 Arizona Board Of Regents On Behalf Of Arizona State University Display and lighting devices comprising phosphorescent excimers with preferred molecular orientation as monochromatic emitters
US11647643B2 (en) 2017-10-17 2023-05-09 Arizona Board Of Regents On Behalf Of Arizona State University Hole-blocking materials for organic light emitting diodes
US12037348B2 (en) 2018-03-09 2024-07-16 Arizona Board Of Regents On Behalf Of Arizona State University Blue and narrow band green and red emitting metal complexes
US12091429B2 (en) 2018-07-16 2024-09-17 Arizona Board Of Regents On Behalf Of Arizona State University Fluorinated porphyrin derivatives for optoelectronic applications
US11878988B2 (en) 2019-01-24 2024-01-23 Arizona Board Of Regents On Behalf Of Arizona State University Blue phosphorescent emitters employing functionalized imidazophenthridine and analogues
US12082490B2 (en) 2019-01-25 2024-09-03 Arizona Board Of Regents On Behalf Of Arizona State University Light outcoupling efficiency of phosphorescent OLEDs by mixing horizontally aligned fluorescent emitters
US11594691B2 (en) 2019-01-25 2023-02-28 Arizona Board Of Regents On Behalf Of Arizona State University Light outcoupling efficiency of phosphorescent OLEDs by mixing horizontally aligned fluorescent emitters
US11785838B2 (en) 2019-10-02 2023-10-10 Arizona Board Of Regents On Behalf Of Arizona State University Green and red organic light-emitting diodes employing excimer emitters
US12120946B2 (en) 2019-10-02 2024-10-15 Arizona Board Of Regents On Behalf Of Arizona State University Green and red organic light-emitting diodes employing excimer emitters
US11945985B2 (en) 2020-05-19 2024-04-02 Arizona Board Of Regents On Behalf Of Arizona State University Metal assisted delayed fluorescent emitters for organic light-emitting diodes

Also Published As

Publication number Publication date
JP2007186490A (en) 2007-07-26
TW200736222A (en) 2007-10-01

Similar Documents

Publication Publication Date Title
WO2007069498A1 (en) Compound for electroluminescent device and method for producing same
Hei et al. Blending ionic and coordinate bonds in hybrid semiconductor materials: a general approach toward robust and solution-processable covalent/coordinate network structures
KR101554354B1 (en) Phenyl-substituted 1,3,5-triazine compound
US7883785B2 (en) Rhodium and iridium complexes
KR102003090B1 (en) Cyclic azine compound having nitrogen-containing fused aromatic group, method for producing same, and organic electroluminescent element using same as constituent component
KR101761431B1 (en) Cyclic azine derivatives, processes for producing these, and organic electroluminescent element containing these as component
JP5261887B2 (en) Monoamine compound, charge transport material, and organic electroluminescence device
JP5761907B2 (en) 1,3,5-triazine derivative, method for producing the same, and organic electroluminescent device comprising them as constituent components
JP5898950B2 (en) 1,3,5-triazine compound, method for producing the same, and organic electroluminescent device comprising them as constituent components
JP2011063584A (en) Triazine derivative, method for producing the same and organic electroluminescent element comprising the same as constituent component
KR102365498B1 (en) Triazine compound and method for producing same
WO2005104628A1 (en) Organic electroluminescent element and manufacturing method thereof, organic compound containing phosphorus and manufacturing method thereof
Kobayashi et al. Quantitative solvent-free thermal synthesis of luminescent Cu (I) coordination polymers
WO2007023840A1 (en) 1,3,5-triazine derivative, method for producing same, and organic electroluminescent device containing same as component
CN104370974A (en) Iridium complex taking nitrogen heterocyclic carbenes as second primary ligand and preparation method of said iridium complex
CN106573940B (en) Diketopyrrolopyrrole semiconducting material and its preparation method and application
TW201202199A (en) Electron transportation material and organic electroluminescent device using the same
JP2009286716A (en) Iridium complex
Cappuccino et al. Mechanochemistry, an easy technique to boost the synthesis of cui pyrazine coordination polymers
US10672999B2 (en) Gold complexes for OLED applications
Nguyen et al. Gold (I) and platinum (II) tetracenes and tetracenyldiacetylides: structural and fluorescence color changes induced by σ-metalation
TW201113255A (en) Material selecting method upon purifying iridium complex by sublimation
JP2008266262A (en) Method for producing bisanthracene-based compound, bisanthracene-based compound, derivative of bisanthracene-based compound and compositom thereof, organic electroluminescent device and light-emitting display
JP5660777B2 (en) Cyclic azine derivative, method for producing the same, and organic electroluminescent device comprising the same
JP6007491B2 (en) 1,2,4,5-Substituted phenyl derivative, method for producing the same, and organic electroluminescent device

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06833998

Country of ref document: EP

Kind code of ref document: A1

点击 这是indexloc提供的php浏览器服务,不要输入任何密码和下载